<SEC-DOCUMENT>0001558370-21-015431.txt : 20211110
<SEC-HEADER>0001558370-21-015431.hdr.sgml : 20211110
<ACCEPTANCE-DATETIME>20211110120138
ACCESSION NUMBER:		0001558370-21-015431
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		20
CONFORMED PERIOD OF REPORT:	20211110
FILED AS OF DATE:		20211110
DATE AS OF CHANGE:		20211110

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GENMAB A/S
		CENTRAL INDEX KEY:			0001434265
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38976
		FILM NUMBER:		211395463

	BUSINESS ADDRESS:	
		STREET 1:		TOLDBODGADE 33
		CITY:			1253 COPENHAGEN K
		STATE:			G7
		ZIP:			00000

	MAIL ADDRESS:	
		STREET 1:		TOLDBODGADE 33
		CITY:			1253 COPENHAGEN K
		STATE:			G7
		ZIP:			00000
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>tmb-20211110x6k.htm
<DESCRIPTION>6-K
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  9.11.0.85--><!--Created on: 11/10/2021 04:58:04 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:1pt;padding-top:1pt;text-align:center;text-indent:0pt;border-bottom:1.0pt solid #000000;border-top:3.0pt solid #000000;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:1pt;font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:6pt;font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-size:18pt;font-weight:bold;">UNITED STATES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-size:18pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">Washington,&#160;D.C. 20549</b></p><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><hr noshade="true" color="#000000" size="1" width="25.0%" style="background-color:#000000;color:#000000;height:1pt;position:relative;top:0.6em;border:none;margin:0 auto;" align="center"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-size:18pt;font-weight:bold;"><font style="display:inline-block;visibility:hidden;width:0pt;">&#8203;</font><br></b><b style="font-family:'Arial','Helvetica','sans-serif';font-size:18pt;font-weight:bold;">FORM&#160;6-K</b></p><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><hr noshade="true" color="#000000" size="1" width="25.0%" style="background-color:#000000;color:#000000;height:1pt;position:relative;top:0.6em;border:none;margin:0 auto;" align="center"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE&#160;13a-16 OR&#160;15d-16</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">OF THE SECURITIES EXCHANGE ACT OF 1934</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">FOR THE&#160;MONTH OF NOVEMBER 2021</b></p><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><hr noshade="true" color="#000000" size="1" width="25.0%" style="background-color:#000000;color:#000000;height:1pt;position:relative;top:0.6em;border:none;margin:0 auto;" align="center"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;white-space:pre-wrap;">COMMISSION FILE NUMBER 001-38976  </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-size:18pt;font-weight:bold;">Genmab A/S<br></b><font style="background-color:#ffffff;color:#333333;font-family:'Arial','Helvetica','sans-serif';font-size:9.5pt;">(Exact name of Registrant as specified in its charter)</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">Kalvebod Brygge 43</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">1560 Copenhagen V</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">Denmark</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;">+45 70 20 27 28<br></b><font style="background-color:#ffffff;color:#333333;font-family:'Arial','Helvetica','sans-serif';font-size:9.5pt;">(Address of principal executive offices)</font></p><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><hr noshade="true" color="#000000" size="1" width="25.0%" style="background-color:#000000;color:#000000;height:1pt;position:relative;top:0.6em;border:none;margin:0 auto;" align="center"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">Indicate by check mark whether the registrant files or will file annual reports under cover Form&#160;20-F or&#160;Form&#160;40-F.</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;">Form&#160;20-F&#160;</font><font style="font-family:'Times New Roman';">&#8999;</font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;white-space:pre-wrap;">      Form&#160;40-F&#160;</font><font style="font-family:'Times New Roman';font-size:10pt;">&#9723;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">Indicate by check mark if the registrant is submitting the Form&#160;6-K in paper as permitted by Regulation&#160;S-T Rule&#160;101(b)(1)</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;">Yes&#160;</font><font style="font-family:'Times New Roman';font-size:10pt;">&#9723;</font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;white-space:pre-wrap;">      No&#160;</font><font style="font-family:'Times New Roman';">&#8999;</font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;white-space:pre-wrap;">  </font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">Indicate by check mark if the registrant is submitting the Form&#160;6-K in paper as permitted by Regulation&#160;S-T Rule&#160;101(b)(7)</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;">Yes&#160;</font><font style="font-family:'Times New Roman';font-size:10pt;">&#9723;</font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;white-space:pre-wrap;">      No&#160;</font><font style="font-family:'Times New Roman';">&#8999;</font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;white-space:pre-wrap;">  </font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="background-color:#ffffff;">Exhibit 99.1 to this report on Form&#160;6-K&#160;shall be deemed to be&#160;</font>incorporated by reference<font style="background-color:#ffffff;">&#160;in Genmab A/S&#8217;s registration statement on&#160;</font><font style="background-color:#ffffff;">Form&#160;S-8</font><font style="background-color:#ffffff;">&#160;(File&#160;No.&#160;333-232693)&#160;and in the outstanding prospectus contained in such registration statement. </font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:6pt;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:1pt;padding-top:1pt;text-align:center;text-indent:0pt;border-bottom:3.0pt solid #000000;border-top:1.0pt solid #000000;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</font></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:0pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">SIGNATURE</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;" align="center"><tr style="height:1pt;"><td style="vertical-align:bottom;width:50.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:3.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:45.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:50.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:bottom;width:49%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">GENMAB A/S</font></p></td></tr><tr><td style="vertical-align:bottom;width:50.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:3.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:45.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:50.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:3.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">BY:</font></p></td><td style="vertical-align:bottom;width:45.3%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">/s/ Anthony Pagano</font></p></td></tr><tr><td style="vertical-align:bottom;width:50.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:3.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:45.3%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">Name: Anthony Pagano</font></p></td></tr><tr><td style="vertical-align:bottom;width:50.99%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:3.69%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:45.3%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">Title: Executive Vice President &amp; Chief Financial Officer</font></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">DATE: November 10, 2021 </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">EXHIBIT&#160;INDEX</b></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;table-layout:auto;width:96.42%;" align="center"><tr style="height:1pt;"><td style="vertical-align:top;width:10.98%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">A</b></p></div></div></td><td style="vertical-align:top;width:89.01%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:10.98%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;margin:0pt;"><u style="font-family:'Arial','Helvetica','sans-serif';text-decoration:underline;text-decoration-color:#000000;">Exhibit</u></p></td><td style="vertical-align:top;width:89.01%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;margin:0pt;"><u style="font-family:'Arial','Helvetica','sans-serif';text-decoration:underline;text-decoration-color:#000000;">Description of Exhibit</u></p></td></tr><tr><td style="vertical-align:top;width:10.98%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:89.01%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:10.98%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';">99.1</font></p></td><td style="vertical-align:top;width:89.01%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';white-space:pre-wrap;">Interim Report Dated November 10, 2021    &#160;</font></p></td></tr><tr><td style="vertical-align:top;width:10.98%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:89.01%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:10.98%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:89.01%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:10.98%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:89.01%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:10.98%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:89.01%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:10.98%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:89.01%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:10.98%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:12.0pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:89.01%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';visibility:hidden;">&#8203;</font></p></td></tr></table></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:avoid;width:79.3%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>tmb-20211110xex99d1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  9.11.0.85--><!--Created on: 11/10/2021 04:58:16 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title>Interim Report for the 6 months ended June 30, 2011</title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">Exhibit 99.1</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20211110xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Genmab Announces Financial Results for the First Nine Months of 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;padding-left:36pt;text-indent:-36pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">November 10, 2021; Copenhagen, Denmark; </b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Interim Report for the First Nine Months Ended September 30, 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Highlights</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:bold;text-align:left;">The U.S. Food and Drug Administration (U.S. FDA) granted Genmab and Seagen Inc. (Seagen) accelerated Approval for TIVDAK&#8482; (tisotumab vedotin-tftv) for patients with recurrent or metastatic cervical cancer</b></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:bold;text-align:left;">DARZALEX</b><sup style="font-family:'Arial','Helvetica','sans-serif';font-size:7.5pt;font-style:normal;font-weight:bold;text-align:left;vertical-align:top;">&#174;</sup><b style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:bold;text-align:left;"> net sales as reported by Johnson &amp; Johnson increased 49% compared to the first nine months of 2020 to USD 4,378 million, resulting in royalty income of DKK 4,167 million</b></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:bold;text-align:left;">Genmab improves its 2021 financial guidance</b></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a name="_Hlk12956096"></a>&#8220;The U.S. FDA approval for TIVDAK represents an important milestone both for the treatment of cervical cancer as well as for Genmab as a company,&#8221; said Jan van de Winkel, Ph.D., Chief Executive Officer of Genmab. &#8220;TIVDAK is the first and only approved antibody-drug conjugate (ADC) for adult patients with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy, providing a new treatment option for patients impacted by this devastating disease. The decision by the U.S. FDA also marks the first regulatory approval for an ADC combining Genmab&#8217;s antibody with Seagen&#8217;s ADC technology and is the first approval for any therapy owned at least 50% by Genmab. This achievement was only possible because of the efforts of our dedicated and talented team, the excellent collaboration with our partner for TIVDAK, Seagen, and the patients, families and caregivers as well as the nurses, physicians and study teams who participated in our clinical trials.&#8221;</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Financial Performance First Nine Months of 2021</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Net sales of DARZALEX by Janssen Biotech Inc. (Janssen) were USD 4,378 million in the first nine months of 2021 compared to USD 2,937 million in the first nine months of 2020, an increase of USD 1,441 million, or 49%.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Royalty revenue was DKK 4,698 million in the first nine months of 2021 compared to DKK 3,090 million in the first nine months of 2020, an increase of DKK 1,608 million, or 52%. The increase was driven by higher net sales of DARZALEX, TEPEZZA</font><sup style="font-family:'Arial','Helvetica','sans-serif';font-size:7.5pt;font-style:normal;font-weight:normal;text-align:left;vertical-align:top;">&#174;</sup><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;"> and Kesimpta</font><sup style="font-family:'Arial','Helvetica','sans-serif';font-size:7.5pt;font-style:normal;font-weight:normal;text-align:left;vertical-align:top;">&#174;</sup><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;"> resulting in higher royalties.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Total revenue was DKK 5,863 million in the first nine months of 2021. </font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;"><a name="_Hlk527456255"></a></font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">In addition to the royalty revenue described above, Genmab also recognized DKK 794 million of milestone revenue during the first nine months of 2021. Revenue for the first nine months of 2020 was DKK 8,067 million and included the one-time upfront payment of DKK 4,398 million recognized as license revenue from AbbVie Inc. (AbbVie) pursuant to our collaboration announced in June 2020.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;"><a name="_Hlk527456303"></a></font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Operating expenses were DKK 3,654 million in the first nine months of 2021 compared to DKK 2,641 million in the first nine months of 2020. The increase of DKK 1,013 million, or 38%, was driven by the continued advancement of multiple pipeline projects, the increase in </font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">new employees to support the launch of TIVDAK and </font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">expansion of our product pipeline</font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">, as well as the continued development of commercialization capabilities and Genmab&#8217;s broader organizational infrastructure.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;"><a name="OLE_LINK13"></a><a name="OLE_LINK14"></a></font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Operating result was DKK 2,209 million in the first nine months of 2021 compared to DKK 5,426 million in the first nine months of 2020. The decrease of DKK 3,217 million, or 59%, was driven by lower revenue as a result of the non-recurring license revenue in 2020 associated with the upfront payment from AbbVie and increased operating expenses.</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 67</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 1/38</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20211110xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Genmab Announces Financial Results for the First Nine Months of 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Outlook</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">As announced in Company Announcement No. 66, Genmab is improving its 2021 financial guidance published on August 11, 2021, driven primarily by increased royalty revenue related to the net sales of DARZALEX.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:54.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:54.78%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><font style="font-weight:bold;margin-left:0pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Revised</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Previous</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:54.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><b style="font-weight:bold;">(DKK million)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Guidance</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Guidance</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:54.78%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">7,900 - 8,500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">7,300 - 7,900</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:54.78%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Operating expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">(5,300) - (5,600)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">(5,500) - (5,800)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:54.78%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Operating result</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">2,300 - 3,200</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">1,500 - 2,400</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Conference Call</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Genmab will hold a conference call in English to discuss the results for the first nine months of 2021 today, Wednesday, November 10, at 6:00 pm CET, 5:00 pm GMT or 12:00 pm EST. To join the call dial </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a name="OLE_LINK3"></a><a name="OLE_LINK4"></a>+1 631 913 1422 (U.S. participants) or +44 3333000804 (international participants) and provide conference code 90392669.<br><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">A live and archived webcast of the call and relevant slides will be available at www.genmab.com/investors.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Contact:</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Marisol Peron, Senior Vice President, Global Investor Relations and Communications </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">T: +1 609 524 0065; E: mmp@genmab.com</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">For Investor Relations: </b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Andrew Carlsen, Vice President, Head of Investor Relations</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">T: +45 3377 9558; E: acn@genmab.com<font style="white-space:pre-wrap;">  </font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="display:none;line-height:0pt;margin:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:0pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 67</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 2/38</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20211110xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months Ended September 30, 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;padding-left:18pt;text-indent:-18pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">CONTENTS</b></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;" align="center"><tr style="height:1pt;"><td style="vertical-align:top;width:96.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:3.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:96.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 5pt 0pt;"><b style="color:#029c93;font-weight:bold;">MANAGEMENT&#8217;S REVIEW</b></p></td><td style="vertical-align:top;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 0pt 5pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:96.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 5pt 0pt;"><a href="#CONSOLIDATEDKEYFIGURES_439617"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;line-height:1.27;text-align:left;">CONSOLIDATED KEY FIGURES</font></a></p></td><td style="vertical-align:top;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 0pt 5pt 0pt;">4</p></td></tr><tr><td style="vertical-align:top;width:96.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 5pt 0pt;"><a href="#OUTLOOK_182548"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;line-height:1.27;text-align:left;">OUTLOOK</font></a></p></td><td style="vertical-align:top;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 0pt 5pt 0pt;">5</p></td></tr><tr><td style="vertical-align:top;width:96.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 5pt 0pt;"><a href="#KEY2019PRIORITIES_328557"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;line-height:1.27;text-align:left;">KEY 2021 PRIORITIES</font></a></p></td><td style="vertical-align:top;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 0pt 5pt 0pt;">6</p></td></tr><tr><td style="vertical-align:top;width:96.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 5pt 0pt;"><a href="#PRODUCTPIPELINE_603298"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;line-height:1.27;text-align:left;">PRODUCT PIPELINE</font></a> <a href="#PRODUCTPIPELINE_603298"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;line-height:1.27;text-align:left;">AND TECHNOLOGY PROGRESS FIRST NINE MONTHS OF 2021</font></a></p></td><td style="vertical-align:top;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 0pt 5pt 0pt;">6</p></td></tr><tr><td style="vertical-align:top;width:96.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 5pt 0pt;"><a href="#_SIGNIFICANT_RISKS_AND"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;line-height:1.27;text-align:left;">SIGNIFICANT RISKS AND UNCERTAINTIES</font></a></p></td><td style="vertical-align:top;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 0pt 5pt 0pt;">16</p></td></tr><tr><td style="vertical-align:top;width:96.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 5pt 0pt;"><a href="#FINANCIALREVIEW_601130"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;line-height:1.27;text-align:left;">FINANCIAL REVIEW</font></a></p></td><td style="vertical-align:top;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 0pt 5pt 0pt;">17</p></td></tr><tr><td style="vertical-align:top;width:96.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 5pt 0pt;"><b style="color:#029c93;font-weight:bold;">FINANCIAL STATEMENTS</b></p></td><td style="vertical-align:top;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 0pt 5pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:96.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 5pt 0pt;"><a href="#STATEMENTOFCOMPREHENSIVEINCOMEFORTHE3RDQ"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;line-height:1.27;text-align:left;">STATEMENT OF COMPREHENSIVE INCOME FOR THE 3RD QUARTER OF 2021</font></a></p></td><td style="vertical-align:top;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 0pt 5pt 0pt;">22</p></td></tr><tr><td style="vertical-align:top;width:96.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 5pt 0pt;"><a href="#STATEMENTOFCOMPREHENSIVEINCOMEFORTHEFIRS"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;line-height:1.27;text-align:left;">STATEMENT OF COMPREHENSIVE INCOME FOR THE FIRST NINE MONTHS OF 2021</font></a></p></td><td style="vertical-align:top;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 0pt 5pt 0pt;">23</p></td></tr><tr><td style="vertical-align:top;width:96.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 5pt 0pt;"><a href="#BALANCESHEET_757698"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;line-height:1.27;text-align:left;">BALANCE SHEET AS OF SEPTEMBER 30, 2021</font></a> </p></td><td style="vertical-align:top;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 0pt 5pt 0pt;">24</p></td></tr><tr><td style="vertical-align:top;width:96.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 5pt 0pt;"><a href="#STATEMENTOFCASHFLOWS_489627"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;line-height:1.27;text-align:left;">STATEMENT OF CASH FLOWS FOR THE FIRST NINE MONTHS OF 2021</font></a></p></td><td style="vertical-align:top;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 0pt 5pt 0pt;">25</p></td></tr><tr><td style="vertical-align:top;width:96.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 5pt 0pt;"><a href="#STATEMENTOFCHANGESINEQUITY_43137"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;line-height:1.27;text-align:left;">STATEMENT OF CHANGES IN EQUITY FOR THE FIRST NINE MONTHS OF 2021</font></a></p></td><td style="vertical-align:top;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 0pt 5pt 0pt;">26</p></td></tr><tr><td style="vertical-align:top;width:96.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;margin:0pt 0pt 5pt 0pt;"><a href="#NOTESTOTHEFINANCIALSTATEMENTS_435403"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;line-height:1.27;text-align:left;">NOTES&#160;TO THE FINANCIAL STATEMENTS</font></a></p></td><td style="vertical-align:top;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 0pt 5pt 0pt;">27</p></td></tr><tr><td style="vertical-align:top;width:96.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a style="color:#029c93;" href="#ABOUTGENMAB_556806"><b style="color:#029c93;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:bold;text-align:left;">ABOUT GENMAB</b></a></p></td><td style="vertical-align:top;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 0pt 5pt 0pt;">37</p></td></tr><tr><td style="vertical-align:top;width:96.17%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a style="color:#029c93;" href="#DIRECTORSANDMANAGEMENTSSTATEMENTONTHEINT"><b style="color:#029c93;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:bold;text-align:left;">DIRECTORS&#8217; AND MANAGEMENT&#8217;S STATEMENT ON THE INTERIM REPORT</b></a></p></td><td style="vertical-align:top;width:3.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;line-height:1.27;text-align:right;margin:0pt 0pt 5pt 0pt;">38</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 67</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 3/38</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20211110xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months Ended September 30, 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;font-weight:bold;padding-left:21.6pt;text-indent:-21.6pt;margin:0pt 0pt 3pt 0pt;"><b style="color:#029c93;font-weight:bold;">CONSOLIDATED KEY FIGURES</b><b style="font-size:16pt;font-weight:bold;"><a name="_MON_1428392831"></a></b><b style="color:#339966;font-weight:bold;white-space:pre-wrap;">   </b><b style="font-size:16pt;font-weight:bold;"><a name="CONSOLIDATEDKEYFIGURES_439617"></a></b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:36.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:36.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:center;margin:0pt;">3rd Quarter of</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:center;margin:0pt;">3rd Quarter of</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.55%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:center;margin:0pt;">9 Months Ended</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.55%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:center;margin:0pt;">9 Months Ended</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:9.72%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:center;margin:0pt;">Full Year</p></td></tr><tr><td style="vertical-align:bottom;width:36.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:9.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:center;margin:0pt;">2021</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:center;margin:0pt;">2020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:center;margin:0pt;">September 30,&#160;2021</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:center;margin:0pt;">September 30,&#160;2020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:9.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:center;margin:0pt;">2020</p></td></tr><tr><td style="vertical-align:bottom;width:36.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">(DKK million)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.55%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.55%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:8.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:36.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">Income Statement</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:9.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:8.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:36.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,310</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,724</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.55%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 5,863</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.55%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 8,067</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:8.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 10,111</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:36.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Research and development expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (1,114)</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (721)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.55%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (2,883)</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.55%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (2,211)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:8.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (3,137)</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:36.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Selling, general and administrative expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (306)</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (145)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.55%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (771)</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.55%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (430)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:8.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (661)</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:36.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Operating expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (1,420)</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (866)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.55%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (3,654)</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.55%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (2,641)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:8.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (3,798)</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:36.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Operating result</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 890</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 858</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.55%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,209</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.55%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 5,426</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:8.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 6,313</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:36.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Net financial items</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 281</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (187)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.55%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 808</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.55%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (73)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:8.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (409)</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:36.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Net result</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:9.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 890</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 530</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,292</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 4,177</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:8.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 4,758</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:36.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.55%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.55%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:8.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:36.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">Balance Sheet</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:9.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:8.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:36.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Marketable securities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 10,014</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 8,577</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.55%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 10,014</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.55%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 8,577</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:8.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 8,819</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:36.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Cash and cash equivalents</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 8,729</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 8,892</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.55%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 8,729</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.55%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 8,892</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:8.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 7,260</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:36.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Total non-current assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,031</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,018</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.55%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,031</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.55%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,018</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:8.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,352</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:36.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Total assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 23,985</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 21,522</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.55%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 23,985</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.55%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 21,522</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:8.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 21,143</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:36.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Shareholders&#39; equity</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 21,285</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 18,477</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.55%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 21,285</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.55%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 18,477</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:8.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 19,121</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:36.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Share capital</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:9.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 66</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 65</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 66</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 65</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:8.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 66</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:36.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.55%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.55%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:8.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:36.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">Cash Flow Statement</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:9.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:8.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:36.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Cash flow from operating activities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 447</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 5,078</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.55%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,987</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.55%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 7,231</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:8.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 6,433</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:36.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Cash flow from investing activities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (1,621)</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (2,565)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.55%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (655)</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.55%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (1,637)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:8.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (2,351)</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:36.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Cash flow from financing activities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 24</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 19</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.55%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (436)</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.55%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 38</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:8.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 71</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:36.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Investment in tangible assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:9.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (77)</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (46)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (184)</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (249)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:8.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (307)</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:36.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.55%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.55%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:8.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:36.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;"><b style="font-weight:bold;">Financial Ratios</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:9.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:8.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:36.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Basic net result per share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 13.61</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 8.13</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.55%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 35.05</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.55%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 64.16</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:8.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 73.00</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:36.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Diluted net result per share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 13.47</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 8.04</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.55%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 34.72</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.55%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 63.46</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:8.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 72.21</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:36.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Period-end share market price</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,809</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,300</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.55%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,809</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.55%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,300</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:8.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,463</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:36.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Price / book value</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 8.71</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 8.09</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.55%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 8.71</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.55%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 8.09</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:8.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 8.50</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:36.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Shareholders&#39; equity per share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 322.50</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 284.26</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.55%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 322.50</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.55%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 284.26</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:8.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 289.71</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:36.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Equity ratio</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 89</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 86</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.55%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 89</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.55%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 86</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:8.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 90</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:36.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Shares outstanding</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 65,685,053</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 65,498,346</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.55%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 65,685,053</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.55%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 65,498,346</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:8.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 65,545,748</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:36.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Average number of employees (FTE*)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,089</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 683</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.55%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 967</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.81%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.55%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;">622</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:8.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 656</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:36.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">Number of employees at the end of the period</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:9.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,136</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.83%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 712</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,136</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.81%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.55%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;">712</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:8.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;text-align:right;margin:0pt 2.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 781</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:1.33%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7pt;visibility:hidden;">&#8203;</font></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;"><font style="white-space:pre-wrap;">* Full-time equivalent  </font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 67</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 4/38</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20211110xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months Ended September 30, 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a name="_Toc16514641"></a><b style="color:#029c93;font-size:11pt;font-weight:bold;">OUTLOOK</b><font style="color:#029c93;font-size:11pt;"> </font><a name="OUTLOOK_182548"></a><a name="_Hlk22722517"></a></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:54.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:54.78%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><font style="font-weight:bold;margin-left:0pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Revised</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Previous</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:54.78%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><b style="font-weight:bold;">(DKK million)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Guidance</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.86%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Guidance</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:54.78%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">7,900 - 8,500</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">7,300 - 7,900</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:54.78%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Operating expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">(5,300) - (5,600)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">(5,500) - (5,800)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:54.78%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Operating result</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">2,300 - 3,200</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">1,500 - 2,400</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">As announced in Company Announcement No. 66, Genmab is improving its 2021 financial guidance published on August 11, 2021, driven primarily by increased royalty revenue related to the net sales of DARZALEX and lower operating expense resulting from timing of investments for R&amp;D activities and organizational capability build.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Revenue</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Genmab expects its 2021 revenue to be in the range of DKK 7,900&#8211;8,500 million, an increase compared to previous guidance of DKK 7,300&#8211;7,900 million, driven primarily by the continued strong growth of DARZALEX net sales. Genmab&#8217;s projected revenue for 2021 primarily consists of DARZALEX royalties of DKK 5,800&#8211;6,200 million. Such royalties are based on Genmab&#8217;s revised estimate of DARZALEX 2021 net sales of USD 5.9&#8211;6.2 billion compared to Genmab&#8217;s previous estimate of USD 5.6&#8211;5.9 billion. Since the second quarter of 2020, Janssen has reduced its royalty payments to Genmab by what it claims to be Genmab&#8217;s share of Janssen&#8217;s royalty payments to Halozyme in connection with subcutaneous (SC) sales. Given the ongoing arbitration, Genmab has reflected this as a reduction to estimated 2021 revenue. The remainder of Genmab&#8217;s revenue consists of royalties from TEPEZZA, Kesimpta and RYBREVANT<sup style="font-size:7.5pt;vertical-align:top;">&#174;</sup>, reimbursement revenue, milestones for epcoritamab and daratumumab, and other milestones. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Operating Expenses</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Genmab anticipates its 2021 operating expenses to be in the range of DKK 5,300&#8211;5,600 million, a decrease compared to previous guidance of DKK 5,500&#8211;5,800 million. Operating expenses continue to be driven by the advancement of Genmab&#8217;s clinical programs, continued investment in research and development, as well as building Genmab&#8217;s commercial organization and broader organizational infrastructure. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Operating Result</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Genmab now expects its 2021 operating result to be in the range of DKK 2,300&#8211;3,200 million, an increase compared to previous guidance of DKK 1,500&#8211;2,400 million, driven primarily by the increase in royalty revenue related to the net sales of DARZALEX.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Outlook: Risks and Assumptions</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">In addition to factors already mentioned, the estimates above are subject to change due to numerous reasons, including but not limited to the achievement of certain milestones associated with Genmab&#8217;s collaboration agreements; ongoing binding arbitration of two matters under Genmab&#8217;s license agreement with Janssen relating to daratumumab; the timing and variation of development activities (including activities carried out by Genmab&#8217;s collaboration partners) and related income and costs; DARZALEX, Kesimpta, TEPEZZA and RYBREVANT net sales and royalties paid to Genmab; and currency exchange rates (the 2021 guidance assumes a USD/DKK exchange rate of 6.0). The financial guidance assumes that no significant new agreements are entered into during the remainder of 2021 that could materially affect the results. Refer to the section &#8220;Significant Risks and Uncertainties&#8221; in this interim report. </p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 67</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 5/38</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20211110xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months Ended September 30, 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Additionally, the COVID-19 pandemic could potentially have a material adverse impact on Genmab&#8217;s business and financial performance, including clinical trials, projected regulatory approval timelines, supply chain and revenues, and cause Genmab&#8217;s actual results to differ materially from 2021 Guidance and Key 2021 Priorities in this interim report. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">The global outbreak of COVID-19 may have long-term impacts on the development, regulatory approval and commercialization of Genmab&#8217;s product candidates and on net sales of approved products created by Genmab and developed and marketed by Genmab or Genmab&#8217;s collaboration partners. The longer the pandemic continues, the more severe the impacts described below will be on Genmab&#8217;s business. Genmab has established a COVID-19 response team, led by the CEO, that closely monitors the evolving situation, develops and implements precautionary measures to help limit the impact of COVID-19 at the workplace and on our communities, and ensures business continuity. Genmab is also actively monitoring the potential impact on Key 2021 Priorities and assessing the situation on an ongoing basis in close contact with clinical trial sites, physicians and contract research organizations to evaluate the impact and challenges posed by the COVID-19 situation and manage them accordingly. The full extent and nature of the impact of the COVID-19 pandemic and related containment measures on Genmab&#8217;s business and financial performance is uncertain as the situation continues to evolve. The factors discussed above, as well as other factors which are currently unforeseeable, may result in further and other unforeseen material adverse impacts on Genmab&#8217;s business and financial performance, including on the net sales of DARZALEX, Kesimpta, TEPEZZA and RYBREVANT, by Genmab&#8217;s partners and on Genmab&#8217;s royalty and milestone revenue therefrom.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;font-weight:bold;padding-left:21.6pt;text-indent:-21.6pt;margin:12pt 0pt 3pt 0pt;"><b style="font-size:16pt;font-weight:bold;"><a name="_Toc16514642"></a></b><b style="color:#029c93;font-weight:bold;">KEY 2021 PRIORITIES</b><b style="font-size:16pt;font-weight:bold;"><a name="KEY2019PRIORITIES_328557"></a></b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;" align="center"><tr style="height:1pt;"><td style="background-color:#c0c0c0;vertical-align:top;width:23.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="background-color:#c0c0c0;vertical-align:top;width:6.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="color:#008080;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="background-color:#c0c0c0;vertical-align:top;width:2.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="background-color:#c0c0c0;vertical-align:top;width:66.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td></tr><tr><td style="vertical-align:top;width:23.16%;border-bottom:1px solid #a6a6a6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:1pt 0pt 1pt 3.6pt;"><b style="color:#029c93;font-weight:bold;">Priority</b></p></td><td style="vertical-align:top;width:6.94%;border-bottom:1px solid #a6a6a6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:1pt 0pt 1pt 0pt;"><b style="color:#029c93;font-family:'Times New Roman';font-size:12pt;font-weight:bold;">&#10003;</b></p></td><td colspan="2" style="vertical-align:top;width:69.89%;border-bottom:1px solid #a6a6a6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:1pt 0pt 1pt 0pt;"><b style="color:#029c93;font-weight:bold;">Targeted Milestones</b></p></td></tr><tr><td style="vertical-align:top;width:23.16%;border-top:1px solid #a6a6a6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:1pt 0pt 1pt 3.6pt;"><b style="color:#029c93;font-weight:bold;">Bring our own medicines to patients</b></p></td><td style="vertical-align:top;width:6.94%;border-top:1px solid #a6a6a6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:1pt 0pt 1pt 0pt;"><b style="color:#029c93;font-family:'Times New Roman';font-weight:bold;">&#10003;</b></p></td><td style="vertical-align:top;width:2.93%;border-top:1px solid #a6a6a6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:1pt 0pt 1pt 0pt;"><font style="font-family:'Times New Roman';">&#9679;</font></p></td><td style="vertical-align:top;width:66.95%;border-top:1px solid #a6a6a6;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:1pt 0pt 1pt 0pt;">Tisotumab vedotin<sup style="font-size:7.5pt;vertical-align:top;">1</sup> &#8211; U.S. FDA decision on BLA and progress to market</p></td></tr><tr><td style="vertical-align:top;width:23.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:1pt 0pt 1pt 3.6pt;"><font style="font-weight:bold;margin-left:0pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:6.94%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:1pt 0pt 1pt 0pt;"><font style="color:#029c93;">X*</font></p></td><td style="vertical-align:top;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:1pt 0pt 1pt 0pt;"><font style="font-family:'Times New Roman';">&#9679;</font></p></td><td style="vertical-align:top;width:66.95%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:1pt 0pt 1pt 0pt;">Tisotumab vedotin &#8211; JNDA submission in cervical cancer</p></td></tr><tr><td style="vertical-align:top;width:23.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:1pt 0pt 1pt 3.6pt;"><font style="font-weight:bold;margin-left:0pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:6.94%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:1pt 0pt 1pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:1pt 0pt 1pt 0pt;"><font style="font-family:'Times New Roman';">&#9679;</font></p></td><td style="vertical-align:top;width:66.95%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Epcoritamab<sup style="font-size:7.5pt;vertical-align:top;">2</sup> &#8211; acceleration and maximization of development program by advancing expansion cohorts and initiating additional Phase 3 trials</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:1pt 0pt 1pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td rowspan="4" style="background-color:#e5e5e6;vertical-align:top;width:23.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:1pt 0pt 1pt 3.6pt;"><b style="color:#029c93;font-weight:bold;">Build world-class differentiated product </b></p></td><td style="background-color:#e5e5e6;vertical-align:top;width:6.94%;margin:0pt;padding:0pt;"></td><td style="background-color:#e5e5e6;vertical-align:top;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:1pt 0pt 1pt 0pt;"><font style="font-family:'Times New Roman';">&#9679;</font></p></td><td style="background-color:#e5e5e6;vertical-align:top;width:66.95%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:1pt 0pt 1pt 0pt;">DuoBody-PD-L1x4-1BB<sup style="font-size:7.5pt;vertical-align:top;">3 </sup>&#8211; expansion cohort data</p></td></tr><tr><td style="background-color:#e5e5e6;display:none;vertical-align:top;width:23.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:1pt 0pt 1pt 3.6pt;"><font style="font-weight:bold;margin-left:0pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e5e5e6;vertical-align:top;width:6.94%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:1pt 0pt 1pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e5e5e6;vertical-align:top;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:1pt 0pt 1pt 0pt;"><font style="font-family:'Times New Roman';">&#9679;</font></p></td><td style="background-color:#e5e5e6;vertical-align:top;width:66.95%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:1pt 0pt 1pt 0pt;">DuoBody-CD40x4-1BB<sup style="font-size:7.5pt;vertical-align:top;">3</sup> &#8211; dose escalation data</p></td></tr><tr><td style="background-color:#e5e5e6;display:none;vertical-align:top;width:23.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:1pt 0pt 1pt 3.6pt;"><font style="font-weight:bold;margin-left:0pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e5e5e6;vertical-align:top;width:6.94%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:1pt 0pt 1pt 0pt;"><b style="color:#029c93;font-family:'Times New Roman';font-weight:bold;">&#10003;</b></p></td><td style="background-color:#e5e5e6;vertical-align:top;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:1pt 0pt 1pt 0pt;"><font style="font-family:'Times New Roman';">&#9679;</font></p></td><td style="background-color:#e5e5e6;vertical-align:top;width:66.95%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Tisotumab vedotin &#8211; data in other tumor indication</p></td></tr><tr><td style="background-color:#e5e5e6;display:none;vertical-align:top;width:23.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:1pt 0pt 1pt 3.6pt;"><font style="font-weight:bold;margin-left:0pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e5e5e6;vertical-align:top;width:6.94%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:1pt 0pt 1pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e5e5e6;vertical-align:top;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:1pt 0pt 1pt 0pt;"><font style="font-family:'Times New Roman';">&#9679;</font></p></td><td style="background-color:#e5e5e6;vertical-align:top;width:66.95%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Earlier-stage products &#8211; progress and expand innovative product pipeline</p></td></tr><tr><td rowspan="2" style="vertical-align:top;width:23.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:1pt 0pt 1pt 3.6pt;"><b style="color:#029c93;font-weight:bold;">Become leading integrated innovation powerhouse</b></p></td><td style="vertical-align:top;width:6.94%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:1pt 0pt 1pt 0pt;"><b style="color:#029c93;font-family:'Times New Roman';font-weight:bold;">&#10003;</b></p></td><td style="vertical-align:top;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:1pt 0pt 1pt 0pt;"><font style="font-family:'Times New Roman';">&#9679;</font></p></td><td style="vertical-align:top;width:66.95%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:1pt 0pt 1pt 0pt;">Operational commercialization model in U.S. and Japan</p></td></tr><tr><td style="display:none;vertical-align:top;width:23.16%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:1pt 0pt 1pt 3.6pt;"><font style="color:#029c93;font-weight:bold;margin-left:0pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:6.94%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:1pt 0pt 1pt 0pt;"><font style="color:#029c93;font-family:'Segoe UI Emoji';font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:2.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:1pt 0pt 1pt 0pt;"><font style="font-family:'Times New Roman';">&#9679;</font></p></td><td style="vertical-align:top;width:66.95%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Further strengthen solid financial foundation </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:1pt 0pt 1pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1.&#160;Co-development w/ Seagen; 2. Co-development w/ AbbVie; 3. Co-development w/ BioNTech SE (BioNTech)</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">*Potential JNDA filing timeline postponed to include Phase 3 InnovaTV301 data</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">PRODUCT PIPELINE</b><a name="PRODUCTPIPELINE_603298"></a><b style="color:#029c93;font-weight:bold;"> AND TECHNOLOGY PROGRESS FIRST NINE MONTHS OF 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">As of the end of the third quarter of 2021, Genmab&#8217;s proprietary pipeline of product candidates, where we are responsible for at least 50% of development, consisted of six antibodies in clinical development </p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 67</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 6/38</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20211110xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months Ended September 30, 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">including Genmab&#8217;s first U.S. FDA approved product, TIVDAK, which Genmab is co-developing and co-promoting in the U.S. with Seagen. In addition to our own pipeline, there are also multiple products in development by third-party companies, including four approved products that incorporate Genmab technology and innovation. Beyond the antibodies in clinical development, our pipeline also includes around 20 in-house and partnered pre-clinical programs. An overview of the development status of each of our products is provided in the following sections. Detailed descriptions of dosing, efficacy and safety data from certain clinical trials have been disclosed in company announcements and media releases published via the Nasdaq Copenhagen stock exchange and may also be found in Genmab&#8217;s filings with the U.S. Securities and Exchange Commission (SEC). Additional information is available on Genmab&#8217;s website, www.genmab.com. The information accessible through our website is not part of and is not incorporated by reference herein.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a name="PRODUCTPIPELINEANDTECHNOLOGYPROGRESSFIRS"></a><font style="color:#339966;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-size:11pt;font-weight:bold;">Genmab Proprietary Products</b><sup style="color:#029c93;font-size:8.25pt;font-weight:bold;vertical-align:top;">1 </sup><b style="color:#029c93;font-size:11pt;font-weight:bold;">in Development</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><img src="tmb-20211110xex99d1005.jpg" alt="Chart&#10;&#10;Description automatically generated" style="display:inline-block;height:215.75pt;left:0%;padding-bottom:0.25pt;position:relative;top:0pt;width:468pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;min-height:11.0pt;text-indent:18pt;margin:0pt 36pt 0pt -18pt;"><sup style="font-size:6pt;vertical-align:top;">1</sup>Product candidates where Genmab has &#8805;50% ownership. Certain products in co-development, partners as indicated</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;min-height:11.0pt;text-indent:18pt;margin:0pt 36pt 0pt -18pt;"><sup style="font-size:6pt;vertical-align:top;">2</sup>See U.S. prescribing information for precise indication and safety information</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;min-height:11.0pt;text-indent:18pt;margin:0pt 36pt 0pt -18pt;"><sup style="font-size:6pt;vertical-align:top;">3</sup>Genmab is developing HexaBody<sup style="font-size:6pt;vertical-align:top;">&#174;</sup>-CD38 in an exclusive worldwide license and option agreement with Janssen</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;min-height:11.0pt;text-indent:0pt;margin:0pt 36pt 0pt 0pt;"><font style="font-size:8pt;margin-bottom:11pt;margin-right:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">TIVDAK &#8211; First and only U.S. FDA approved ADC for recurrent or metastatic cervical cancer</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">An ADC directed to tissue factor (TF), a protein highly prevalent in solid tumors, including cervical cancer, which is associated with poor prognosis</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Accelerated approval granted by the U.S. FDA for </font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">TIVDAK</font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">, the first and only approved ADC for the treatment of adult patients with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">The approval was based on data from the innovaTV 204 (NCT03438396) Phase 2 single-arm clinical study evaluating tisotumab vedotin as monotherapy in patients with previously treated recurrent or metastatic cervical cancer; potential Japanese New Drug Application (JNDA) filing timeline postponed to include Phase 3 innovaTV 301 (NCT04697628) data </font></td></tr></table></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 67</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 7/38</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20211110xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months Ended September 30, 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">In addition to the Phase 3 study in recurrent or metastatic cervical cancer, multiple</font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;"> Phase 2 clinical studies in other solid tumors are ongoing</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Developed and co-promoted in the U.S. in collaboration with Seagen</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;min-height:11.0pt;text-indent:0pt;margin:0pt 36pt 11pt 0pt;">TIVDAK is an ADC composed of Genmab&#8217;s human monoclonal antibody directed to TF and Seagen&#8217;s ADC technology that utilizes a protease-cleavable linker that covalently attaches the microtubule-disrupting agent monomethyl auristatin E (MMAE) to the antibody. Genmab used technology licensed from Medarex to generate the TF antibody forming part of TIVDAK. TIVDAK is the first and only U.S. FDA approved ADC for the treatment of adult patients with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy. TIVDAK is being co-developed by Genmab and Seagen, under an agreement in which the companies share all costs and profits for the product on a 50:50 basis. Under a joint commercialization agreement, Genmab will co-promote TIVDAK in the U.S. and lead commercial operational activities in Japan. Seagen will lead operational commercial activities in the U.S., Europe and China with a 50:50 cost and profit split in those markets. In any other markets, Seagen will commercialize TIVDAK and Genmab will receive royalties based on a percentage of aggregate net sales ranging from the mid-teens to the mid-twenties. The companies will continue the practice of joint decision-making on the worldwide development and commercialization strategy for TIVDAK. The companies have a broad clinical development program for TIVDAK, including a confirmatory Phase 3 study in recurrent or metastatic cervical cancer.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;min-height:11.0pt;text-indent:0pt;margin:0pt 36pt 11pt 0pt;">Please consult the U.S. Prescribing Information for TIVDAK for the labeled indication and safety information, including the boxed warning.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Third Quarter 2021 Updates</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">September: As fully described above, the U.S. FDA granted accelerated approval to Genmab and Seagen for TIVDAK. The Biologics License Application (BLA) seeking accelerated approval of TIVDAK was submitted to the U.S. FDA in February 2021 and accepted in April 2021 with a target action date of October 10, 2021. The approval was based on data from the innovaTV 204 Phase 2 clinical study.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">September: Genmab and Seagen presented interim data from two cohorts of the Phase 1b/2 innovaTV 205 (NCT03786081) multi-cohort, open-label trial of tisotumab vedotin in recurrent or metastatic cervical cancer at the European Society for Medical Oncology Virtual Congress 2021 as part of a featured mini oral presentation. Genmab and Seagen also presented data from dose-escalation cohorts of the innovaTV 205 study at the 2021 International Gynecologic Cancer Society Annual Meeting held August 30 &#8211; September 2, 2021.</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">First Half 2021 Updates</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">May: Data from the innovaTV 204 study was published in </font><i style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:italic;font-weight:normal;text-align:left;">The Lancet Oncology</i><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">, &#8220;Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study.&#8221;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;white-space:pre-wrap;">January: A Phase 3 study of tisotumab vedotin versus chemotherapy in recurrent or metastatic cervical cancer (innovaTV 301) was announced.  </font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 67</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 8/38</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20211110xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months Ended September 30, 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Epcoritamab (DuoBody</b><sup style="color:#029c93;font-size:7.5pt;font-weight:bold;vertical-align:top;">&#174;</sup><b style="color:#029c93;font-weight:bold;">-CD3xCD20) &#8211; Potential Best-in-class Product Candidate</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Proprietary bispecific antibody created with Genmab&#8217;s DuoBody technology </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Five ongoing clinical studies across different settings and histologies, including a Phase 3 study (NCT04628494) in relapsed / refractory diffuse large B-cell lymphoma (DLBCL) with more studies in planning</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Developed in collaboration with AbbVie</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="background-color:#ffffff;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Epcoritamab is a proprietary bispecific antibody created using Genmab&#8217;s DuoBody technology. Epcoritamab targets CD3, which is expressed on T-cells, and CD20, a clinically well-validated target on malignant B-cells. Genmab used technology licensed from Medarex to generate the CD20 antibody forming part of epcoritamab. Epcoritamab is being co-developed by Genmab and AbbVie. The first Phase 3 clinical study of epcoritamab in relapsed / refractory DLBCL is ongoing. In addition, Phase 1/2 clinical studies in B-cell non-Hodgkin lymphoma (B-NHL) including chronic lymphocytic leukemia (NCT04623541) and in combination with standard of care therapies for B-NHL (NCT04663347) are ongoing.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Third Quarter 2021 Update</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">September: Data from the Phase 1/2 EPCORE NHL-1 (NCT03625037) study was published in </font><i style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:italic;font-weight:normal;text-align:left;">The Lancet, </i><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">&#8220;Dose escalation of subcutaneous epcoritamab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: an open-label, phase 1/2 study.&#8221; </font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">First Half 2021 Updates</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">June: Updated dose escalation data, including progression free survival, from the Phase 1/2 EPCORE NHL-1 study of epcoritamab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma was presented during an oral session at the International Conference on Malignant Lymphoma and poster sessions at the American Society of Clinical Oncology Annual Meeting and the European Hematology Association (EHA) Congress.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">February: &#8220;Epcoritamab induces potent anti-tumor activity against malignant B-cells from patients with DLBCL, FL and MCL, irrespective of prior CD20 monoclonal antibody treatment&#8221; was published in </font><i style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:italic;font-weight:normal;text-align:left;">Blood Cancer Journal</i><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">January: The first patient was dosed in the Phase 3 study of SC epcoritamab versus investigator&#8217;s choice of chemotherapy in patients with relapsed or refractory DLBCL. This triggered a DKK 245 million (USD 40 million) milestone to Genmab under the collaboration with AbbVie.</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">DuoBody-PD-L1x4-1BB (GEN1046) &#8211; Bispecific Next Generation Checkpoint Immunotherapy</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Bispecific antibody created with Genmab&#8217;s DuoBody technology </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Clinical studies in solid tumors ongoing</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Developed in collaboration with BioNTech</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">DuoBody-PD-L1x4-1BB (GEN1046) is a proprietary bispecific antibody, jointly owned by Genmab and BioNTech, created using Genmab&#8217;s DuoBody technology. It is being co-developed by Genmab and BioNTech under an agreement in which the companies share all costs and profits for the product on a 50:50 basis. DuoBody-PD-L1x4-1BB targets PD-L1 and 4-1BB, selected to block inhibitory PD 1 / PD-L1 axis and simultaneously conditionally activate essential co-stimulatory activity via 4-1BB using inert DuoBody antibody format. Two clinical studies (NCT03917381, NCT04937153) in solid tumors are ongoing.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 67</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 9/38</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20211110xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months Ended September 30, 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">DuoBody-CD40x4-1BB (GEN1042) &#8211; Potential First-in-Class Bispecific Agonistic Antibody</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Bispecific antibody created with Genmab&#8217;s DuoBody technology </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Phase 1/2 clinical study (NCT04083599) in solid tumors ongoing </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Developed in collaboration with BioNTech</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">DuoBody-CD40x4-1BB (GEN1042) is a proprietary bispecific antibody, jointly owned by Genmab and BioNTech, created using Genmab&#8217;s DuoBody technology. It is being co-developed by Genmab and BioNTech under an agreement in which the companies share all costs and profits for the product on a 50:50 basis. CD40 and 4-1BB were selected as targets to enhance both dendritic cells (DC) and antigen-dependent T-cell activation, using an inert DuoBody format. A Phase 1/2 clinical study of DuoBody-CD40x4-1BB in solid tumors is ongoing.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Third Quarter 2021 Update</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">September: The ongoing Phase 1/2 study was updated to include multiple expansion cohorts including in combination with pembrolizumab in first-line non-small cell lung cancer (NSCLC), in first-line head and neck squamous cell carcinoma (HNSCC) and in first-line melanoma and in combination with pembrolizumab and chemotherapy in first-line HNSCC and in first-line pancreatic ductal adenocarcinoma. </font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">First Half 2021 Update</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">April/May:</font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;"> </font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Preclinical data was presented at the American Association for Cancer Research Annual Meeting.</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">DuoHexaBody</b><sup style="color:#029c93;font-size:7.5pt;font-weight:bold;vertical-align:top;">&#174;</sup><b style="color:#029c93;font-weight:bold;">-CD37 (GEN3009) &#8211; First DuoHexaBody Program in the Clinic</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Antibody product created with Genmab&#8217;s DuoHexaBody technology</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Phase 1/2 clinical study (NCT04358458) in hematologic malignancies ongoing </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Developed in collaboration with AbbVie</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">DuoHexaBody-CD37 (GEN3009) is a bispecific antibody created with Genmab&#8217;s proprietary DuoHexaBody technology platform. The DuoHexaBody platform combines the dual targeting of our DuoBody technology with the enhanced potency of our HexaBody technology, creating bispecific antibodies with target-mediated enhanced hexamerization. DuoHexaBody-CD37 is being co-developed by Genmab and AbbVie on a 50:50 basis and a Phase 1/2 clinical study in hematologic malignancies is ongoing. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">HexaBody-CD38 (GEN3014) &#8211; Latest Proprietary Program in the Clinic</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Proprietary antibody therapeutic created with Genmab&#8217;s HexaBody technology </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Phase 1/2 clinical study (NCT04824794) in hematological malignancies ongoing</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Developed in an exclusive worldwide license and option agreement with Janssen</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">HexaBody-CD38 (GEN3014) is a human CD38 monoclonal antibody product incorporating our HexaBody technology. In preclinical models of hematological malignancies, as presented at ASH in December 2019, HexaBody-CD38 demonstrated enhanced CDC and had shown potent anti-tumor activity. In June 2019, Genmab entered into an exclusive worldwide license and option agreement with Janssen to develop and commercialize HexaBody-CD38. A Phase 1/2 clinical study in hematologic malignancies is ongoing. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">First Half 2021 Update</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">March: First patient dosed in first-in-human study of HexaBody-CD38.</font></td></tr></table></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 67</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 10/38</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20211110xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months Ended September 30, 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">HexaBody-DR5/DR5 (GEN1029) </b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Proprietary antibody therapeutic created with Genmab&#8217;s HexaBody technology</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Composed of two non-competing HexaBody antibody molecules that target two distinct DR5 epitopes</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Genmab has decided to stop the development of HexaBody-DR5/DR5 as data was not supportive of Genmab&#8217;s strict go/no-go criteria. </font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="background-color:#ffffff;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">HexaBody-DR5/DR5 (GEN1029) is a product comprising a mixture of two non-competing HexaBody molecules that target two distinct epitopes on death receptor 5 (DR5), a cell surface receptor that mediates a process called programmed cell death. Increased expression of DR5 has been reported in several types of tumors. The product, which was being evaluated in a Phase 1/2 clinical study (NCT03576131) in solid tumors, was created with our HexaBody technology and DR5 antibodies acquired from IDD Biotech. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Third Quarter 2021 Update</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">September: Genmab has decided to stop the development of HexaBody-DR5/DR5 as data was not supportive of Genmab&#8217;s strict go/no-go criteria. Preliminary activity was shown, but the narrow therapeutic index does not support further development. </font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-size:11pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">DuoBody-CD3x5T4 (GEN1044)</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Bispecific antibody product created with Genmab&#8217;s DuoBody technology </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Developed in collaboration with AbbVie</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Genmab and AbbVie have decided to stop the development of DuoBody-CD3x5T4 as data was not supportive of the companies&#8217; strict go/no-go criteria</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">DuoBody-CD3x5T4 (GEN1044) is a bispecific antibody created with Genmab&#8217;s proprietary DuoBody technology platform. DuoBody-CD3x5T4 was being co-developed by Genmab and AbbVie on a 50:50 basis and was being evaluated in a Phase 1/2 clinical study (NCT04424641) in solid tumors. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Third Quarter 2021 Update</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">September: Genmab and AbbVie have decided to stop the development of DuoBody-CD3x5T4 as data was not supportive of the companies&#8217; strict go/no-go criteria. The maximum tolerated dose was reached at a dose level that is below the one expected to be active. </font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-size:11pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-size:11pt;font-weight:bold;">Products Created by Genmab or Incorporating Genmab&#8217;s Innovation</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><font style="font-size:10pt;">In addition to Genmab&#8217;s own pipeline of product candidates our innovation and proprietary technology are applied in the pipelines of third-party companies. These companies are running clinical development programs with antibodies created by Genmab or created using Genmab&#8217;s DuoBody bispecific antibody technology. The programs run from Phase 1 development to approved medicines. The tables in this section include those therapies that have been approved as well as clinical stage products in Phase 2 development or later. Under the agreements for these products Genmab is entitled to certain potential milestones and royalties.</font> </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 67</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 11/38</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20211110xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months Ended September 30, 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-size:11pt;font-weight:bold;">Approved Medicines</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-size:11pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><img src="tmb-20211110xex99d1006.jpg" alt="Table&#10;&#10;Description automatically generated" style="display:inline-block;height:208.95pt;width:468pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><sup style="font-size:6pt;vertical-align:top;">*</sup>See local country prescribing information for precise indications and safety information</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">DARZALEX (daratumumab) &#8211; Redefining the Treatment of Multiple Myeloma</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">First-in-class human CD38 monoclonal antibody</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Developed by Janssen under an exclusive worldwide license from Genmab to develop, manufacture and commercialize daratumumab </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Intravenous (IV) formulation approved in combination with other therapies for frontline and for relapsed/refractory multiple myeloma in territories including the U.S., Europe and Japan and as monotherapy for heavily pretreated or double-refractory multiple myeloma in territories including the U.S. and Europe</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">First and only SC CD38-directed antibody approved in territories including the U.S., Europe and Japan for the treatment of certain multiple myeloma indications, known as DARZALEX </font><i style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:italic;font-weight:normal;text-align:left;">FASPRO</i><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;"> (daratumumab and hyaluronidase-fihj) in the U.S., and DARZALEX SC in Europe</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">SC daratumumab is the first and only approved therapy for light-chain (AL) amyloidosis in the U.S., Europe and Japan</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Net sales of DARZALEX by Janssen were USD 4,378 million in the first nine months of 2021</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">DARZALEX is a human monoclonal antibody that binds with high affinity to the CD38 molecule, which is highly expressed on the surface of multiple myeloma cells and is also expressed by AL amyloidosis plasma cells. Genmab used technology licensed from Medarex to generate the CD38 antibody forming part of daratumumab. Daratumumab is being developed by Janssen under an exclusive worldwide license from Genmab to develop, manufacture and commercialize daratumumab. Under the terms of the agreement, Genmab is entitled to double digit royalties between 12% and 20%. Daratumumab (marketed as DARZALEX for IV administration and as DARZALEX <i style="font-style:italic;">FASPRO </i>in the United States and as DARZALEX SC in Europe for SC administration) is approved in certain territories for the treatment of </p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 67</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 12/38</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20211110xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months Ended September 30, 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">adult patients with certain multiple myeloma indications and is the only<i style="font-style:italic;"> </i>approved therapy in the U.S., Europe and Japan for the treatment of adult patients with AL amyloidosis.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Please consult the U.S. Prescribing Information and the European Summary of Product Characteristics<font style="color:#0070c0;"> </font>for DARZALEX and DARZALEX SC and the U.S. Prescribing Information for DARZALEX FASPRO<b style="color:#0070c0;font-size:13pt;font-weight:bold;"> </b>for the labeled indication and safety information.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Third Quarter 2021 Updates</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">August: Janssen received approval in Japan for the daratumumab SC formulation (daratumumab and hyaluronidase-fihj) in combination with bortezomib, cyclophosphamide, and dexamethasone (VCd) for the treatment of adult patients with newly diagnosed systemic AL amyloidosis. The approval was based on the Phase 3 ANDROMEDA (AMY3001 / NCT03201965) clinical study.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">July: Janssen was granted an approval by the U.S. FDA for daratumumab SC in combination with pomalidomide and dexamethasone (Pd) for the treatment of adult patients with multiple myeloma who have received one prior therapy containing a proteasome inhibitor (PI) and lenalidomide and were lenalidomide refractory, or who have received at least two prior therapies that included lenalidomide and a PI and have demonstrated disease progression on or after the last therapy. The approval was based on the APOLLO (MMY3013 /</font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;"> </font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">NCT03180736) clinical study.</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">First Half 2021 Updates</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">June: Janssen received approval from the European Commission (EC) for DARZALEX SC in two indications: in combination with VCd for the treatment of adult patients with newly diagnosed systemic AL amyloidosis and in combination with Pd for the treatment of adult patients with multiple myeloma who have received one prior therapy containing a PI and lenalidomide and were lenalidomide refractory, or who have received at least two prior therapies that included lenalidomide and a PI and have demonstrated disease progression on or after the last therapy. The approvals follow positive opinions from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) in May 2021. The approvals were based on the Phase 3 ANDROMEDA and APOLLO clinical studies, respectively.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">June: Overall survival results from Janssen&#8217;s Phase 3 MAIA (MMY3008 / NCT02252172) study of daratumumab in combination with lenalidomide and dexamethasone (D-Rd) versus Rd alone in patients with newly diagnosed multiple myeloma who were ineligible for autologous stem cell transplant were presented during the late-breaking oral session at EHA. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">April: Janssen received approval in China based on the Phase 3 LEPUS (MMY3009, NCT03234972) study of daratumumab in combination with bortezomib and dexamethasone in Chinese patients with relapsed or refractory multiple myeloma. </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">January: Janssen was granted U.S. FDA approval for the use of DARZALEX </font><i style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:italic;font-weight:normal;text-align:left;">FASPRO</i><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;"> in combination with VCd for the treatment of adult patients with newly diagnosed AL amyloidosis. The approval was based on data from the Phase 3 ANDROMEDA study.</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Kesimpta (ofatumumab) &#8211; Approved in RMS in the U.S. </b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Human CD20 monoclonal antibody developed by Novartis Pharma AG (Novartis) under a license agreement with Genmab</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Approved in territories including the U.S., EU and Japan for treatment of relapsing forms of multiple sclerosis (RMS) in adults</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">First B-cell therapy that can be self-administered by patients at home using the Sensoready</font><sup style="font-family:'Arial','Helvetica','sans-serif';font-size:7.5pt;font-style:normal;font-weight:normal;text-align:left;vertical-align:top;">&#174;</sup><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;"> autoinjector pen</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 67</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 13/38</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20211110xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months Ended September 30, 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Kesimpta is a human monoclonal antibody that targets an epitope on the CD20 molecule encompassing parts of the small and large extracellular loops. Genmab used technology licensed from Medarex to generate the CD20 antibody forming part of Kesimpta. Kesimpta was approved by the U.S. FDA in August 2020 and the EC in March 2021 for the treatment of RMS in adults. Kesimpta is the first B-cell therapy that can be self-administered by patients at home using the Sensoready autoinjector pen, once monthly after starting therapy. Additional studies with RMS patients are ongoing. Kesimpta is being developed and marketed worldwide by Novartis under a license agreement between Genmab and Novartis. Under the terms of the agreement, Genmab is entitled to 10% royalties on net sales of Kesimpta.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Please consult the U.S. Prescribing Information and the European Summary of Product Characteristics for the labeled indication and safety information for Kesimpta. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">First Half 2021 Updates</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">March: The EC granted Novartis marketing authorization for the use of Kesimpta in the treatment of RMS in adults with active disease defined by clinical or imaging features. This was preceded in January 2021 by a positive opinion from the CHMP of the EMA recommending marketing authorization in the same indication.</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">TEPEZZA (teprotumumab-trbw) &#8211; First U.S. FDA-approved medicine for the treatment of thyroid eye disease</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Developed and commercialized by Horizon Therapeutics, plc (Horizon) for thyroid eye disease (TED)</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">First and only U.S. FDA-approved medicine for the treatment of TED</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Also being explored in diffuse cutaneous systemic sclerosis (dcSSC)</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Teprotumumab, approved by the U.S. FDA in January 2020 under the trade name TEPEZZA, is a human monoclonal antibody that targets the Insulin-like Growth Factor 1 Receptor (IGF-1R), a well-validated target. Genmab used technology licensed from Medarex to generate the IGF-1R antibody forming part of teprotumumab. TEPEZZA is being developed and is commercialized by Horizon. The antibody was created by Genmab under a collaboration with Roche Holding AG (Roche) and development and commercialization of the product is now being conducted by Horizon under a sublicense from Roche. Under the terms of Genmab&#8217;s agreement with Roche, Genmab will receive mid-single digit royalties on sales of TEPEZZA. In December 2020, Horizon announced that there was a supply disruption related to the production of TEPEZZA due to U.S. government-mandated COVID-19 vaccine production requirements. Subsequently, Horizon announced that it had resumed supplying the market beginning in April 2021, ending the supply disruption. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Please consult the U.S. Prescribing Information for the labeled indication and safety information for TEPEZZA.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">RYBREVANT (amivantamab-vmjw) &#8211; First regulatory approval for a DuoBody product</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Part of Genmab and Janssen DuoBody research and license agreement</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">First U.S. FDA approved product created using Genmab&#8217;s proprietary DuoBody technology platform</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Under the agreement with Janssen, Genmab will receive royalties on net sales of RYBREVANT</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 67</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 14/38</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20211110xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months Ended September 30, 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;min-height:11.0pt;text-indent:0pt;margin:0pt 36pt 11pt 0pt;">Janssen&#8217;s RYBREVANT is a fully human bispecific antibody that targets EGFR and Met, two validated cancer targets. In July 2012, Genmab entered into a collaboration with Janssen to create and develop bispecific antibodies using Genmab&#8217;s DuoBody technology platform. The two antibody libraries used to produce amivantamab were both generated by Genmab. The antibody pair used to create RYBREVANT was selected in collaboration between Genmab and Janssen. Subsequent development work was led by Janssen.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;min-height:11.0pt;text-indent:0pt;margin:0pt 36pt 11pt 0pt;">In 2021, Janssen received approval from the U.S. FDA for RYBREVANT for the treatment of adult patients with locally advanced or metastatic NSCLC with epidermal growth factor receptor (EGFR) exon 20 insertion mutations whose disease has progressed on or after platinum-based chemotherapy. This is the first regulatory approval for a therapy that was created using Genmab&#8217;s proprietary DuoBody bispecific technology platform. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;min-height:11.0pt;text-indent:0pt;margin:0pt 36pt 11pt 0pt;">Please consult the U.S. Prescribing Information for RYBREVANT for the labeled indication and safety information.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">First Half 2021 Update</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">May: Janssen was granted U.S. FDA approval for the use of </font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">RYBREVANT </font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">for the treatment of adult patients with locally advanced or metastatic NSCLC with EGFR exon 20 insertion mutations whose disease has progressed on or after platinum-based chemotherapy.</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Clinical Stage Product Candidates</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-size:11pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-family:'Georgia';font-weight:bold;"><img src="tmb-20211110xex99d1007.jpg" alt="Graphical user interface&#10;&#10;Description automatically generated with medium confidence" style="display:inline-block;height:130.95pt;width:468pt;"></b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;min-height:11.0pt;text-indent:0pt;margin:0pt 36pt 11pt 0pt;"><sup style="font-size:6pt;vertical-align:super;">*</sup><font style="vertical-align:super;">UltiMab</font><sup style="font-size:6pt;vertical-align:super;">&#174; </sup><font style="vertical-align:super;">transgenic mouse technology licensed from Medarex, Inc., a wholly owned subsidiary of Bristol Myers Squibb.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-size:11pt;font-weight:bold;">Preclinical Programs</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Broad preclinical pipeline of around 20 programs </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Preclinical pipeline includes both partnered products and in-house programs based on our proprietary technologies or antibodies</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Multiple new IND applications expected to be submitted over coming years</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Genmab has entered multiple strategic collaborations to support the expansion of our innovative pipeline</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Our preclinical pipeline includes immune effector function enhanced antibodies developed with our HexaBody technology and bispecific antibodies created with our DuoBody<sup style="font-size:7.5pt;vertical-align:top;"> </sup>platform. We are also working with our partners, including AbbVie, BioNTech, Immatics Biotechnologies GmbH, CureVac N.V. </p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 67</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 15/38</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20211110xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months Ended September 30, 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">(CureVac) and Bolt Biotherapeutics, Inc. (Bolt), to generate additional new product concepts. A number of the preclinical programs are carried out in cooperation with our collaboration partners.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Third Quarter 2021 Update</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">July: First CTA submitted for DuoBody-CD3xB7H4 (GEN1047).</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">First Half 2021 Update</b></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">May: Genmab and Bolt entered into an oncology research and development collaboration. The companies will evaluate Genmab antibodies and bispecific antibody engineering technologies in combination with Bolt&#8217;s proprietary Boltbody&#8482; immune-stimulating antibody conjugate (ISAC) technology platform, with the goal of discovering and developing next-generation, immune-stimulatory, antibody-based conjugate therapeutics for the treatment of cancer.</font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;"> </font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">The research collaboration will evaluate multiple bispecific ISAC concepts to identify up to three clinical candidates for development. Genmab will fund the research, along with the preclinical and clinical development of these candidates through clinical proof of concept.</font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;"> </font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Under the terms of the agreement, Genmab paid Bolt an upfront payment of USD 10 million and a USD 15 million equity investment in Bolt in June 2021. Bolt is eligible to receive total potential milestone payments of up to USD 285 million per therapeutic candidate exclusively developed and commercialized by Genmab, along with tiered royalties. Genmab will fully fund preclinical and early clinical development of all candidates. If a candidate is co-developed, development costs will be split 50:50 between the two companies, and the companies will be solely responsible for commercialization costs in their respective territories and shall pay each other royalties on product sales.</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;text-indent:0pt;margin:12pt 0pt 3pt 0pt;"><b style="font-size:16pt;font-weight:bold;"><a name="_SIGNIFICANT_RISKS_AND"></a></b><b style="color:#029c93;font-weight:bold;">SIGNIFICANT RISKS AND UNCERTAINTIES</b><b style="font-size:16pt;font-weight:bold;"><a name="SIGNIFICANTRISKSANDUNCERTAINTIES_402181"></a></b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">As a biotech company, Genmab faces a number of risks and uncertainties. These are common for the industry and relate to operations, intellectual property, research and development, commercialization and financial activities. For further information about risks and uncertainties which Genmab faces, refer to the 2020 Annual Report filed with NASDAQ Copenhagen in February 2021 and the Form 20-F filed with the SEC in March 2021. At the date of this interim report, there have been no significant changes to Genmab&#8217;s overall risk profile since the publication of the Form 20-F; however, the full extent and nature of the impact of the COVID-19 pandemic and related containment measures on our business and financial performance is uncertain as the situation continues to develop. See Genmab&#8217;s Form 20-F for a detailed summary of risks related to our collaborations as well as risks related to the COVID-19 pandemic. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a name="OLE_LINK16"></a><a name="OLE_LINK15"></a><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 67</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 16/38</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20211110xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months Ended September 30, 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;font-weight:bold;padding-left:21.6pt;text-indent:-21.6pt;margin:0pt 0pt 3pt 0pt;"><b style="color:#029c93;font-weight:bold;">FINANCIAL REVIEW</b><b style="font-size:16pt;font-weight:bold;"><a name="FINANCIALREVIEW_601130"></a></b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a name="OLE_LINK6"></a><a name="OLE_LINK7"></a>The interim report is prepared on a consolidated basis for the Genmab group. The financial statements are published in Danish Kroner (DKK).</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Revenue</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Genmab&#8217;s revenue was DKK 5,863 million for the first nine months of 2021 compared to DKK 8,067 million for the first nine months of 2020. The decrease of DKK 2,204 million, or 27%, was primarily driven by the one-time upfront payment of DKK 4,398 million recognized as license revenue from AbbVie pursuant to our collaboration announced in June 2020, partly offset by higher DARZALEX royalties as well as milestone revenue from various collaboration partners.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:55.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:18.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:18.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:55.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><b style="font-weight:bold;">(DKK million)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;width:18.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">First 9 Months <br>2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:18.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">First 9 Months <br>2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:55.97%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Royalties</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:18.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 4,698</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 3,090</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.97%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Reimbursement revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:18.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 371</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 294</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.97%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Milestone revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:18.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 794</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 95</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">License revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:18.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 4,588</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><b style="font-weight:bold;">Total revenue</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:18.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 5,863</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 8,067</b></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Royalties</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Royalty revenue amounted to DKK 4,698 million in the first nine months of 2021 compared to DKK 3,090 million in the first nine months of 2020. The increase of DKK 1,608 million, or 52%, was primarily driven by higher DARZALEX royalties achieved under our daratumumab collaboration with Janssen. The table below summarizes Genmab&#8217;s royalty revenue by product. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:55.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:18.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:18.98%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:55.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><b style="font-weight:bold;">(DKK million)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;width:18.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">First 9 Months <br>2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:18.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">First 9 Months <br>2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:55.97%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">DARZALEX </p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:18.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 4,167</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,898</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.97%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">TEPEZZA </p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:18.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 384</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 178</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.97%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Kesimpta </p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:18.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 140</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.98%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Other</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:18.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 7</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 13</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.97%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><b style="font-weight:bold;">Total royalties</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:18.99%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 4,698</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:18.98%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 3,090</b></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Net sales of DARZALEX by Janssen were USD 4,378 million in the first nine months of 2021 compared to USD 2,937 million in the first nine months of 2020. The increase of USD 1,441 million, or 49%, was driven by the continued strong uptake of DARZALEX. Royalty revenue on net sales of DARZALEX<sup style="font-size:7.5pt;vertical-align:top;"> </sup>was DKK 4,167 million in the first nine months of 2021 compared to DKK 2,898 million in the first nine months of 2020, an increase of DKK 1,269 million. The percentage increase in royalties of 44% is lower than the percentage increase in the underlying net sales primarily due to the lower exchange rate between the USD and DKK in the first nine months of 2021 compared to the first nine months of 2020 and the impact of Janssen&#8217;s continued withholding of a portion of the royalty payments owed to Genmab. Since the second quarter of 2020, Janssen has reduced its quarterly royalty payments to Genmab by what Janssen claims to be Genmab&#8217;s share of Janssen&#8217;s royalty payments to Halozyme in connection with SC sales. Given the ongoing arbitration, Genmab has reflected this reduction in its royalty revenues each quarter. The impact to royalties was estimated to be DKK 270 million in the first nine months of 2021 compared to DKK 21 million in the first nine months of 2020. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 67</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 17/38</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20211110xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months Ended September 30, 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">TEPEZZA was launched by Horizon in the first quarter of 2020. In December 2020, Horizon announced that there was a supply disruption related to the production of TEPEZZA due to U.S. government-mandated COVID-19 vaccine production requirements. Subsequently, Horizon announced that it had resumed supplying the market beginning in April 2021. Royalties, which are based on net sales, amounted to DKK 384 million during the first nine months of 2021 compared to DKK 178 million during the first nine months of 2020. The increase of DKK 206 million was driven by the strong uptake of TEPEZZA.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Novartis was granted U.S. FDA approval for Kesimpta in relapsing multiple sclerosis and Genmab started recognizing royalties on net sales of Kesimpta during the third quarter of 2020. Royalties, which are based on net sales, amounted to DKK 140 million for the first nine months of 2021. Royalties for the third quarter of 2020 were not material.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Janssen was granted U.S. FDA approval for RYBREVANT, a fully human bispecific antibody that targets EGFR and cMet, and Genmab started recognizing royalties on net sales of RYBREVANT during the second quarter of 2021. Royalties were not material through September 30, 2021.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Royalty revenue fluctuations from period to period are due primarily to the level of product net sales as well as foreign currency exchange rates. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Reimbursement Revenue</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Reimbursement revenue amounted to DKK 371 million in the first nine months of 2021 compared to DKK 294 million in the first nine months of 2020. The increase of DKK 77 million, or 26%, was primarily driven by higher activities under our collaboration agreement with BioNTech for DuoBody-PD-L1x4-1BB.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Milestone Revenue</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a name="_Hlk14190762"></a>Milestone revenue was DKK 794 million in the first nine months of 2021 compared to DKK 95 million in the first nine months of 2020, an increase of DKK 699 million, primarily driven by the following:</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'ArialMT';visibility:hidden;">&#8203;</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">AbbVie milestone of DKK 245 million (USD 40 million) triggered by the first patient dosed in the Phase 3 study of epcoritamab, </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">DARZALEX FASPRO milestone of DKK 184 million (USD 30 million) driven by the first commercial sale in the U.S. for patients with newly diagnosed AL amyloidosis,</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Janssen DuoBody milestone of DKK 152 million (USD 25 million) driven by U.S. FDA approval for RYBREVANT, and</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">DARZALEX SC milestone of DKK 125 million (USD 20 million) driven by the first commercial sale in the EU for patients with newly diagnosed AL amyloidosis.</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Milestone revenue may fluctuate significantly from period to period due to both the timing of achievements and the varying amount of each individual milestone under our license and collaboration agreements.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">License Revenue</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">There was no license revenue during the first nine months of 2021. License revenue was DKK 4,588 million during the first nine months of 2020, which was primarily driven by the delivery of licenses for three programs under the AbbVie collaboration of DKK 4,398 million and the payment of DKK 188 million (USD 30 million) from Novartis as a result of Novartis&#8217;s plan to transition Arzerra (ofatumumab) to an oncology access program for chronic lymphocytic leukemia patients in the U.S.</p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 67</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 18/38</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20211110xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months Ended September 30, 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Collaboration Revenue</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">In September 2021, Genmab and Seagen announced U.S. FDA accelerated approval for TIVDAK in previously treated recurrent or metastatic cervical cancer. Collaboration revenue was not material for the third quarter of 2021.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Refer to Financial Statement Note 2 in this interim report for further details about revenue.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Research and Development Costs</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Research and development costs amounted to DKK 2,883 million in the first nine months of 2021 compared to DKK 2,211 million in the first nine months of 2020. The increase of DKK 672 million, or 30%, was driven by the continued advancement of epcoritamab and DuoBody-PD-L1x4-1BB under our collaborations with AbbVie and BioNTech, respectively, and the increase in new employees to support the expansion of our product pipeline. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Research and development costs accounted for 79% of total operating expenses in the first nine months of 2021 compared to 84% in the first nine months of 2020. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Selling, General and Administrative Expenses</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Selling, general and administrative expenses were DKK 771 million in the first nine months of 2021 compared to DKK 430 million in the first nine months of 2020. The increase of DKK 341 million, or 79%, was driven by the increase in new employees to support the launch of TIVDAK, as well as expansion of commercialization capabilities and Genmab&#8217;s broader organizational infrastructure.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Selling, general and administrative expenses accounted for 21% of total operating expenses in the first nine months of 2021 compared to 16% in the first nine months of 2020.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Operating Result </b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Operating result was DKK 2,209 million in the first nine months of 2021 compared to DKK 5,426 million in the first nine months of 2020. The decrease of DKK 3,217 million, or 59%, was driven by lower revenue and increased operating expenses as described above.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Net Financial Items</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Net financial items for the first nine months of 2021 was income of DKK 808 million compared to expense of DKK 73 million in the first nine months of 2020. The increase of DKK 881 million was primarily driven by the strengthening of the USD against the DKK on Genmab&#8217;s USD denominated portfolio and cash holdings, partly offset by the loss on other investments due to the change in fair value of Genmab&#8217;s investments in common shares of CureVac and Bolt, and the loss on marketable securities driven by movements in interest rates in the United States and Europe. Refer to Financial Statement Note 4 in this interim report for further details about the net financial items.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Corporate Tax</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Corporate tax expense for the first nine months of 2021 was DKK 725 million compared to DKK 1,176 million for the first nine months of 2020. The decrease in corporate tax expense is primarily the result of Genmab&#8217;s lower net result before tax. The effective tax rate in the first nine months of 2021 was 24% compared to 22% in the first nine months of 2020. <a name="_Hlk85637634"></a>The increase in the effective tax rate is primarily due to the inability to deduct certain subsidiary losses for tax purposes.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 67</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 19/38</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20211110xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months Ended September 30, 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Net Result </b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Net result for the first nine months of 2021 was DKK 2,292 million compared to DKK 4,177 million in the first nine months of 2020. The decrease was driven by the items described above. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Liquidity and Capital Resources</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:56.02%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:19.95%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:19.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:56.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><b style="font-weight:bold;">(DKK million)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:19.95%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">September&#160;30,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:56.02%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Marketable securities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:19.95%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 10,014</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 8,819</font></p></td></tr><tr><td style="vertical-align:bottom;width:56.02%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Cash and cash equivalents</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:19.95%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 8,729</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 7,260</font></p></td></tr><tr><td style="vertical-align:bottom;width:56.02%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Shareholders&#39; equity</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:19.95%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 21,285</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 19,121</font></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:56.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:19.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:19.19%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:56.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><b style="font-weight:bold;">Cash Flow (DKK million)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;width:19.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">First 9 Months <br>2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:19.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">First 9 Months <br>2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:56.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Cash provided by operating activities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:19.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,987</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.19%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 7,231</font></p></td></tr><tr><td style="vertical-align:bottom;width:56.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Cash (used in) investing activities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:19.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (655)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.19%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (1,637)</font></p></td></tr><tr><td style="vertical-align:bottom;width:56.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Cash (used in) provided by financing activities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:19.22%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (436)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.57%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.19%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 38</font></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Net cash provided by operating activities is primarily related to our operating result, changes in operating assets and liabilities, reversal of net financial items, and adjustments related to non-cash transactions. In the first nine months of 2021, as compared to the first nine months of 2020, the primary driver of lower cash provided by operating activities was due to the upfront payment from AbbVie included in our operating result collected in July 2020, and higher positive working capital adjustments in 2020 related to DARZALEX milestones achieved in the fourth quarter of 2019 that were received in 2020 of DKK 1.7 billion.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Net cash used in investing activities primarily reflects differences between the proceeds received from sale and maturity of our investments and amounts invested, and the investment in tangible assets. Purchases of marketable securities exceeded sales and maturities in both periods, but to a greater extent in the first nine months of 2020. For the first nine months of 2021, investing activities also includes the proceeds from the sale of CureVac shares of DKK 438 million.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="background-color:#ffff00;font-size:9pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Net cash used in financing activities is primarily related to the exercise of warrants, purchase of treasury shares, lease payments, and payment of withholding taxes on behalf of employees on net settled Restricted Stock Units (RSUs). In the first nine months of 2021, the primary driver of the cash used in financing activities was&#160;related to cash payments for the purchase of treasury shares of DKK 447 million.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">As of September 30, 2021, Genmab&#8217;s USD denominated cash and cash equivalents, and marketable securities represents 86% of Genmab&#8217;s total cash and cash equivalents, and marketable securities, compared to 83% as of December 31, 2020.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Cash and cash equivalents included short-term marketable securities of DKK 187 million at the end of September 2021, compared to DKK 2,206 million at the end of December 2020. In accordance with our accounting policy, securities purchased with a maturity of less than ninety days at the date of acquisition are classified as cash and cash equivalents. Refer to Financial Statement Note 3 in this interim report for further details about our marketable securities.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 67</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 20/38</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20211110xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months Ended September 30, 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Balance Sheet</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">As of September 30, 2021, total assets were DKK 23,985 million compared to DKK 21,143 million on December 31, 2020. As of September 30, 2021, assets are mainly comprised of cash and cash equivalents of DKK 8,729 million, marketable securities of DKK 10,014 million and current receivables of DKK 3,211 million. The current receivables consist primarily of amounts related to royalties and milestones from our collaboration agreements.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">As of September 30, 2021, total liabilities were DKK 2,700 million compared to DKK 2,022 million on December 31, 2020. The increase in total liabilities of DKK 678 million, or 34%, was primarily driven by corporate tax payable of DKK 469 million and an increase in lease liabilities of DKK 118 million related to the commencement of leases in Japan and the United States.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Shareholders&#8217; equity as of September 30, 2021 was DKK 21,285 million compared to DKK 19,121 million on December 31, 2020. The increase of DKK 2,164 million, or 11%, was driven primarily by Genmab&#8217;s net result and the issuance of shares related to the share-based compensation plans, partly offset by the purchase of treasury shares. Genmab&#8217;s equity ratio was 89% as of September 30, 2021 compared to 90% as of December 31, 2020. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Employees</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">As of September 30, 2021, the total number of employees was 1,136 compared to 712 employees as of September 30, 2020. The increase in employees was primarily driven by the expansion and acceleration of our pipeline, as well as the investment in the expansion of commercialization capabilities, including support for the launch of TIVDAK, and broader organizational infrastructure.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:51.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:21.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.89%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:20.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:51.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><b style="font-weight:bold;">Employees</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:21.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">September&#160;30,&#160;2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">September&#160;30,&#160;2020</b></p></td></tr><tr><td style="vertical-align:bottom;width:51.89%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Research and development employees</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.89%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:21.72%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 871</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.89%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.59%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 595</font></p></td></tr><tr><td style="vertical-align:bottom;width:51.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Selling, general and administrative employees</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:21.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 265</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 117</font></p></td></tr><tr><td style="vertical-align:bottom;width:51.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;"><b style="font-weight:bold;">Total employees</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:21.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,136</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.89%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.59%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 712</b></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Legal Matter &#8211; Janssen Binding Arbitration </b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">In September 2020, Genmab commenced binding arbitration of two matters arising under its license agreement with Janssen relating to daratumumab. Under the license agreement, Genmab is, among other things, entitled to royalties from Janssen on sales of daratumumab (marketed as DARZALEX for IV administration and as DARZALEX <i style="font-style:italic;">FASPRO</i> in the United States and as DARZALEX SC in Europe for SC administration). The arbitration first is to settle whether Genmab is required to share in Janssen&#8217;s royalty payments to Halozyme Therapeutics, Inc. (Halozyme) for the Halozyme enzyme technology used in the SC formulation of daratumumab. The royalties Janssen pays to Halozyme represent a mid-single digit percentage rate of SC daratumumab sales. Janssen has started reducing its royalty payments to Genmab by what it claims to be Genmab&#8217;s share of Janssen&#8217;s royalty payments to Halozyme beginning in the second quarter of 2020 and has continued to do so through September 30, 2021. Given the ongoing arbitration, Genmab has reflected this reduction in its royalty revenues each quarter. The impact to royalties was estimated to be DKK 270 million in the first nine months of 2021 compared to DKK 21 million in the first nine months of 2020.The arbitration is also to settle whether Janssen&#8217;s obligation to pay royalties on sales of licensed product extends, in each applicable country, until the expiration or invalidation of the last-to-expire relevant Genmab-owned patent or the last-to-expire relevant Janssen-owned patent covering the product, as further defined and described in the license agreement. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 67</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 21/38</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20211110xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months Ended September 30, 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;font-weight:bold;text-indent:0pt;margin:0pt 0pt 3pt 0pt;"><b style="font-size:16pt;font-weight:bold;"><a name="_Toc16514647"></a></b><b style="color:#029c93;font-weight:bold;">STATEMENT OF COMPREHENSIVE INCOME FOR THE 3RD QUARTER OF </b><b style="font-size:16pt;font-weight:bold;"><a name="STATEMENTOFCOMPREHENSIVEINCOMEFORTHE3RDQ"></a></b><b style="color:#029c93;font-weight:bold;">2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:70.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:13.31%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:70.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Income Statement</b></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">3rd Quarter of</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">3rd Quarter of</p></td></tr><tr><td style="vertical-align:bottom;width:70.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:13.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">2020</p></td></tr><tr><td style="vertical-align:bottom;width:70.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">(DKK million)</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:70.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:70.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Revenue</b></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 2,310</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,724</b></p></td></tr><tr><td style="vertical-align:bottom;width:70.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:70.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Research and development expenses</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (1,114)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (721)</font></p></td></tr><tr><td style="vertical-align:bottom;width:70.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Selling, general and administrative expenses</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (306)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (145)</font></p></td></tr><tr><td style="vertical-align:bottom;width:70.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Operating expenses</b></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (1,420)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (866)</b></p></td></tr><tr><td style="vertical-align:bottom;width:70.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:70.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Operating result</b></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 890</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 858</b></p></td></tr><tr><td style="vertical-align:bottom;width:70.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:70.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Financial income</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 511</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 533</font></p></td></tr><tr><td style="vertical-align:bottom;width:70.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Financial expenses</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (230)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (720)</font></p></td></tr><tr><td style="vertical-align:bottom;width:70.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:70.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Net result before tax</b></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,171</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 671</b></p></td></tr><tr><td style="vertical-align:bottom;width:70.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:70.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Corporate tax</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (281)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (141)</font></p></td></tr><tr><td style="vertical-align:bottom;width:70.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:70.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Net result</b></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 890</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 530</b></p></td></tr><tr><td style="vertical-align:bottom;width:70.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:70.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Basic net result per share</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 13.61</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 8.13</font></p></td></tr><tr><td style="vertical-align:bottom;width:70.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Diluted net result per share</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 13.47</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 8.04</font></p></td></tr><tr><td style="vertical-align:bottom;width:70.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:70.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Statement of Comprehensive Income</b></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:70.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:70.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Net result</b></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 890</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 530</b></p></td></tr><tr><td style="vertical-align:bottom;width:70.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:70.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Other comprehensive income:</b></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:70.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:70.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Amounts which will be re-classified to the income statement:</b></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:70.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Adjustment of foreign currency fluctuations on subsidiaries</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (24)</font></p></td></tr><tr><td style="vertical-align:bottom;width:70.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.31%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:70.99%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total comprehensive income</b></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:13.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 892</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:13.31%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 506</b></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a name="_Toc16514648"></a><a name="_MON_1411968110"></a><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 67</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 22/38</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20211110xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months Ended September 30, 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;font-weight:bold;text-indent:0pt;margin:0pt 0pt 3pt 0pt;"><b style="color:#029c93;font-weight:bold;">STATEMENT OF COMPREHENSIVE INCOME FOR THE FIRST NINE MONTHS OF 2021</b><b style="font-size:16pt;font-weight:bold;"><a name="STATEMENTOFCOMPREHENSIVEINCOMEFORTHEFIRS"></a><a name="FIRSTNINEMONTHSOF2019_377366"></a></b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:49.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.75%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:49.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Income Statement</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.75%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">9 Months Ended</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">9 Months Ended</p></td></tr><tr><td style="vertical-align:bottom;width:49.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.75%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Note</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:19.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">September 30, 2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">September 30, 2020</p></td></tr><tr><td style="vertical-align:bottom;width:49.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">(DKK million)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.75%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.75%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Revenue</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.75%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">2</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:19.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 5,863</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 8,067</b></p></td></tr><tr><td style="vertical-align:bottom;width:49.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.75%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Research and development expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.75%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (2,883)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (2,211)</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Selling, general and administrative expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.75%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:19.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (771)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (430)</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Operating expenses</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.75%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:19.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (3,654)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (2,641)</b></p></td></tr><tr><td style="vertical-align:bottom;width:49.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.75%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Operating result</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.75%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 2,209</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 5,426</b></p></td></tr><tr><td style="vertical-align:bottom;width:49.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.75%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Financial income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.75%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">4</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,211</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 616</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Financial expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.75%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">4</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:19.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (403)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (689)</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.75%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Net result before tax</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.75%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 3,017</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 5,353</b></p></td></tr><tr><td style="vertical-align:bottom;width:49.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.75%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Corporate tax</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.75%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:19.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (725)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (1,176)</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.75%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Net result</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.75%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:19.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 2,292</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 4,177</b></p></td></tr><tr><td style="vertical-align:bottom;width:49.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.75%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Basic net result per share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.75%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 35.05</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 64.16</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Diluted net result per share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.75%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 34.72</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 63.46</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.75%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Statement of Comprehensive Income</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.75%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:49.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.75%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Net result</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.75%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:19.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 2,292</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 4,177</b></p></td></tr><tr><td style="vertical-align:bottom;width:49.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.75%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Other comprehensive income:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.75%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.75%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Amounts which will be re-classified to the income statement:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.75%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Adjustment of foreign currency fluctuations on subsidiaries</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.75%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:19.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 30</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (24)</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.75%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:49.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total comprehensive income</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.75%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:19.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 2,322</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.25pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 4,153</b></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 67</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 23/38</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20211110xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months Ended September 30, 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;font-weight:bold;text-indent:0pt;margin:0pt 0pt 3pt 0pt;"><b style="font-size:16pt;font-weight:bold;"><a name="_Hlk85106963"></a></b><b style="color:#029c93;font-weight:bold;">BALANCE SHEET</b><b style="font-size:16pt;font-weight:bold;"><a name="BALANCESHEET_757698"></a></b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:55.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:15.36%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:55.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">September&#160;30,&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">December&#160;31,&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:55.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Note</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">2020</p></td></tr><tr><td style="vertical-align:bottom;width:55.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">(DKK million)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">ASSETS</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:55.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Intangible assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 275</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 338</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Property, plant and equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 583</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 453</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Right-of-use assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">7</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 374</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 283</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Receivables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 33</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 20</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Deferred tax assets</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 179</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 177</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Other investments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">3</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 587</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,081</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Total non-current assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 2,031</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 2,352</b></p></td></tr><tr><td style="vertical-align:bottom;width:55.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Corporate tax receivable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 249</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Receivables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 3,211</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,463</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Marketable securities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">3</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 10,014</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 8,819</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Cash and cash equivalents</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 8,729</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 7,260</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Total current assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 21,954</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 18,791</b></p></td></tr><tr><td style="vertical-align:bottom;width:55.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Total assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 23,985</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 21,143</b></p></td></tr><tr><td style="vertical-align:bottom;width:55.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">SHAREHOLDERS&#8217; EQUITY AND LIABILITIES</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:55.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Share capital</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 66</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 66</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Share premium</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 11,996</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 11,894</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Other reserves</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 84</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 54</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Retained earnings</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 9,139</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 7,107</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Shareholders&#39; equity</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 21,285</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 19,121</b></p></td></tr><tr><td style="vertical-align:bottom;width:55.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Provisions</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 9</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 4</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">7</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 374</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 277</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Deferred revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 487</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 487</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Other payables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Total non-current liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 870</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 769</b></p></td></tr><tr><td style="vertical-align:bottom;width:55.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Corporate tax payable</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 469</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;width:11.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Lease liabilities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">7</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 63</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 42</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Deferred revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 26</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 26</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Other payables</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,272</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,185</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Total current liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,830</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,253</b></p></td></tr><tr><td style="vertical-align:bottom;width:55.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Total liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 2,700</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 2,022</b></p></td></tr><tr><td style="vertical-align:bottom;width:55.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Total shareholders&#39; equity and liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:15.36%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 23,985</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 21,143</b></p></td></tr><tr><td style="vertical-align:bottom;width:55.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Share-based instruments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">5</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:55.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Related parties</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">6</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:55.14%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Subsequent events to the balance sheet date</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.67%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">8</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.86%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.36%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.87%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.21%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a name="_MON_1411968448"></a><a name="_MON_1428926110"></a><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 67</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 24/38</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20211110xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months Ended September 30, 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;font-weight:bold;text-indent:0pt;margin:0pt 0pt 3pt 0pt;"><b style="color:#029c93;font-weight:bold;">STATEMENT OF CASH FLOWS</b><b style="font-size:16pt;font-weight:bold;"><a name="STATEMENTOFCASHFLOWS_489627"></a></b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:55.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:4.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:55.63%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:4.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;">9 Months Ended</p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;">9 Months Ended</p></td></tr><tr><td style="vertical-align:bottom;width:55.63%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:4.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Note</b></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;width:17.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;">September&#160;30,&#160;2021</p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-family:'Calibri','Helvetica','sans-serif';font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:17.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;">September&#160;30,&#160;2020</p></td></tr><tr><td style="vertical-align:bottom;width:55.63%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">(DKK million)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.63%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.63%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Net result before tax</b></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:4.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 3,017</b></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 5,353</b></p></td></tr><tr><td style="vertical-align:bottom;width:55.63%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:4.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.63%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Reversal of financial items, net</p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:4.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (808)</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 73</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.63%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Adjustments for non-cash transactions</p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:4.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 376</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 319</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.63%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Changes in operating assets and liabilities</p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:4.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;width:17.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (756)</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,487</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.63%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:4.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.63%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Cash flow from operating activities before financial items</b></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:4.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,829</b></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 7,232</b></p></td></tr><tr><td style="vertical-align:bottom;width:55.63%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:4.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.63%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Interest received</p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:4.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 169</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 110</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.63%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Interest elements of lease payments</p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:4.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;">7</p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (9)</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (6)</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.63%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Interest paid</p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:4.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (8)</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.63%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Corporate taxes paid</p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:4.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;width:17.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (2)</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (97)</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.63%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:4.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.63%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Cash flow from operating activities</b></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:4.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;width:17.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,987</b></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 7,231</b></p></td></tr><tr><td style="vertical-align:bottom;width:55.63%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:4.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.63%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Investment in tangible assets</p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:4.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (184)</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (249)</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.63%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Marketable securities bought</p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:4.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (13,529)</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (8,311)</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.63%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Marketable securities sold</p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:4.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 12,712</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 6,923</font></p></td></tr><tr><td style="vertical-align:middle;width:55.63%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Other investments bought</p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:4.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;">3</p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (92)</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td></tr><tr><td style="vertical-align:middle;width:55.63%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Other investments sold</p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:4.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;">3</p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;width:17.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 438</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.63%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:4.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.63%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Cash flow from investing activities</b></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:4.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;width:17.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (655)</b></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (1,637)</b></p></td></tr><tr><td style="vertical-align:bottom;width:55.63%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:4.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.63%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Warrants exercised</p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:4.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 102</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 87</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.63%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Principal elements of lease payments</p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:4.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (50)</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (30)</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.63%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Purchase of treasury shares</p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:4.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (447)</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.63%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Payment of withholding taxes on behalf of employees on net settled RSUs</p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:4.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;width:17.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (41)</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (19)</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.63%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:4.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.63%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Cash flow from financing activities</b></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:4.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;width:17.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (436)</b></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 38</b></p></td></tr><tr><td style="vertical-align:bottom;width:55.63%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:4.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.63%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Change in cash and cash equivalents</b></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:4.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 896</b></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 5,632</b></p></td></tr><tr><td style="vertical-align:bottom;width:55.63%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Cash and cash equivalents at the beginning of the period</p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:4.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 7,260</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 3,552</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.63%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Exchange rate adjustments</p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:4.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;width:17.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 573</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (292)</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.63%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:4.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.63%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Cash and cash equivalents at the end of the period</b></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:4.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;width:17.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 8,729</b></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 8,892</b></p></td></tr><tr><td style="vertical-align:bottom;width:55.63%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:4.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.63%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Cash and cash equivalents include:</b></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:4.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.63%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Bank deposits</p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:4.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 8,542</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 5,927</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.63%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Short-term marketable securities</p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:4.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;width:17.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 187</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,965</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.63%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:4.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.43%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:55.63%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Cash and cash equivalents at the end of the period</b></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:4.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;width:17.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 8,729</b></p></td><td style="vertical-align:bottom;width:1.74%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:17.43%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 8,892</b></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 67</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 25/38</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20211110xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months Ended September 30, 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;font-weight:bold;padding-left:21.6pt;text-indent:-21.6pt;margin:0pt;"><b style="font-size:16pt;font-weight:bold;"><a name="_Hlk85117610"></a></b><b style="color:#029c93;font-weight:bold;">STATEMENT OF CHANGES IN EQUITY</b><b style="font-size:16pt;font-weight:bold;"><a name="STATEMENTOFCHANGESINEQUITY_43137"></a></b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">Share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">Share</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">Translation</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">Retained</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">Shareholders&#39;</p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">capital</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">premium</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">reserves</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">earnings</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">equity</p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">(DKK million)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Balance at December 31, 2019</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 65</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 11,755</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 98</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 2,130</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 14,048</b></p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Net result</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 4,177</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 4,177</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Other comprehensive income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (24)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (24)</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Total comprehensive income</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (24)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 4,177</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 4,153</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Transactions with owners:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Exercise of warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 120</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 120</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Share-based compensation expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 149</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 149</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Net settlement of RSUs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (19)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (19)</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tax on items recognized directly in equity</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 26</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 26</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Balance at September 30, 2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 65</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 11,875</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 74</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 6,463</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 18,477</b></p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Balance at December 31, 2020</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 66</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 11,894</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 54</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 7,107</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 19,121</b></p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Net result</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,292</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,292</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Other comprehensive income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 30</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 30</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Total comprehensive income</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 30</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,292</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,322</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Transactions with owners:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Exercise of warrants</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 102</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 102</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Purchase of treasury shares</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (447)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (447)</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Share-based compensation expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 228</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 228</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Net settlement of RSUs</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (41)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (41)</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:31.91%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Balance at September 30, 2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.03%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 66</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 11,996</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.68%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 84</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.11%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 9,139</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.38%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 21,285</b></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 67</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 26/38</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20211110xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months Ended September 30, 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;font-weight:bold;padding-left:21.6pt;text-indent:-21.6pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">NOTES TO THE FINANCIAL STATEMENTS</b><b style="font-size:16pt;font-weight:bold;"><a name="NOTESTOTHEFINANCIALSTATEMENTS_435403"></a></b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Note 1 &#8211; Basis of Presentation</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Accounting Policies</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">These interim statements of the Genmab group (Genmab or the Company) have been prepared in accordance with IAS 34 as issued by the International Accounting Standards Board (IASB) and in accordance with IAS 34 as endorsed by the EU and additional Danish disclosure requirements for interim reports of listed companies. The interim report has not been reviewed or audited by Genmab&#8217;s external auditors. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">The interim report has been prepared using the same accounting policies as outlined in Section 1 &#8211; Basis of Presentation in the financial statements in the Genmab 2020 Annual Report (Annual Report). A number of new or amended standards became applicable for the current reporting period. Genmab was not required to change its accounting policies as a result of adopting these standards. These interim financial statements should be read in conjunction with the Annual Report. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Management Judgements and Estimates under IFRS</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">In preparing interim reports, certain provisions under IFRS require management to make judgements (various accounting estimates and assumptions), which may significantly impact the group&#8217;s financial statements. For a description of significant judgements and estimates, refer to Note 1.3 in the Annual Report.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Information about Geographical Areas</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Genmab is managed and operated as one business unit, which is reflected in the organizational structure and internal reporting. No separate lines of business or separate business entities have been identified with respect to any licensed products, product candidates or geographical markets and no segment information is currently prepared for internal reporting. Refer to Note 2.2 in the Annual Report for further details.</p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 67</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 27/38</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20211110xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months Ended September 30, 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a name="_MON_1428393242"></a><a name="_MON_1428926213"></a><b style="color:#029c93;font-weight:bold;">Note 2 &#8211; Revenue </b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Genmab enters into license and collaboration agreements that contain provisions that are within the scope of IFRS 15, under which it licenses certain rights to its product candidates to third parties and also may participate in the development and commercialization of the product candidates. The terms of these arrangements typically include payment to Genmab of one or more of the following: non-refundable, upfront license fees; exclusive designation fees; annual license maintenance fees; additional target fees; development, regulatory and commercial milestone payments; reimbursements for research and development services; and royalties on net sales of licensed products. Each of these payments results in revenue from contracts with customers. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">In September 2020, Genmab commenced binding arbitration of two matters arising under its license agreement with Janssen relating to daratumumab. Under the license agreement, Genmab is, among other things, entitled to royalties from Janssen on sales of daratumumab (marketed as DARZALEX for IV administration and as DARZALEX FASPRO in the United States and as DARZALEX SC in Europe for SC administration). The arbitration first is to settle whether Genmab is required to share in Janssen&#8217;s royalty payments to Halozyme for the Halozyme enzyme technology used in the SC formulation of daratumumab. The royalties Janssen pays to Halozyme represent a mid-single digit percentage rate of SC daratumumab sales. Janssen has started reducing its royalty payments to Genmab by what it claims to be Genmab&#8217;s share of Janssen&#8217;s royalty payments to Halozyme beginning in the second quarter of 2020 and has continued to do so through September 30, 2021. Given the ongoing arbitration, Genmab has reflected this reduction in its royalty revenues each quarter. The impact to royalties was estimated to be DKK 270 million in the first nine months of 2021 compared to DKK 21 million in the first nine months of 2020. The arbitration is also to settle whether Janssen&#8217;s obligation to pay royalties on sales of licensed product extends, in each applicable country, until the expiration or invalidation of the last-to-expire relevant Genmab-owned patent or the last-to-expire relevant Janssen-owned patent covering the product, as further defined and described in the license agreement. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">The table below summarizes Genmab&#8217;s revenue by type and collaboration partner under Genmab&#8217;s agreements. This information provides the reader additional information regarding the nature, amount, timing and uncertainty of Genmab&#8217;s revenue and how cash flows might be affected by economic factors.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:58.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:20.41%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:15.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:58.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:20.41%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">9 Months Ended</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.49%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">9 Months Ended</p></td></tr><tr><td style="vertical-align:bottom;width:58.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:20.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">September&#160;30,&#160;2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">September&#160;30,&#160;2020</p></td></tr><tr><td style="vertical-align:bottom;width:58.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">(DKK million)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:20.41%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.49%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:58.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Revenue by type:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:20.41%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.49%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:58.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Royalties</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:20.41%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 4,698</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.49%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 3,090</font></p></td></tr><tr><td style="vertical-align:bottom;width:58.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Reimbursement revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:20.41%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 371</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.49%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 294</font></p></td></tr><tr><td style="vertical-align:bottom;width:58.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Milestone revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:20.41%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 794</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.49%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 95</font></p></td></tr><tr><td style="vertical-align:bottom;width:58.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">License revenue</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:20.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 4,588</font></p></td></tr><tr><td style="vertical-align:bottom;width:58.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:20.41%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.49%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:58.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:20.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 5,863</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 8,067</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:20.41%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.49%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:58.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Revenue by collaboration partner:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:20.41%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.49%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:58.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Janssen</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:20.41%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 4,722</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.49%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2,961</font></p></td></tr><tr><td style="vertical-align:bottom;width:58.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">AbbVie</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:20.41%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 245</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.49%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 4,398</font></p></td></tr><tr><td style="vertical-align:bottom;width:58.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Roche</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:20.41%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 384</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.49%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 185</font></p></td></tr><tr><td style="vertical-align:bottom;width:58.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Seagen</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:20.41%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 87</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.49%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 158</font></p></td></tr><tr><td style="vertical-align:bottom;width:58.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">BioNTech</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:20.41%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 284</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.49%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 136</font></p></td></tr><tr><td style="vertical-align:bottom;width:58.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Novartis</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:20.41%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 141</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.49%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 202</font></p></td></tr><tr><td style="vertical-align:bottom;width:58.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Other collaboration partners</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:20.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 27</font></p></td></tr><tr><td style="vertical-align:bottom;width:58.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:20.41%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.49%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:58.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.79%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:20.41%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 5,863</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.8%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.49%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 2.75pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 8,067</b></p></td></tr></table></div></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 67</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 28/38</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20211110xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months Ended September 30, 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">AbbVie Collaboration Agreement </b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">On June 10, 2020, Genmab entered into a broad collaboration agreement with AbbVie to jointly develop and commercialize epcoritamab (DuoBody-CD3xCD20), DuoHexaBody-CD37 and DuoBody-CD3x5T4 and a discovery research collaboration for future differentiated antibody therapeutics for cancer. Under the terms of the agreement, Genmab received a USD 750 million (DKK 4,911 million) upfront payment in July 2020. Genmab recognized DKK 4,398 million as license revenue during the first nine months of 2020 driven by the delivery of licenses for the three programs described above. Genmab recorded DKK 513 million as deferred revenue related to co-development activities for product concepts and is expected to be recognized as revenue activities are performed, which is estimated to be over a seven-year period. No revenue has been recognized in the first nine months of 2021 or 2020 as co-development activities for product concepts have not yet commenced. Refer to Note 2.1 in the Annual Report for further details of the AbbVie collaboration agreement.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Note 3 &#8211; Financial Instruments</b> </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:50.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:20.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:20.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.18%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:50.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:20.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">September&#160;30,&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">December&#160;31,&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:50.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:20.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">2020</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:50.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">(DKK million)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:20.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:50.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:20.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:50.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Marketable securities</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:20.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 10,014</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 8,819</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:50.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Other investments</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:20.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 587</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,081</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:50.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Financial assets measured at fair value</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:20.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 10,601</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.09%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 9,900</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:50.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.09%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.18%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Genmab&#8217;s marketable securities are administrated by external investment managers. The investment guidelines and managers are reviewed regularly to reflect changes in market conditions, Genmab&#8217;s activities and financial position. At the beginning of 2021, Genmab&#8217;s investment policy was amended to allow investments in debt rated BBB- or greater by S&amp;P or Fitch and in debt rated Baa3 or greater by Moody&#8217;s. The amended policy also includes additional allowable investment types such as corporate debt, commercial paper, certificates of deposit, and certain types of AAA rated asset-backed securities. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Genmab&#8217;s portfolio is spread over a number of different securities with a focus on liquidity and security. Genmab&#8217;s marketable securities in USD, DKK, EUR, and GBP denominated securities as a percentage of total marketable securities was as follows: </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:33.44%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:27.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:27.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.3%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:33.44%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="2" style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:31.23%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">September&#160;30,&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:31.23%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">December&#160;31,&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:33.44%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:31.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:31.23%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">2020</p></td></tr><tr><td style="vertical-align:bottom;width:33.44%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Percent</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:27.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:3.3%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.3%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:33.44%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:27.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:3.3%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.3%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:33.44%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">USD</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:27.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 74</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:3.3%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 70</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.3%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:33.44%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">DKK</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:27.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 16</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:3.3%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 19</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.3%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:33.44%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">EUR</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:27.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 9</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:3.3%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.93%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 10</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.3%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:33.44%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">GBP</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:27.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:3.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">%</p></td></tr><tr><td style="vertical-align:bottom;width:33.44%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.66%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:27.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 100</b></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:3.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:27.93%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 100</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.3%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">%</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">As of September 30, 2021, 72% of Genmab&#8217;s marketable securities were long-term A rated or higher, or short-term A-1 / P-1 rated by S&amp;P, Moody&#8217;s or Fitch compared to 100% as of December 31, 2020. The </p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 67</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 29/38</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20211110xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months Ended September 30, 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">change in portfolio mix is driven by Genmab&#8217;s amendment to its investment policy in 2021 which included the expansion of allowed investment grade ratings for Genmab&#8217;s portfolio. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Fair Value Measurement </b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">For financial instruments that are measured in the balance sheet at fair value, IFRS 13 for financial instruments requires disclosure of fair value measurements by level of the following fair value measurement hierarchy for: </p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Level 1 &#8211; Quoted prices (unadjusted) in active markets for identical assets or liabilities</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Level 2 &#8211; Inputs other than quoted prices included within level 1 that are observable for the asset or liability, either directly (that is, as prices) or indirectly (that is, derived from prices)</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;text-align:left;">Level 3 &#8211; Inputs for the asset or liability that are not based on observable market data (that is, unobservable inputs).</font></td></tr></table><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:middle;width:26.01%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;white-space:nowrap;width:10.69%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;white-space:nowrap;width:10.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;white-space:nowrap;width:6.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;white-space:nowrap;width:6.34%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;white-space:nowrap;width:6.13%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;white-space:nowrap;width:6.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;white-space:nowrap;width:6.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:middle;white-space:nowrap;width:6.27%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:50%;transform:translate(0,-50%);width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:middle;width:26.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">(DKK million)</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></td><td colspan="7" style="vertical-align:middle;white-space:nowrap;width:39.65%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">September&#160;30,&#160;2021</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td colspan="7" style="vertical-align:middle;white-space:nowrap;width:30.52%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">December&#160;31,&#160;2020</b></p></td></tr><tr><td style="vertical-align:middle;width:26.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Assets Measured at Fair Value</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:10.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Level&#160;1</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:10.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Level&#160;2</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:6.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Level&#160;3</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:6.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:6.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Level&#160;1</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:6.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Level&#160;2</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:6.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Level&#160;3</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:middle;white-space:nowrap;width:6.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total</b></p></td></tr><tr><td style="vertical-align:middle;width:26.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:10.69%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:10.7%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:6.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:6.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:6.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:6.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:middle;white-space:nowrap;width:6.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:26.01%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Marketable securities</p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:10.69%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 10,014</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:10.7%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> -</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:6.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> -</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:6.34%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 10,014</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:6.13%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;">8,819</p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:6.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> -</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:6.2%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> -</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:6.27%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;">8,819</p></td></tr><tr><td style="vertical-align:bottom;width:26.01%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;margin:0pt;">Other investments</p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:10.69%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;">562</p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:10.7%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> -</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:6.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;">25</p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:6.34%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 587</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:6.13%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1,067</p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:6.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> -</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:6.2%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;">14</p></td><td style="vertical-align:middle;white-space:nowrap;width:1.9%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-size:8pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:middle;white-space:nowrap;width:6.27%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1,081</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Marketable Securities</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">All fair values are determined by reference to external sources using unadjusted quoted prices in established markets for Genmab&#8217;s marketable securities (Level 1). </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Other Investments </b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Other investments as of September 30, 2021 consist primarily of a DKK 495 million investment in common shares of CureVac, compared to DKK 1,067 million as of December 31, 2020. During the first nine months of 2021, Genmab sold 35% of its investment in common shares of CureVac. Proceeds received from the sale of shares were DKK 438 million. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">During the second quarter of 2021, Genmab made an investment in common shares of Bolt. As of September 30, 2021, the investment in Bolt was valued at DKK 67 million. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">The investments in CureVac and Bolt are recorded at fair value through profit and loss. The fair value of Genmab&#8217;s investments in CureVac and Bolt are determined using unadjusted quoted prices in established markets (Level 1).</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 67</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 30/38</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20211110xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months Ended September 30, 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Note 4 &#8211; Financial Income and Expenses</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:56.49%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:56.49%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">9 Months Ended</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">9 Months Ended</p></td></tr><tr><td style="vertical-align:bottom;width:56.49%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:19.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">September&#160;30,&#160;2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">September&#160;30,&#160;2020</p></td></tr><tr><td style="vertical-align:bottom;width:56.49%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">(DKK million)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:56.49%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:56.49%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Financial income:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:56.49%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Interest and other financial income</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 162</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 126</font></p></td></tr><tr><td style="vertical-align:bottom;width:56.49%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Gain on other investments, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 490</font></p></td></tr><tr><td style="vertical-align:bottom;width:56.49%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Foreign exchange rate gain, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:19.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1,049</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td></tr><tr><td style="vertical-align:bottom;width:56.49%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;"> </b><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;"> </b><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:56.49%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total financial income</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:19.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 1,211</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 616</b></p></td></tr><tr><td style="vertical-align:bottom;width:56.49%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:56.49%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Financial expenses:</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:56.49%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Interest and other financial expenses</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (10)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (7)</font></p></td></tr><tr><td style="vertical-align:bottom;width:56.49%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Loss on marketable securities, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (184)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (37)</font></p></td></tr><tr><td style="vertical-align:bottom;width:56.49%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Loss on other investments, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (209)</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td></tr><tr><td style="vertical-align:bottom;width:56.49%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Foreign exchange rate loss, net</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:19.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><font style="white-space:pre-wrap;"> &#8212;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="white-space:pre-wrap;"> (645)</font></p></td></tr><tr><td style="vertical-align:bottom;width:56.49%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:56.49%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total financial expenses</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:19.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (403)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (689)</b></p></td></tr><tr><td style="vertical-align:bottom;width:56.49%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.37%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:56.49%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Net financial items</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:19.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 808</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.38%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.37%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> (73)</b></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Foreign exchange rate gain, net was DKK 1,049 million in the first nine months of 2021 as compared to foreign exchange rate loss, net of DKK 645 million in the first nine months of 2020. The increase was driven by the strengthening of the USD against the DKK in 2021 that positively impacted our USD denominated marketable securities portfolio and cash holdings. Refer to Note 4.2 in the Annual Report for further details of foreign currency risk. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="background-color:#ffffff;">Loss on other investments, net was DKK 209 million in the first nine months of 2021 as compared to gain on other investments, net of DKK 490 million in the first nine months of 2020. The decrease was driven&#160;by the change in fair value of Genmab&#8217;s investment in common shares of CureVac and Bolt.&#160;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"> <font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Loss on marketable securities, net of DKK 184 million in the first nine months of 2021 was primarily driven by the movements in interest rates in the United States and Europe.<font style="white-space:pre-wrap;">  </font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Note 5 &#8211; Share-Based Instruments</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Restricted Stock Unit Program</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Genmab A/S established an RSU program as an incentive for all the Genmab group&#8217;s employees, members of the Executive Management, and members of the Board of Directors. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">For details of the RSU program prior to changes in 2021, refer to Note 4.6 in the Annual Report.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">In February 2021, the RSU program was amended (the &#8220;2021 RSU Program&#8221;). Under the terms of the 2021 RSU Program, the Board may decide, in its sole discretion, to accelerate the vesting of the RSUs held by a participant, or accelerate the vesting of the RSUs and make a cash settlement in case of (1) a change of control event as defined in the 2021 RSU Program, if a participant&#8217;s employment terms are </p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 67</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 31/38</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20211110xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months Ended September 30, 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">materially changed to his or her detriment during the 12-month period following the change in control event, or if the participant, who is a member of the Board, is replaced by a new board member or such participant&#39;s seat on the Board is eliminated due to a reduction in the number of board members, or (2) certain other extraordinary transactions as described in the 2021 RSU Program. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Under the terms of the 2021 RSU Program, in the event an RSU holder separates from the Company under circumstances in which the RSU holder is considered a &#8220;bad-leaver,&#8221; such as being dismissed for cause or during the employment probationary period, unvested RSUs will be forfeited. RSU holders may maintain a pro rata portion of unvested RSUs if they separate from the Company under circumstances where they are considered &#8220;good-leavers,&#8221; such as dismissal without cause or termination of employment due to the Company&#8217;s material breach of the RSU holder&#8217;s employment terms, or if the participant is a member of the Board, if the membership of the Board ceases for any other reason than as a result of the participants death. All unvested RSUs will be forfeited in the event of termination of employment due to the RSU holder&#8217;s death.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">During the first nine months of 2021, 159,567 RSUs were granted with a weighted average fair value of DKK 2,149.55 per RSU. During the first nine months of 2020, 22,672 RSUs were granted with a weighted average fair value of DKK 1,491.16 per RSU. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">During the first nine months of 2021, 54,188 RSUs vested, compared to 41,111 RSUs during the first nine months of 2020. Genmab settles RSUs using shares issued from treasury stock. A portion of the settlement is withheld to satisfy individual statutory tax withholding obligations in certain jurisdictions which remain in Genmab&#8217;s treasury share account.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Warrant Program</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Genmab A/S established warrant programs as an incentive for all the Genmab group&#8217;s employees, and members of the Executive Management. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">For details of the warrant programs prior to changes in 2021, refer to Note 4.6 in the Annual Report. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">In February 2021, the Warrant Program was amended (the &#8220;2021 Warrant Program&#8221;). Under the terms of the 2021 Warrant Program, the Board may decide, in its sole discretion, to accelerate the vesting of the warrants held by a warrant holder in case of (1) a change of control event as defined in the 2021 Warrant Program, if a warrant holder&#8217;s employment terms are materially changed to his or her detriment during the 12-month period following a change in control event, or (2) certain other extraordinary transactions as described in the 2021 Warrant Program.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;min-height:11.0pt;text-indent:0pt;margin:0pt 36pt 11pt 0pt;">Under the 2021 Warrant Program, if a warrant holder separates from the Company under circumstances in which the warrant holder is considered a &#8220;bad-leaver,&#8221; such as being dismissed for cause or during the employment probationary period, unvested warrants will be forfeited. Warrant holders may maintain a pro rata portion of unvested warrants if they separate from the Company under circumstances where they are considered &#8220;good-leavers,&#8221; such as dismissal without cause or termination of employment due to the Company&#8217;s material breach of the warrant holder&#8217;s employment terms. All unvested warrants will be forfeited in the event of termination of employment due to the warrant holder&#8217;s death.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">During the first nine months of 2021, 147,568 warrants were granted to Genmab employees with a weighted average exercise price of DKK 2,189.21 per warrant and a weighted average Black-Scholes fair </p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 67</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 32/38</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20211110xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months Ended September 30, 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">market value of DKK 683.79 per warrant. During the first nine months of 2020, 49,323 warrants were granted to Genmab employees with a weighted average exercise price of DKK 1,548.22 per warrant and a weighted average Black-Scholes fair market value of DKK 465.70 per warrant.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;min-height:11.0pt;text-indent:0pt;margin:0pt 36pt 11pt 0pt;">During the first nine months of 2021, 139,305 warrants were exercised with a weighted average exercise price on date of grant of DKK 731.29 with proceeds to Genmab of DKK 102 million. The warrants exercised increased share capital accordingly and corresponded to approximately 0.21% of share capital. During the first nine months of 2020, 423,844 warrants were exercised with a weighted average exercise price on date of grant of DKK 283.83 with proceeds to Genmab of DKK 120 million. The warrants exercised increased share capital accordingly and corresponded to approximately 0.65% of share capital.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Share-based compensation expense</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;min-height:11.0pt;text-indent:0pt;margin:0pt 36pt 11pt 0pt;">Share-based compensation expenses related to Genmab RSU and warrant programs for the first nine months of 2021 totaled DKK 228 million compared to DKK 149 million for the first nine months of 2020. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Share repurchases</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">In general, Genmab intends to purchase its own shares in order to cover a portion of the obligations in relation to RSUs. Authorization to purchase Genmab shares up to a nominal value of DKK 500,000 (500,000 shares) was given by the shareholders at the annual general meeting in March 2016. As of December 31, 2020, a total of 225,000 shares, with a nominal value of DKK 225,000, had been repurchased under the March 2016 authorization. The March 2016 authorization expired in March 2021. Additionally, in March 2019, Genmab shareholders authorized the repurchase up to an additional nominal value of DKK 500,000 (500,000 shares). A portion of the shares that may be repurchased under this authorization may be used to cover Genmab&#8217;s obligations in relation to the RSUs. Moreover, in April 2021, Genmab shareholders authorized us to repurchase up to an additional nominal value of DKK 500,000 (500,000 shares) to cover obligations under Genmab&#8217;s share-based remuneration programs.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">During the first nine months of 2021, Genmab acquired 200,000 of its own shares under a share buy-back program, representing approximately 0.3% of share capital. The total amount paid to acquire the shares, including directly attributable costs, was DKK 447 million and has been recognized as a deduction to shareholders&#8217; equity. These shares are classified as treasury shares and are presented within retained earnings on the balance sheet as of September 30, 2021. There were no share repurchases during the first nine months of 2020. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 6pt 0pt;">As of September 30, 2021, 295,405 treasury shares were held by Genmab to cover the obligations in relation to the RSU program and to mitigate the dilutive effect of share capital increases resulting from future exercises of warrants.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Note 6 &#8211; Related Parties</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Genmab&#8217;s related parties are Genmab A/S&#8217; (parent company) subsidiaries, Board of Directors, Executive Management, and close members of the family of these persons. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Genmab has service agreements with, and has made equity compensation grants to, members of Executive Management in the ordinary course of business.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Transactions with Related Parties</b></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 67</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 33/38</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20211110xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months Ended September 30, 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">During the first nine months of 2021, there were no material related party transactions. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Key Changes to Executive Management and the Board of Directors</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">During the first nine months of 2021, there was one change to the Executive Management team. Effective March 1, 2021, Tahamtan Ahmadi, previously Senior Vice President, Head of Oncology, was appointed Executive Vice President and Chief Medical Officer, Head of Experimental Medicines. He joins the existing Executive Management team of Jan van de Winkel, President and Chief Executive Officer, Judith Klimovsky, Executive Vice President and Chief Development Officer, Anthony Pagano, Executive Vice President and Chief Financial Officer and Anthony Mancini, Executive Vice President and Chief Operating Officer.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">There were no changes to the Board of Directors during the first nine months* of 2021. Following Genmab A/S&#8217; Annual General Meeting on April 13, 2021, the Board of Directors is comprised of five independent board members, one non-independent board member, and three employee-elected board members. They are Deirdre P. Connelly (Chair), Pernille Erenbjerg (Deputy Chair), Rolf Hoffmann, Dr. Paolo Paoletti, Jonathan Peacock, Dr. Anders Gersel Pedersen, Peter Storm Kristensen, Dr. Mijke Zachariasse and Rima Bawarshi Nassar, respectively.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;">*As a subsequent event, Jonathan Peacock will step&#160;down from the Board of Directors effective November 15, 2021, due to increased&#160;responsibilities in connection with his other board commitments. Genmab will initiate a search for a new board member as his replacement who will be nominated for election at the 2022 Annual General Meeting.&#160;</i></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><i style="font-style:italic;white-space:pre-wrap;">  </i><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 67</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 34/38</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20211110xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months Ended September 30, 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Note 7 &#8211; Leases</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Amounts recognized in the balance sheet</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">The balance sheet shows the following amounts relating to leases:</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="color:#029c93;font-weight:bold;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:57.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:57.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:17.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">September&#160;30,&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;&#160;&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">December&#160;31,&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:57.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:17.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">2020</p></td></tr><tr><td style="vertical-align:bottom;width:57.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">(DKK million)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:17.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Right-of-use assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:17.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;">&#160;&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:57.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Properties</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:17.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 372</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 280</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:17.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 2</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 3</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:17.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total right-of-use assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:17.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;">374</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 283</b></p></td></tr><tr><td style="vertical-align:bottom;width:57.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:17.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Lease liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:17.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Current</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:17.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 63</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 42</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Non-current</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:17.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 374</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 277</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:17.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.47%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:57.82%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total lease liabilities</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">&#160;</b></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:17.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 437</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 319</b></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">During the first nine months of 2021, there were additions to Genmab&#8217;s right-of-use assets and lease liabilities related to the commencement of leases in Japan and the United States with respect to office space. During the first nine months of 2020, there were additions to Genmab&#8217;s right-of-use assets and lease liabilities related to the commencement of leases in the United States and the Netherlands with respect to office and laboratory space.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Significant leases not yet commenced</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">During 2020, Genmab entered into a lease agreement with respect to the new headquarters in Denmark with a commencement date in March 2023 and is non-cancellable until March 2038. The total future minimum payments over the term of the lease are approximately DKK 337 million and estimated capital expenditures to fit out the space are approximately DKK 40 million. </p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">During 2019, Genmab entered into a lease agreement with respect to office and laboratory space in the Netherlands with a commencement date in February 2022 and is non-cancellable until January 2032. The total future minimum payments over the term of the lease are approximately DKK 113 million and estimated capital expenditures to fit out the space are approximately DKK 74 million.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 67</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 35/38</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20211110xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months Ended September 30, 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Amounts recognized in the statement of comprehensive income</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">The statement of comprehensive income shows the following amounts relating to leases:</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:51.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:20.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.07%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:21.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:51.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:20.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">9 Months Ended</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.85%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">9 Months Ended</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:51.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:20.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">September&#160;30,&#160;2021</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Calibri','Helvetica','sans-serif';">&#160;&#160;&#160;&#160;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;">September&#160;30,&#160;2020</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:51.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">(DKK million)</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:20.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.85%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:51.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Depreciation charge of right-of-use assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e6e6e6;vertical-align:bottom;white-space:nowrap;width:20.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.85%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:51.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Properties</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:20.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 39</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.85%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 24</font></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:51.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Equipment</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:20.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1</font></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:51.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:20.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.85%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:51.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Total depreciation charge of right-of-use assets</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:20.48%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 40</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.85%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> 25</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:51.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:20.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.85%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:51.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Interest expense</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:20.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 9</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.85%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 6</font></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:51.5%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Expense relating to short-term leases</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="background-color:#e7e6e6;vertical-align:bottom;white-space:nowrap;width:20.48%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 1</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.07%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.85%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3.5pt 0pt 0pt;"><font style="white-space:pre-wrap;"> 3</font></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Interest expense is included in net financial items and expenses relating to short-term leases are included in operating expenses in the statement of comprehensive income.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="color:#029c93;font-weight:bold;">Note 8 - Subsequent Events to the Balance Sheet Date</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Jonathan Peacock will step&#160;down from the Board of Directors effective November 15, 2021, due to increased&#160;responsibilities in connection with his other board commitments.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">No other events have occurred subsequent to the balance sheet date that could significantly affect the financial statements as of September 30, 2021.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 67</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 36/38</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20211110xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months Ended September 30, 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;font-weight:bold;padding-left:21.6pt;text-indent:-21.6pt;margin:0pt 0pt 3pt 0pt;"><b style="font-size:16pt;font-weight:bold;"><a name="_Toc16514653_0"></a></b><b style="color:#029c93;font-weight:bold;">ABOUT GENMAB</b><b style="font-size:16pt;font-weight:bold;"><a name="ABOUTGENMAB_556806"></a></b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;"><i style="font-size:7.5pt;font-style:italic;">Genmab is an international biotechnology company with a core purpose to improve the lives of people with cancer. For more than 20 years, Genmab&#8217;s vision to transform cancer treatment has driven its passionate, innovative and collaborative teams to invent next-generation antibody technology platforms and leverage translational research and data sciences, fueling multiple differentiated cancer treatments that make an impact on people&#8217;s lives. To develop and deliver novel therapies to patients, Genmab has formed 20+ strategic partnerships with biotechnology and pharmaceutical companies. Genmab&#8217;s proprietary pipeline includes bispecific T-cell engagers, next-generation immune checkpoint modulators, effector function enhanced antibodies and antibody-drug conjugates.</i></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;"><i style="font-size:7.5pt;font-style:italic;"> </i><font style="font-size:7.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;"><i style="font-size:7.5pt;font-style:italic;">Genmab is headquartered in Copenhagen, Denmark with locations in Utrecht, the Netherlands, Princeton, New Jersey, U.S. and Tokyo, Japan. For more information, please visit </i><i style="color:#029c93;font-size:7.5pt;font-style:italic;">Genmab.com</i><i style="font-size:7.5pt;font-style:italic;"> and follow us on </i><i style="color:#029c93;font-size:7.5pt;font-style:italic;">Twitter.com/Genmab</i><i style="font-size:7.5pt;font-style:italic;">.</i></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;"><i style="font-size:7.5pt;font-style:italic;">This Interim Report contains forward looking statements. The words &#8220;believe&#8221;, &#8220;expect&#8221;, &#8220;anticipate&#8221;, &#8220;intend&#8221; and &#8220;plan&#8221; and similar expressions identify forward looking statements. Actual results or performance may differ materially from any future results or performance expressed or implied by such statements. The important factors that could cause our actual results or performance to differ materially include, among others, risks associated with pre-clinical and clinical development of products, uncertainties related to the outcome and conduct of clinical trials including unforeseen safety issues, uncertainties related to product manufacturing, the lack of market acceptance of our products, our inability to manage growth, the competitive environment in relation to our business area and markets, our inability to attract and retain suitably qualified personnel, the unenforceability or lack of protection of our patents and proprietary rights, our relationships with affiliated entities, changes and developments in technology which may render our products or technologies obsolete, and other factors. For a further discussion of these risks, please refer to the risk management sections in Genmab&#8217;s most recent financial reports, which are available on </i><i style="color:#029c93;font-size:7.5pt;font-style:italic;">www.genmab.com</i><i style="font-size:7.5pt;font-style:italic;"> and the risk factors included in Genmab&#8217;s most recent Annual Report on Form 20-F and other filings with the U.S. Securities and Exchange Commission (SEC), which are available at </i><i style="color:#029c93;font-size:7.5pt;font-style:italic;">www.sec.gov</i><i style="font-size:7.5pt;font-style:italic;">. Genmab does not undertake any obligation to update or revise forward looking statements in this Interim Report nor to confirm such statements to reflect subsequent events or circumstances after the date made or in relation to actual results, unless required by law. </i></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:7pt;margin:0pt;"><i style="font-size:8pt;font-style:italic;">Genmab A/S and/or its subsidiaries own the following trademarks: Genmab</i><sup style="font-size:6pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-size:8pt;font-style:italic;">; the Y-shaped Genmab logo</i><sup style="font-size:6pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-size:8pt;font-style:italic;">; Genmab in combination with the </i><i style="font-size:7.5pt;font-style:italic;">Y-shaped Genmab logo</i><sup style="font-size:5.62pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-size:7.5pt;font-style:italic;">; HuMax&#174;; DuoBody</i><sup style="font-size:5.62pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-size:7.5pt;font-style:italic;">; DuoBody in combination with the DuoBody logo</i><sup style="font-size:5.62pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-size:7.5pt;font-style:italic;">; HexaBody</i><sup style="font-size:5.62pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-size:7.5pt;font-style:italic;">; HexaBody in combination with the HexaBody logo</i><sup style="font-size:5.62pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-size:7.5pt;font-style:italic;">; DuoHexaBody</i><sup style="font-size:5.62pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-size:7.5pt;font-style:italic;">; and HexElect</i><sup style="font-size:5.62pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-size:7.5pt;font-style:italic;">. </i><i style="font-size:8pt;font-style:italic;">TIVDAK</i><sup style="font-size:6pt;font-style:italic;vertical-align:top;">TM</sup><i style="font-size:8pt;font-style:italic;"> is a trademark of Seagen Inc. </i><i style="font-size:7.5pt;font-style:italic;">Kesimpta</i><sup style="font-size:5.62pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-size:7.5pt;font-style:italic;"> and Sensoready</i><sup style="font-size:5.62pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-size:7.5pt;font-style:italic;"> are trademarks of Novartis AG or its affiliates. DARZALEX</i><sup style="font-size:5.62pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-size:7.5pt;font-style:italic;">, DARZALEX FASPRO</i><sup style="font-size:5.62pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-size:7.5pt;font-style:italic;"> and RYBREVANT</i><sup style="font-size:5.62pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-size:7.5pt;font-style:italic;"> are trademarks of Johnson &amp; Johnson. TEPEZZA</i><sup style="font-size:5.62pt;font-style:italic;vertical-align:top;">&#174;</sup><i style="font-size:7.5pt;font-style:italic;"> is a trademark of Horizon Therapeutics Ireland DAC. </i></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:7.5pt;font-style:italic;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 67</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 37/38</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:always;width:76.47%;border-width:0;"><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><img src="tmb-20211110xex99d1002.jpg" alt="Graphic" style="display:inline-block;height:44.99pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:151.48pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Arial Bold';font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-size:13pt;font-weight:bold;">Interim Report for the First Nine Months Ended September 30, 2021</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:9pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;font-weight:bold;text-indent:0pt;margin:0pt 0pt 3pt 0pt;"><b style="font-size:16pt;font-weight:bold;"><a name="_Toc16514654"></a></b><b style="color:#029c93;font-weight:bold;">DIRECTORS&#8217; AND MANAGEMENT&#8217;S STATEMENT ON THE INTERIM REPORT</b><b style="font-size:16pt;font-weight:bold;"><a name="DIRECTORSANDMANAGEMENTSSTATEMENTONTHEINT"></a></b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;min-height:11.0pt;text-indent:0pt;margin:0pt 36pt 11pt 0pt;">The Board of Directors and the Executive Management have today considered and adopted the unaudited interim report of the Genmab group for the nine months ended September 30, 2021.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;min-height:11.0pt;text-indent:0pt;margin:0pt 36pt 11pt 0pt;">The interim report is prepared in accordance with IAS 34, &#8220;Interim Financial Reporting,&#8221; as issued by the IASB and in accordance with IAS 34 as endorsed by the EU, and additional Danish disclosure requirements for interim reports of listed companies.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;min-height:11.0pt;text-indent:0pt;margin:0pt 36pt 11pt 0pt;">We consider the applied accounting policies to be appropriate and, in our opinion, the interim report gives a true and fair view of the assets and liabilities, financial position, results of operation and cash flows of the group.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;min-height:11.0pt;text-indent:0pt;margin:0pt 36pt 11pt 0pt;">Furthermore, we consider the Management&#8217;s Review to give a true and fair account of the development in the group&#8217;s activities and financial affairs, results of operations and the group&#8217;s financial position as a whole as well as a description of the significant risks and uncertainties which the group faces, as further described in our 2020 Annual Report and the Form 20-F filed with the U.S. Securities and Exchange Commission in March 2021.</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Copenhagen, November 10, 2021</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;font-style:italic;font-weight:bold;text-indent:0pt;margin:12pt 0pt 3pt 0pt;"><b style="color:#029c93;font-style:normal;font-weight:bold;">Executive Management</b></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;" align="center"><tr style="height:1.25pt;"><td style="vertical-align:bottom;width:19.4%;margin:0pt;padding:0pt;"><div style="height:1.25pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td colspan="2" style="vertical-align:bottom;width:18.49%;margin:0pt;padding:0pt;"><div style="height:1.25pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td colspan="2" style="vertical-align:bottom;width:17.58%;margin:0pt;padding:0pt;"><div style="height:1.25pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td colspan="2" style="vertical-align:top;width:19.45%;margin:0pt;padding:0pt;"><div style="height:1.25pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td colspan="2" style="vertical-align:bottom;width:25.06%;margin:0pt;padding:0pt;"><div style="height:1.25pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr style="height:14.7pt;"><td colspan="2" style="vertical-align:bottom;width:20%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><img src="tmb-20211110xex99d1008.jpg" alt="Graphic" style="display:inline-block;height:43.2pt;left:0%;padding-bottom:0.3pt;position:relative;top:0pt;width:86.52pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td colspan="2" style="vertical-align:bottom;width:20%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><img src="tmb-20211110xex99d1009.jpg" alt="A picture containing text, opener, clipart, tool&#10;&#10;Description automatically generated" style="display:inline-block;height:34.8pt;left:0%;padding-bottom:0pt;position:relative;top:0pt;width:91.06pt;"></p></td><td colspan="2" style="vertical-align:bottom;width:20%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><img src="tmb-20211110xex99d1010.jpg" alt="A picture containing hanger&#10;&#10;Description automatically generated" style="display:inline-block;height:38.5pt;left:0%;padding-bottom:0.5pt;position:relative;top:0pt;width:66pt;"></p></td><td colspan="2" style="vertical-align:bottom;width:20%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><img src="tmb-20211110xex99d1011.jpg" alt="A picture containing text, insect&#10;&#10;Description automatically generated" style="display:inline-block;height:42.54pt;left:0%;padding-bottom:0pt;position:relative;top:0pt;width:86.4pt;"></p></td><td style="vertical-align:bottom;width:20%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><img src="tmb-20211110xex99d1012.jpg" alt="A picture containing sky&#10;&#10;Description automatically generated" style="display:inline-block;height:34.48pt;left:0%;padding-bottom:0.05pt;position:relative;top:0pt;width:88.8pt;"></p></td></tr><tr style="height:14.7pt;"><td colspan="2" style="vertical-align:bottom;width:20%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Jan van de Winkel</p></td><td colspan="2" style="vertical-align:bottom;width:20%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Anthony Pagano</p></td><td colspan="2" style="vertical-align:bottom;width:20%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Judith Klimovsky</p></td><td colspan="2" style="vertical-align:bottom;width:20%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Anthony Mancini</p></td><td style="vertical-align:bottom;width:20%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Tahamtan Ahmadi</p></td></tr><tr style="height:13.95pt;"><td colspan="2" style="vertical-align:top;width:20%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">(President &amp; CEO)</p></td><td colspan="2" style="vertical-align:bottom;width:20%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">(Executive Vice President &amp; CFO)</p></td><td colspan="2" style="vertical-align:bottom;width:20%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">(Executive Vice President &amp; CDO)</p></td><td colspan="2" style="vertical-align:bottom;width:20%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">(Executive Vice President &amp; COO)</p></td><td style="vertical-align:top;width:20%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">(Executive Vice President &amp; CMO)</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:11pt;font-style:italic;font-weight:bold;padding-left:28.8pt;text-indent:-28.8pt;margin:12pt 0pt 3pt 0pt;"><b style="color:#029c93;font-style:normal;font-weight:bold;">Board of Directors</b></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;" align="center"><tr style="height:3.4pt;"><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><div style="height:3.4pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><div style="height:3.4pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:33.35%;margin:0pt;padding:0pt;"><div style="height:3.4pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:33.35%;margin:0pt;padding:0pt;"></td></tr><tr style="height:45.85pt;"><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><img src="tmb-20211110xex99d1013.jpg" alt="A close-up of a drawing&#10;&#10;Description automatically generated with low confidence" style="display:inline-block;height:45.81pt;left:0%;padding-bottom:0.7pt;position:relative;top:0pt;width:67.8pt;"></p></td><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><img src="tmb-20211110xex99d1014.jpg" alt="Graphic" style="display:inline-block;height:25.4pt;left:0%;padding-bottom:0.1pt;position:relative;top:0pt;width:87.63pt;"></p></td><td style="vertical-align:bottom;width:33.35%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><img src="tmb-20211110xex99d1015.jpg" alt="Graphic" style="display:inline-block;height:25.2pt;left:0%;padding-bottom:0.3pt;position:relative;top:0pt;width:122.4pt;"></p></td></tr><tr><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Deirdre P. Connelly</p></td><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Pernille Erenbjerg </p></td><td style="vertical-align:bottom;width:33.35%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Anders Gersel Pedersen</p></td></tr><tr><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">(Chair)</p></td><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">(Deputy Chair)</p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:33.35%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><img src="tmb-20211110xex99d1016.jpg" alt="A picture containing text&#10;&#10;Description automatically generated" style="display:inline-block;height:30pt;width:104pt;"></p></td><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><img src="tmb-20211110xex99d1017.jpg" alt="Text&#10;&#10;Description automatically generated with low confidence" style="display:inline-block;height:28pt;left:0%;padding-bottom:0.5pt;position:relative;top:0pt;width:58pt;"></p></td><td style="vertical-align:bottom;width:33.35%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><img src="tmb-20211110xex99d1018.jpg" alt="Text, letter&#10;&#10;Description automatically generated" style="display:inline-block;height:38.61pt;left:0%;padding-bottom:0.4pt;position:relative;top:0pt;width:86.4pt;"></p></td></tr><tr><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:33.35%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Rolf Hoffmann</p></td><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Paolo Paoletti</p></td><td style="vertical-align:bottom;width:33.35%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Jonathan Peacock</p></td></tr><tr style="height:29.2pt;"><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><img src="tmb-20211110xex99d1019.jpg" alt="Text, letter&#10;&#10;Description automatically generated" style="display:inline-block;height:33pt;width:71pt;"></p></td><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><img src="tmb-20211110xex99d1020.jpg" alt="A picture containing text&#10;&#10;Description automatically generated" style="display:inline-block;height:25.31pt;left:0%;padding-bottom:0.2pt;position:relative;top:0pt;width:112.8pt;"></p></td><td style="vertical-align:bottom;width:33.35%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><img src="tmb-20211110xex99d1021.jpg" alt="Graphic" style="display:inline-block;height:21pt;width:120pt;"></p></td></tr><tr><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"></td><td style="vertical-align:bottom;width:33.35%;margin:0pt;padding:0pt;"></td></tr><tr><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Mijke Zachariasse</p></td><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Rima Bawarshi Nassar</p></td><td style="vertical-align:bottom;width:33.35%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">Peter Storm Kristensen</p></td></tr><tr><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">(Employee elected)</p></td><td style="vertical-align:bottom;width:33.32%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">(Employee elected)</p></td><td style="vertical-align:bottom;width:33.35%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;">(Employee elected)</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;display:table;margin-bottom:30pt;min-height:36pt;width:100%;"><div style="display:table-cell;vertical-align:bottom;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:24pt 0pt 0pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;table-layout:fixed;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Genmab A/S</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Tel: +45 7020 2728</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Company Announcement no. 67</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Kalvebod Brygge 43</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">Fax: +45 7020 2729</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">Page 38/38</p></td></tr><tr><td style="vertical-align:top;width:33.33%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">1560 Copenhagen V, Denmark</p></td><td style="vertical-align:top;width:33.34%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;margin:0pt;">www.genmab.com</p></td><td style="vertical-align:top;width:33.32%;margin:0pt;padding:0pt 5.4pt 0pt 5.4pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:8pt;text-align:right;margin:0pt;">CVR no. 2102 3884</p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:avoid;width:76.47%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>tmb-20211110xex99d1009.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20211110xex99d1009.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !K 1@# 2(  A$! Q$!_\0
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M^GQ*\+V;:U+K5AKMM;QM)=V)M5@*H,$F-E +$#)Y(Z<!B<5Z4BJB*BJ%51@
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M')W= ?X2 ?E!YI1IREL-R2/HVBO-?#OQAT6]\(MK&O3VVGW,<K1&UC<O))@
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M^BCGZD'H 2,'Q#\7=*L8;33O"D8UK5+M%%O'%GRXL\*'[Y_V!SQSMXSH^ /
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E-AM5;[S#+.WU=LL?Q-;5%.[$%%%%(84444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>tmb-20211110xex99d1021.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20211110xex99d1021.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  J / # 2(  A$! Q$!_\0
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M:,V.QGGE2;4)4<H=R01C$:GU.>6/U_*EN]%L;Z]2[N(BTJ(8\AB,KG/..O\
M]<UH]Z#3NPL58;"TM\^3;1)NZD( 3]3WJU112&%%%% !1110 4444 %%%% !
:1110 4444 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>tmb-20211110xex99d1005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20211110xex99d1005.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" *4!9<# 2(  A$! Q$!_\0
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M!DE&!((P0<\#D>HH [.BN"G^+?ARWU2>V>+4C8V]S]EFU9;4FSCE_NM)GKG
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M<<9]8HH \)G\!>)+OP#XZOY=,,.K>)+R&XBTM'5FB19]_P S9 +89B?]WU)
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M\LFJJMC %8E)(5PVYN?NC'?D9)7Z"HHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/OFN[N\O;[3[WSIKF3.U5DMMD:* %5%W-@ 9^8Y)- '>4444 %%%% !1110
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M!_Z!-I_WZ%'_  BF@_\ 0)M/^_0K8HHYF'L*?\J^XQ_^$4T'_H$VG_?H4?\
M"*:#_P! FT_[]"M?(HS1S,/84_Y49'_"*:#_ - FT_[]"C_A%-!_Z!-I_P!^
MA4FC:[::XM^;02C[%>2V4OF*!F2,X;'/(]ZU*.9A["G_ "HQ_P#A%-!_Z!-I
M_P!^A1_PBF@_] FT_P"_0K8HHYF'L*?\J^XQ_P#A%-!_Z!-I_P!^A1_PBF@_
M] FT_P"_0K7S5'2=5M]8LVNK8.(UGE@.\8.Z.1HV_#*G'M1S,/84_P"5%;_A
M%-!_Z!-I_P!^A1_PBF@_] FT_P"_0J_?7UMIFGW-_>2>7;6T333/@G:B@DG
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M+V%/^5?<8_\ PBF@_P#0)M/^_0H_X130?^@3:?\ ?H5L44<S#V%/^5?<8_\
MPBF@_P#0)M/^_0H_X130?^@3:?\ ?H5L44<S#V%/^5?<8_\ PBF@_P#0)M/^
M_0H_X130?^@3:?\ ?H5L44<S#V%/^5?<8_\ PBF@_P#0)M/^_0H_X130?^@3
M:?\ ?H5L44<S#V%/^5?<8_\ PBF@_P#0)M/^_0H_X130?^@3:?\ ?H5L44<S
M#V%/^5?<8_\ PBF@_P#0)M/^_0H_X130?^@3:?\ ?H5L44<S#V%/^5?<8_\
MPBF@_P#0)M/^_0H_X130?^@3:?\ ?H5L44<S#V%/^5?<8_\ PBF@_P#0)M/^
M_0H_X130?^@3:?\ ?H5L44<S#V%/^5?<8_\ PBF@_P#0)M/^_0H_X130?^@3
M:?\ ?H5L44<S#V%/^5?<8_\ PBF@_P#0)M/^_0H_X130?^@3:?\ ?H5L44<S
M#V%/^5?<8Q\*Z#@_\2FT_P"_0KY8_M"[_P"?B3\Z^OST-?&]:TVV<&-IPC:R
M+/\ :%W_ ,_$GYT?VA=_\_$GYU6HK0\_E78L_P!H7?\ S\2?G1_:%W_S\2?G
M5:B@.5=BS_:%W_S\2?G1_:%W_P _$GYU6HH#E78L_P!H7?\ S\2?G1_:%W_S
M\2?G5:B@.5=BS_:%W_S\2?G1_:%W_P _$GYU6HH#E78L_P!H7?\ S\2?G1_:
M%W_S\2?G5:B@.5=BS_:%Y_S\2?G6IX;N9[KQ3I%O/(TD,M["CHQR&4N 0?;%
M85;'A/\ Y'+0_P#L(0?^C%I/8J$8\RT-35)'BU>]CC8JB3NJJ.@ 8\54^T3?
M\]&_.K&L?\AS4/\ KYD_]"-4JT6QY\U[S)?M$W_/1OSH^T3?\]&_.HJ*9)+]
MHF_YZ-^='VB;_GHWYU%10!+]HF_YZ-^='VB;_GHWYU%10!+]HF_YZ-^='VB;
M_GHWYU%10!+]HF_YZ-^='VB;_GHWYU%10!+]HF_YZ-^='VB;_GHWYU%10!N>
M%?\ 2_%.G07'[R&28!D;D$>AKT+^R-/_ .?*#_O@5Y[X-_Y''2O^NXKT^M*2
MU9Q9DW&E!QTU?Z%/^R-._P"?.#_O@4?V1IW_ #YP?]\"KM%;V1XWM9]V4O[(
MT[_GS@_[X%']D:=_SYP?]\"KM%%D'M9]V4O[(T[_ )\X/^^!1_9&G?\ /G!_
MWP*NT460>UGW92_LC3O^?.#_ +X%']D:=_SYP?\ ? J[119![6?=E+^R-._Y
M\X/^^!1_9&G?\^<'_? J[119![6?=E+^R-._Y\X/^^!1_9&G?\^<'_? J[11
M9![6?<I?V1IW_/G!_P!\"K6G:)IDE_$CV-NRG.04'H:?5S2O^0E#^/\ (U,T
MN5G3@YR>(@F^J(/["TK_ *!]O_W[%']@Z5_T#[?_ +]BM&BL3U&]3._L'2O^
M@?;_ /?L4?V#I7_0/M_^_8K1HH%<SO[!TK_H'V__ '[%']@Z5_T#[?\ []BM
M&B@+F=_8.E?] ^W_ ._8H_L'2O\ H'V__?L5HT4!<SO[!TK_ *!]O_W[%']@
MZ5_T#[?_ +]BM&B@+F=_8.E?] ^W_P"_8H_L'2O^@?;_ /?L5HT4!<SO[!TK
M_H'V_P#W[%']@Z5_T#[?_OV*T:* N4(]!TDRJ#I]OR?^>8K0_P"$;T7_ *!E
MK_W[%.B_UR?6M*LYO4]'!Q3B[F7_ ,(WHO\ T#+7_OV*/^$;T7_H&6O_ '[%
M:E%9W9V<D>QE_P#"-Z+_ - RU_[]BC_A&]%_Z!EK_P!^Q6I13NQ<D>QE_P#"
M-Z+_ - RU_[]BC_A&]%_Z!EK_P!^Q6I11=CY(]BO;^%]">$%M*M"?^N0J;_A
M%=!_Z!-I_P!^A6C:_P"H'UJ>N>4G<]BE1IN"]U&/_P (IH/_ $";3_OT*/\
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M<YJ_"KWOQ>N;B(JT&FZ,MM,?2::42!?P2,'_ (&/6@#L:*** "BBB@ HHHH
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MHJDT&H&3<M[$$\Q&V^1D[ /F7.[J3SGMZ&D6#4?*VF^B,FQQN\CC<3\IQNZ
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]>8>#?\ D<=*_P"NXKU 5I2^)G#F?\&'J_T#%&***Z#Q!,4N*** N&*,444
M)BC%+10 8I,4M% "8HQ2T4 &*MZ5_P A*'\?Y&JE7-*_Y"4/X_R-1/X6=."_
MWFGZK\RS2XI*6L3UWNQ,4M%% @Q1BBB@!,5M:.,V[_[_ /05C5LZ-_Q[O_O_
M -!65;X3U,H_WCY&CM%&T4M%<9]583 HQ2T4!83:*-HI:*!6$VBC I:*!B8%
M&*6B@+"8%&VEHH"PF*-M+10%A,"C:*6B@+";:,?2EHH"PFT48I:* L)M%&VE
MHH%9"8HVTM% [";11MI:* L)M%&VEHH"PF!1M%+10%A-M&T4M% 6$P*,4M%
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MUI]3SL?M$****U/-"BBB@ HHHH **** "BBB@ HHHH *V/"?_(Y:'_V$+?\
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MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BLK_ (2;0_\
MH+V/_@0G^-'_  DVA_\ 07L?_ A/\:?*S/VU/^9&K165_P )-H?_ $%['_P(
M3_&C_A)M#_Z"]C_X$)_C1RL/;4_YD:M%97_"3:'_ -!>Q_\  A/\:/\ A)M#
M_P"@O8_^!"?XT<K#VU/^9&K165_PDVA_]!>Q_P# A/\ &C_A)M#_ .@O8_\
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M-H?_ $%['_P(3_&C_A)M#_Z"]C_X$)_C1RL/;4_YD:M%97_"3:'_ -!>Q_\
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M_P"@O8_^!"?XT<K#VU/^9&K165_PDVA_]!>Q_P# A/\ &C_A)M#_ .@O8_\
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MO_W]%']IV/\ S^6__?T5O='C<DNQ:HJK_:=C_P _EO\ ]_11_:=C_P _EO\
M]_11=!R2[%JBJO\ :=C_ ,_EO_W]%']IV/\ S^6__?T470<DNQ:HJK_:=C_S
M^6__ ']%']IV/_/Y;_\ ?T470<DNQ:HJK_:=C_S^6_\ W]%']IV/_/Y;_P#?
MT470<DNQ:HJK_:=C_P _EO\ ]_11_:=C_P _EO\ ]_11=!R2[%JKFE?\A*'\
M?Y&LG^T['_G\M_\ OX*LZ=JVG1W\3R7ULJC.295 '!]ZF;]UG3@XM8B#:ZHU
MZ*H_VUI?_01M/^_R_P"-']M:7_T$;3_O\O\ C6)ZC>I>HJC_ &UI?_01M/\
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M5E?\)-H?_07L?_ A/\:/^$FT/_H+V/\ X$)_C1RL/;4_YD:M%97_  DVA_\
M07L?_ A/\:/^$FT/_H+V/_@0G^-'*P]M3_F1JT5E?\)-H?\ T%['_P "$_QH
M_P"$FT/_ *"]C_X$)_C1RL/;4_YD:M%97_"3:'_T%['_ ,"$_P :/^$FT/\
MZ"]C_P"!"?XT<K#VU/\ F1JT5E?\)-H?_07L?_ A/\:/^$FT/_H+V/\ X$)_
MC1RL/;4_YD:M%97_  DVA_\ 07L?_ A/\:/^$FT/_H+V/_@0G^-'*P]M3_F1
MJT5E?\)-H?\ T%['_P "$_QH_P"$FT/_ *"]C_X$)_C1RL/;4_YD:M%9UMKF
ME7EPL%MJ-K+,V=J),K$X&>@/I12LRE.,M4RU]DMO^>$?_?(H^R6W_/"/_OD5
MYSJ7Q.UV+Q7J^AZ+X(GU?^S'1)9HKT)]]<C*^6<=^YZ5U_A/6M6UW2Y;G6-
MET2X2<QK;2S"4LH52'SM'<D8Q_#1=AR1[&O]DMO^>$?_ 'R*/LEM_P \(_\
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M'5F90P++PP!Z4@EC,AC#J9 ,E<\@?2B[#DCV(_LEM_SPC_[Y%'V2V_YX1_\
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MW,;=\>6PC/L,4OB#1MOQ(@T:PTGPT]G!I0>QL-6+K;KNE<RM%&J,N_(7/&<
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M% 60_P U_P"^WYT>:_\ ?;\Z910%D/\ ,D_OM^=:_A5V;QAHBLQ(-_ ""?\
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M* NQGDQ_\\T_[Y%'DQ_\\T_[Y%/HH"[&>3'_ ,\T_P"^11Y,?_/-/^^13Z*
MNQGDQ_\ /-/^^11Y,?\ SS3_ +Y%/HH"[&>3'_SS3_OD4>3%_P \T_[Y%/HH
M"[&>5%_SS3_OD5;TN&(ZC#^[3O\ PCT-5ZN:5_R$H?Q_D:B?PLZ<$[XB%^Z_
M,F\B'_GDG_?(H\B'_GE'_P!\BI**Q/5>Y']GA_YY)_WR*/L\/_/)/^^14E%
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M1-*J -(%SM#'J<9.,],FJ=UX;T.^LK>RN]&T^>TMAB"&6U1DB&,852,+QZ4
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MX4*+5X5,0 Z#81C ^E<=<:_XCM?%O@#3;\PVLFIQ7O\ :=O  Z.\<(9=K$9
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M554#))/)/6MZB@ HHHH **** $/2OC>OL@]*^-ZUI]3SL?L@HHHK4\T****
M"BBB@ HHHH **** "BBB@ K8\)_\CEH?_80M_P#T8M8];'A/_D<M#_["%O\
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M2[&C151;)UNS/]LN""X;RRPVC"E<=.G.[Z@?2B@:;[%RBBBD4%%%% !1110
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M0ZW@>4+'/[[[Q?\ [9?_ &7Z46#G\C3/0U\;U]:(=;V'S%L,XA^Z7Z_\M?\
M[']:^4E^RXY,V?E]/^!?_6K2FMSS\=*_*045.?LN>/-QENN/^ __ %Z7_1-I
MYFSA?3K_ !?_ %JU//N5Z*G_ -%W=9=N6],X_A_^O2G[)MX,N[:OIC.>?PQT
MH"Y7HJPOV3?\QFV[CTQG;CC\<TA^S;.#+NVCKC&[//X8H"Y!15@?8]_)FV[C
MZ9VXX_'-(?LVS@R[MHZXQNSS^&* N04597[%O^8S;=YZ8SMQQ^.:C_T?9UDW
M;/;&[/\ +%(+D5%6O]"W=9\;O;[N/YYJ,?9]G)DW;?;&[/\ +%,+D-;'A/\
MY'+0_P#L(0?^C%J@?L6_@S[=PZXSMQ_/-:GA/[/_ ,)=H?\ K-_VV#TQN\U<
M?ABD]BH/WD7-8_Y#E_\ ]?,G_H1JE5[5-O\ :UYYN?,^T/OV].ISC\:J#R\<
M[LX[8ZUJMCSIOWF,HJ0^5GC?C(].G>C]UC^/.#Z?A021T4_]UG^/''_UZ7]U
MC^///I^% 7(Z*?\ N\\[NWI^-=/X3\''Q:+O[/=B!K9H]P=,Y5BW(QW 7IW]
M12;25V73A*I+EBKLY6BO36^#EZ -NJ0'[W6,CI]W\^_I_M4+\'+P@[M5A!^7
M@1D]?O?EV]?]FI]I'N='U'$?RGF5%>F'X.WVX :G 5RW.PYP/NG'OW';_:I?
M^%.7FW/]JPAL+QY9QD_>&?;L>_HM'M(]P^HXC^4\RHKTW_A3M[NQ_:<&,L,[
M#T'W3CW[CMZM1_PIV\\O/]J0[]JG;Y9QD_>&?0=CCGT6CVD>X?4<1_*<=X-_
MY''2O^NXKT^L[1OA;?:3K5K??VA!(()2V-I!*@?*?J3U';U-="_AO5_(S'+9
M&7RDX;=M\S/S?\!QT[YJZ=6";NSEQ^68JK3C&$=F_P!"A16E'X;U,R_O)[41
M^:W*AB?+Q\I_WL]1TQWJ)_#FM^5\DMAYGDCJ7QYF>1T^[COUSVK;V]/N>7_8
M>._D_(I45J#PWJ/F\SVPC\T\@-GR]O!_WMWX8[U ?#FM^5Q+8>9Y0."7QYF>
M1_NX[]<]J/;T^X?V)COY/R*5%:@\-ZAYO,]ML\WJ%;/E[>O^]N[=,57'AS7-
MG,FG[_)SU?'F;NG3[N._7/:CV]/N']AX[^3\BG16FWAO4?,^2>VV><.2&SY>
MWD_[V[MTQ4,?AS6O)_>2V(E\IN%W[?,S\HZ?=QU/7/:CV]/N']AX[^3\BE16
MD_AO4_-_=S6AC\U>6#9\O'S?\"ST'3%,3PYJ_D_/-9>;Y;\#=MWY^7\,=>_U
MH]O3[A_8F._D_(H45HMX;U7S?EFM/+\Q.2&SLQ\WXYZ#IBD7PWJWE?--9^9Y
M;\#=C?GY/PQU[@],T?6*?</[#QW\GY&?5S2O^0E#^/\ (U(?#>K^<0LUEY>]
M.3NSLQ\_XYZ?KBIK?0]6MG29)+-I567@[L;ND?X?WOTS4RKTW%JYOALGQE.M
M"<H:)KL%)4B:1K.X[WL<9B^[OZ?\M/\ [']<4K:1J_\  ]D3B7KN_P"V?_V7
MZ9K+VL>YZ#R[$W^$CHJ1-(UCG>]D/]5]W?\ ]M/_ +']<4/I&L9&Q[+'[WKN
M_P"V?_V7Z9H]K#N+^SL3_*1T5(FD:OM^>2SW8B^[NQG_ ):?I]W]:0Z1K/F#
M#V/E[I,YWYVX_=_CG[WZ4>UAW#^SL3_*,K9T;_CV?_?_ *"LHZ1J_D\267F[
M(^/FQOS^\_#'3]:MV-MK-JY1OL)B,TA)!?=Y>WY/^!9Z]L=*SJSC*-DSOR["
M5J-;GG&RL;E%93'7?(^4:?YOE1]2^WS-WS_\!V].^>M.0ZS]H&\6/D><_P!T
MMN\O;\GMNW=>V.E<]CW^?R-.BLB0Z_Y'[H:?YODI]XOM\W=\_P#P';T[YZU-
M&=6^T#S19^3Y[?=+;O*V_+_P+=U[8HL'/Y&C16,Y\1>3^[73?-\A?O%\>=NY
M_P" [>G?-6@=4\XY%KY?G]BV?)V_^A[OPQ18.?R+]%8H/B/R?F&E^;Y!Z&3'
MG;N/^ ;?QS[5:)U3S_E%IY/GCJ6W>5MY_P"!;OPQ[T6#G\C0HK&4^(O(^8:;
MYOD'H7QYN[C_ (#M_'-69#JOG_NQ:>5YZ_>W9\G;S_P/=G';%%@Y_(T**QXC
MX@^SCS1IOG>0^=A?;YN[Y>O\.WKWS4LIUG[2?*%CY'G1_?+[O*Q\_MNST[8Z
MT6#G\C3HK*4ZY]G&X6'G>5)T+[?,S^[_ . X^]WSTH8ZYYYVBP\GS(L9+[MF
M/WGXY^[VQUHL'/Y&K1663K7E<"Q\SRY>[XWY_=_AC[WOTI,ZYYIXL/+WQ=WS
MLQ^\_'/W?UHL'/Y&K1663K7E# L?,VRYR7QNS^Z_#'WOTI$.N;CY@L-N8<;2
M^<?\M?\ [']:+!S^1JT5E2'7,CREL,9FSN+_ /;+_P"R_2E0ZWL.\6.[;%C!
M?&<_O?PQ]W]:+!S^1J45E,=<WC8+#9NESDOG;C]U^.?O?I2@ZUY7(L?,V1=W
MQNS^]_#'W?UHL'/Y&I165G7/.'RV'E[Y>[YV8_=_CG[WZ4N=:^SG L?.\N+'
M+[=^?WGOC'W>^>M%@Y_(U**RXSK7V@>8+'R?.DSM+[O+Q^[]MV>O;'2F2GQ!
M]G/DC3O/\A,;R^WS<_/TYVXZ=\]:+!S^1K4M9T9U?S_W@L_)\]ON[MWE;?E_
MX%NZ]L57<^(?(.P:;YWD+]XOM\W=\W_ =O3OFBP<_D;-%9Z'5?/_ '@M/)\]
MON[MWE;?E_X%NZ]L558^(_(^4:9YOD#J9-OF[N?^ [?QS[46#G\C:HJ@#JGG
M<BU\OS_5L^3M_P#0]WX8JH#XC\GYETSS/(/0R8\[=Q_P#;^.?:BP<_D;5)5"
M0ZKY_P"Z%IY7GK]XMN\K;\W_  +=T[8JO&?$'V?]X-.\[R7^Z7V^;N^7_@.W
MKWS18.?R-BBLUSJ_G_(+/RO.3[V[=Y6WYO\ @6[IVQ449U[R?W@T_P WR7^Z
M7QYN[Y/^ [>O?/2BP<_D:]%4%.I_;6W"U^R;UQ@MOV;#GVSOQCVSWHI6&I7+
M]%%%!04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >?_%K43IF
MAZ+,]]=V=J^M6T=W):RR1N8#NWC,?S=.PYXK!\/^(M%N_B-H]GX4\2:K>0R1
MS_VC:7]S,R! F4*BX^;?NQ]S/R@DX&<]?\0-&U36+#1WTBWBN+C3]7M[\Q2S
M>4'6,L2-V#C/ Z&J-YI'B?Q7JN@SZKIVGZ/9Z7?"];R;YKB>1E4A4'[M5"G/
MS<DD4 ==K.KVF@Z->:K?R;+6TB:60C&2 .@SC))X [D@5@6?B_4DN5_M[PU<
MZ192023QW9E$Z1J@W,)]HQ$=O(R2#TSGBL[4?A%X7?0=7LM(L%L+J_M6@\\3
M2-@[E=<AB>-Z*3WP*E>T\8^)TFTK6;.ST?3&MY[:\>WN!<->[XR@,8*CRT!8
MM\WS9 &,9- #[+QY?3?V=>WOAJXL]$U.2*.TO3<I(^9<>49(U^X&+ 9W'!(S
MC-8%EJNHMIGB!FO[HM%XVBMHR9F)2$SVX,8YX3#,-O3D^M,T3P)?VLVF:=/X
M*\-0&Q:$SZUN64W*IC/EQ[ RR'');@')&ZM:U\(:M%8ZS"Z1;[OQ5'JL7[SK
M )87)/H<1MQ0!O\ Q N9[/X?:_<VLTD$\5E(T<L3E60A>H(Y!KE8]?U*T\#>
M*?#VJW<B^(=&TN=XKH.5>Z@\IO*N4/7/16()PPY.378^,M+N=;\&:QIEFJFZ
MNK5XH@S8!8C R>U8?Q%\&7?B;0O,T>5+?6X()((Y&.%EAD79+$W48(.1D<,!
MC')H PH_%Z:'XTT%M7U&]%E/X71V14EG#SF1/G*(&^; ;YB/;/-;.D^+K+Q%
M\2K>'2[R[>TCT>X>6*2":%=_G0A6VR*N3@L,C.,GUJ?1_#6HV7C+2M3F2,6U
MMX<73I"'R1,)$;&.XPIYK8FTJZ?Q[::N OV2+3)[5CNYWM+$PX],(U &?\,+
MNYO_ (;:'=7EQ+<7$D!+RS.7=CN;DD\FNGO+J&PLI[RX<)!!&TLC'^%5&2?R
M%>>^$4\<>%_"^G:(?"=C<BT3RS-_; 3=R3G;Y9QU]:[O6=.36-#O]+D8K'>6
MTENS#J ZE2?UH Y'3O$\VD^!].US48Y[[4]>G1[:SA;.Z2<9BA4MA458P 2<
M#Y68Y)YN-XUN]-TV^N/$'AV]L)[41%([=A<I<F1MB+$X !?=P5(!&0>AS6-I
M^FZAK7P[\*G3/+CU7P_<0B2VN6VAY;=6@FB++NVY^?#8/;L<U8OM'\7^*["X
MN+V.TT>:(V\^FV#S"X5+B*7S-\KJH.& 5<*2 "3C- &II?B^_;7K71O$&@MH
M]U?)(]B1=I<)-L +J2N"K@'.,8(!P>*Q+;XIW,]CI&JGPM>?V1JDB6T$Z7,9
MD:X;("",X^4N"H<L!QG !!J_:Z7XA\0^+M'US6],M](AT;[2(H([S[0]P\B!
M-QP@"IC=CG=G&0*I0>#M7C\">#=(,</VK2M1M+BZ'F# 2-R6P>YQ0!3\5>--
M5_X1'78[W2KK1M4TV2QF*6]TLIEADN%&49<')V.I7\,G-='9>-+B/6H],\1Z
M,=$DN899[.1[R.9)5C +JQ7&UU5@Q'(P#\W%9_C+PIK.LW.M2Z88$>ZM=.CM
MY)&X5X;IY6)'H%(/OTID_AO6?&'B2TOO$>FP:7::;;WEM#';WOGO<-.BQL^=
M@ 3;NQG#9QD#I0!*GQ%N5M;;6;SPY<VOAJZ>-8]1DN$WJKL%21XNJH21SDG!
M!QS6F]_-I?Q'AL)K@M9ZU9O+!&[%C'<0;0X7T5HW4XZ9C)ZL<\O)X9\6:IX6
MM? FH:=81:7;I;PRZO%=D^=!$Z$*D6W<LA"#.X[>N"<@#?OH4U?XKZ/Y>[_B
M16$\\[C!4/<%8XT//!VQR-] /6@#LZ*** "BBB@!#TKXWK[(/2OC>M:?4\['
M[1"BBBM3S0HHHH **** "BBB@ HHHH **** "MCPG_R.6A_]A"W_ /1BUCUL
M>$_^1RT/_L(6_P#Z,6D]BX?$C1UC_D.:A_U\R?\ H1JE5W6/^0YJ'_7S)_Z$
M:I5JMCSI_$PHHHH("BBB@ KU7X+_ 'M;_P"V'_M2O*J]5^"_WM;_ .V'_M2L
MZOPG?EW^\(]8HHHKE/I0HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BJ5[?BS=0;:YEW([YAB+@;1G'U/8=S44>KK(#_H5ZO^J^] 1_K/\
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MW?.<8QZC^(=A19ASQ-*DK.75PTXB^Q7H_>R1[C =OR#.[/\ =/8]S39-96.
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MQ=HHHH&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M.8SU)Q5AOB#X772K#4AJ9>WO]WV58[>5Y90N=Q$84O@;3DXP/Q%<M>:+=_\
M"+> ([JWFDNFUZ#4+T!.8Y9!--(3CH!(^/3I4_B8'2/B+)J]]J.K:997&EQ6
M\%_8V4<ZAED<M$Y:*0J3N5AP <$9) H M^,OB+:Z5X?T>]T6ZAG&L720078@
MDGCC0MAWVIC<R] F0Q.>#@BM:W\;Z%%?V.B76K)+K,^V+RDM9$+R>6DA.S!V
M JZGYC@<C)*G'"SZ25T+P_/8PZU,MSXTBOY&U","0J68-+L5%\M&QNP5&-Q/
M<5V.DVDMKXD\=:A%8--<330")6^07 2TCVJ&/&-Q89[9- %NW^(/A:ZU&"QA
MU57DN)C!!+Y,@@ED'\*3%?+8]@ QR>!S4VJ^-O#>BZB;#4-3CBN5"F551W$
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M/_:E>55ZK\%_O:W_ -L/_:E9U?A._+O]X1ZQBC%%%<I]*&*3%+10 8I,4M%
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M/<U**R_^$CT3_H+V'_@2G^-'_"1Z)_T%[#_P)3_&BS#GCW-2BLO_ (2/1/\
MH+V'_@2G^-'_  D>B?\ 07L/_ E/\:+,.>/<U**R_P#A(]$_Z"]A_P"!*?XT
M?\)'HG_07L/_  )3_&BS#GCW-2BLO_A(]$_Z"]A_X$I_C1_PD>B?]!>P_P#
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M>YJ45E_\)'HG_07L/_ E/\:/^$CT3_H+V'_@2G^-%F'/'N:E%9?_  D>B?\
M07L/_ E/\:/^$CT3_H+V'_@2G^-%F'/'N:E%9?\ PD>B?]!>P_\  E/\:/\
MA(]$_P"@O8?^!*?XT68<\>YJ45E_\)'HG_07L/\ P)3_ !H_X2/1/^@O8?\
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MN[F6&VU*TFE;[J1S*S'C/ !]**5BE)/8B_X1O0_^@18?^ Z?X4G_  C6A_\
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M@LR!U8KU#]#M.,XHNP]G#LCK_P#A&M#_ .@/8?\ @.G^%'_"-:'_ - >P_\
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M_P! >P_\!T_PK4HHNP]G#LC*_P"$:T/_ * ]A_X#I_A2_P#"-:'_ - >P_\
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M:T/_ * ]A_X#I_A2_P#"-:'_ - >P_\  =/\*-7URVT6334N4F<ZA>I91>6
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M&JWL$GB3X?1QS*QGFGECVMG>@LY,D>H^9?SHNP]G#LCHO^$;T/\ Z!%A_P"
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M0_\ L(0?^C%I,N$5S+0T]5=X]7OD1BJ+<2!5!P -QXJIY\O_ #T;\S5G6/\
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M;?\ ?I?\*M4460<\NYJZ!H6DW%K(TVF6;D/@%H%/8>U:_P#PC6A_] >P_P#
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M .@/8?\ @.G^%'_"-:'_ - >P_\  =/\*U**+L/9P[(R_P#A&M#_ .@18?\
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M  C6A_\ 0'L/_ =/\*U:*+L/9P[(R_\ A&M#_P"@/8?^ Z?X4?\ "-:'_P!
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MSU$VQO+:.8VLRW$.\9\N100&'N,G\Z +61G&>?2EK,?2$?Q)!K.]0\-I):A
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MX)))NC8'LP(!'H12_#7P[K7AS2M6AUZ6.>]N=4EN?/C.1,I2-=Y'8DJ3CWH
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M** "BBB@ HHHH B:WA:Y2Y,2&>-&1)"HW*K$%@#U )521WVCTJ6BB@ HHHH
M**** "BBB@ HHHH @GM;>Z:$W$$4IAD$L1D0-L< @,,]#@GGWJ>BB@ HHHH
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M ,CCI7_7<5Z>*\P\&_\ (XZ5_P!=Q7IXK2ENSAS3^##U?Z"T445T'B!1110
M4444 =-X:_X])?\ ?_H*VZQ/#7_'I+_O_P!!6W7E5OXC/TS*?]RI^@4445D>
MB%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !16!_PFOAW_H)Q?D?\*/\ A-/#O_03B_(_X4^5F/MZ7\R-
M^BL#_A-?#O\ T$XOR/\ A1_PFOAW_H)Q?D?\*.5]@^L4OYE]YOT5@?\ ":^'
M?^@G%^1_PH_X37P[_P!!.+\C_A1ROL'UBE_,OO-^BL#_ (37P[_T$XOR/^%'
M_":^'?\ H)Q?D?\ "CE?8/K%+^9?>;]%8'_":^'?^@G%^1_PH_X37P[_ -!.
M+\C_ (4<K[!]8I?S+[S?HK _X37P[_T$XOR/^%'_  FOAW_H)Q?D?\*.5]@^
ML4OYE]YOT5@?\)KX=_Z"<7Y'_"C_ (37P[_T$XOR/^%'*^P?6*7\R^\WZ*P/
M^$U\._\ 03B_(_X4?\)KX=_Z"<7Y'_"CE?8/K%+^9?>;]%8'_":^'?\ H)Q?
MD?\ "C_A-?#O_03B_(_X4<K[!]8I?S+[S?HK _X37P[_ -!.+\C_ (4?\)KX
M=_Z"<7Y'_"CE?8/K%+^9?>;]%8'_  FOAW_H)Q?D?\*/^$U\._\ 03B_(_X4
M<K[!]8I?S+[S?HK _P"$U\._]!.+\C_A1_PFOAW_ *"<7Y'_  HY7V#ZQ2_F
M7WF_16!_PFOAW_H)Q?D?\*/^$U\._P#03B_(_P"%'*^P?6*7\R^\WZ*P/^$U
M\._]!.+\C_A1_P )KX=_Z"<7Y'_"CE?8/K%+^9?>;]%8'_":^'?^@G%^1_PH
M_P"$U\._]!.+\C_A1ROL'UBE_,OO-^BL#_A-?#O_ $$XOR/^%'_":^'?^@G%
M^1_PHY7V#ZQ2_F7WF_16!_PFOAW_ *"<7Y'_  H_X37P[_T$XOR/^%'*^P?6
M*7\R^\WZ*P/^$U\._P#03B_(_P"%'_":^'?^@G%^1_PHY7V#ZQ2_F7WF_16!
M_P )KX=_Z"<7Y'_"C_A-?#O_ $$XOR/^%'*^P?6*7\R^\WZ*P/\ A-?#O_03
MB_(_X4?\)KX=_P"@G%^1_P *.5]@^L4OYE]YOT5@?\)KX=_Z"<7Y'_"C_A-?
M#O\ T$XOR/\ A1ROL'UBE_,OO-^BL#_A-?#O_03B_(_X4?\ ":^'?^@G%^1_
MPHY7V#ZQ2_F7WE;5/A_X:UG59]4O;*<WLX5998KV>+>%&%R$<#@>U6[3P=H%
MCHG]C6NG)%8&=;AHU=LO*KJX=FSN8[D7DDYP!TXIO_":^'?^@G%^1_PH_P"$
MU\._]!.+\C_A3Y7V#ZQ2_F7WC=5\%:#K-[/>7=G*+BYB$-P]O=2P>>@Z+((V
M4.,<?-GCBKA\.Z2;W2[L62)-I2/'8^62BPJZA6 4$+C  Y'&.,55_P"$U\._
M]!.+\C_A1_PFOAW_ *"<7Y'_  HY9=@^L4OYE]Y:NO#NE7NOV.N3V:-J=@KI
M;W 8AD5P00<'##!.,YQDXQFIKG2+&[U6RU.>#=>6*R+;R;V&P2 !^ <'(4=0
M<8XK/_X37P[_ -!.+\C_ (4?\)KX=_Z"<7Y'_"EROL'UBE_,OO+.L>&]+UV6
MUFO[>0SVC,T$\$\D$L>X8.'C96 (ZC.#5=/!OA]/#\VA#34_LZ9S)+&78L[D
MYWER=Y?(!W9SP.>*3_A-?#O_ $$XOR/^%'_":^'?^@G%^1_PI\LNP?6*7\R^
M\C_X0;P^UC?6<MG+/'?M&UT\]W-+)+Y9!0&1G+X4@8&<=?4UJW&DV5UJEEJ<
MT.Z\LED2WDW$;!( '& <'.T=0>G%9W_":^'?^@G%^1_PH_X37P[_ -!.+\C_
M (4<LNP?6*7\R^\WZ*P/^$U\._\ 03B_(_X4?\)KX=_Z"<7Y'_"EROL'UBE_
M,OO-^BL#_A-?#O\ T$XOR/\ A1_PFOAW_H)Q?D?\*.5]@^L4OYE]YOT5@?\
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M68>TCW*E%6_[+O/^>#?G1_9=Y_SP;\Z+,/:1[E2BK?\ 9=Y_SP;\Z/[+O/\
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M\+_Z%XGT^YN?W<,<P9W/0"N__MS3?^?M/R/^%:4MV<69>]2@HZZO]#1HK/\
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M._\ 03B_(_X4?\)KX=_Z"<7Y'_"CE?8/K%+^9?>;]%8'_":^'?\ H)Q?D?\
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MUN:4W00>:K#4"@(;J"%XX]3ZFK'Q'TA[#4]3@\,V4=M<2>%IE:.UC5-T2W,
M88''$9<#OS@=J LCUBRUG2-3GF@L-2LKJ:#_ %L<$Z2-'V^8 \?C1'K6D37/
MV>+4K*2?8TGE+.A;:K%6;&<X#*03V(([5YY?7'AF\UWP2O@V737O8[P-_H."
M8['RW\T/M^Z.5&&P=W3G-4[7P[X?_P"%3Z_J-U ;2:[GOA=:A;6_F3A1=..W
M)0!$W+D# .<<F@+(]/T[6-)U@2-I>I65ZL9 <VTZ2;2>F=I..AJ_M'H*\P\(
MWT:_$!+=SX=U2:73G6'4]#)5D@1D.)XPQ50Q(VD$_=(Z$X]0H"R$VCT%&T>@
MI:* LA-H]!1M'H*6B@+(3:/04;1Z"EHH"R$VCT%&T>@I:* LA-H]!1M'H*6B
M@+(0J,'@5\;YK[(/0U\;UK3//QZT09HS116IYH9HS110 9HS110 9HS110 9
M]Z,T44 &:,T44 &:V/"?_(Y:'_V$(/\ T8M8];'A/_D<M#_["$'_ *,6DRX?
M$C1UC_D-W_\ U\R?^A&J57=8_P"0YJ'_ %\R?^A&J5:K8\Z?Q,****" HHHH
M **** "BBB@ HHHH **** -SP;_R..E?]=Q7I]>8>#?^1QTK_KN*]0%:4OB9
MPYG_  8>K_0****Z#Q HHHH **** .E\- ?9)>/X_P"@K;VCT%8OAK_CTE_W
M_P"@K;KRJW\1GZ7E*_V*GZ";1Z"C:/04M%9'HV0FT>@HVCT%+10%D)M'H*-H
M]!2T4!9";1Z"C:/04M% 60FT>@HVCT%+10%D)M'H*-H]!2T4!9";1Z"C:/04
MM% 60FT>@HVCT%+10%D)M'H*-H]!2T4!9";1Z"C:/04M% 60FT>@HVCT%+10
M%D)M'H*-H]!2T4!9";1Z"C:/04M% 60FT>@HVCT%+10%D)M'H*-H]!2T4!9"
M;1Z"C:/04M% 60FT>@HVCT%+10%D)M'H*-H]!2T4!9";1Z"C:/04M% 60FT>
M@HVCT%+10%D)M'H*-H]!2T4!9";1Z"C:/04M% 60FT>@HVCT%+10%D)M'H*-
MH]!2T4!9";1Z"C:/04M% 60FT>E%+10.QXSX?\6Z#X5^*/Q!;6]2BLQ//;&+
M>"=^U'W8P#TR/SKFKB&XUOP3\4_$EG:2?V9JES UG)L(\Y(927D (SC!SG_>
M'8U[U-H.CW%RUS/I5C).QW&5[=&8GUR1FKY Q@XQTQ0!X->>(-*UGQ'\);?3
M;^&ZEM$'VA8FW>262(!6]&RC<=1CW%8<;>&T\,>/D\<"U_X3)KJ?RS.K>;NV
M#R?)]%WY^[QMQN^7%?0]OH6CVB0I;:58PK Y>(1VZ*(V/4K@<$X'(]*DGTK3
MKJ]@O;BPM9KN#_4SR0JSQ_[K$9'X4 >#>(O/5?A?_P )7J]]I$HL[G[3>PRF
M*XA&Q=F6()#$;0V1GDYJYX4N]-MOC-IJ>&?$%_XFBN[*6*_GU#,TELBY92LQ
M P"=HQC'..2PQ[;>:7IVI%#?6%K=&/.SSX5?;GKC(XI]I86=A'Y5E:06T9.=
MD,80?D* /FFV;PE_PK7Q(GB90?&QNIO,^T ?:?M&?D\O'.S/WNV=V>,5U5ZU
MI%X[\$M\0%+69\-HH.I#,(O?^6GF;^-VW&<_Q;?:O:9-*TV?48M1EL+62^B7
M;'<M"ID0<\!L9 Y/YFEO=.L=3MQ;W]G;7<(8.(YXED7(Z'!!&: / /!OANP\
M5Z'\3=)TA/\ 19KA)--XV_=,C0XW<A3A1Z[36U\/-3OOB)XNC\1R(P?0-'CL
MX3<,VQ[V16WRX' !&X$=<;?;'K.J:3-)IMZFAW4&D:E=%6^VI:)*<A@264X#
M$C(YZ9S5#P/X0@\$^'O[,CNY+R:29[BYN9!@S2MC+8R<< #KV]Z //\ XBZ+
MX^UGX;:JFNC1I7MI(;F&+2!*6=5+>8&W^@(88_NGVK9O/C9X=.G:>VAQS:OJ
M=_*D<6FQ@QRH3UWD@@8Z=\GIQDCTSBJ5OH^F6=]-?6NG6D%W/GS9XH%623)R
M=S 9//K0!Y+-XATGPU^T1K5[K-[%9V[Z.D2O)G!<F(XX'HI_*LO3Y]9\0^/?
M'7C'P/!]K62QBL;&9QY0DE/DAF7S,#*"-FP?]G@YKVRZT32;ZX-Q=Z797$QQ
MF26W1FXZ<D9JZD:1(J(BJBC"JHP /04 ?.?ARTUKP_\ %CPC8S>$_L=Y'9,D
MR'4(Y6G#E_-N6<=^6.S).% !Z55N;VUTGX:>-_!ES<$Z_-K^(+3RV,EP#)"0
MRC'((C8_E_>&?I%K*U>\2\>VA:ZC7:DQC!=1Z!NH')IDFF6$NHQ:C)8VSWT2
M[([EHE,J+SP&QD#D_F: /"/BM9LFHZ5I_AQ;J7Q3;:0Z:DUFW'V,1X(D'0D\
MXYSR."2E;&HV<_B'P#X1L_!.AOJOA9<R7]E]LCMI)&C(*QR,WJ^XO@')&01D
M&O8H[&TANI;J.U@2XE $DJQ@._U/4TEG86>G1&*RM(+:(MN*01A%)]< =>!^
M5 'C_P .+_Q?/!XTATO1+&SNWUJXG$]]=^9##<%XP]NRQC<<)N(<<$XKT72K
M36[C27D\7P:+-J$$KR6S6".R1KLP&'F#(?EQD=B/>MZ"UM[7S?L\$4/FN9)/
M+0+O<]6..I/K4I (P1D&@#PO3O\ DTQ_^N$W_I6U<9K,WAJ+X;Z;-:^.-7O]
M9AAM9(]&NIOM%JLHV[D\IDVA5&[ )(P,<YKZ=&F6"V'V!;*V%GT^SB)?+ZY^
M[C'7FHK71-)L9Q/9Z796\HX$D-NB-^8% 'A/C:ZBNOBQX5NO$>IW?ATS>'XY
M+J>RF,,EO(?.)0-@D?-\OTK5^&]Q8P?%W4[?P]JMQX@TZZT]9+K4KT%YXI%.
M OFE06!XX''(_N5['>:-I>H2B6]TVSN9 NT/- KD#TR1TY/YU/:V=M90B&TM
MXK>(<A(D"+^0H GHHHH **** "BBB@ HHHH **** ."\1W-OX;^).C^(M2E:
M+3+FPETQYWP(K:4NLB,[=@V&7/08&<5J1^.M*O\ Q+8:+HDT&K/<+)+<SVDZ
MO':1J.&<KD9+84#WS732QQS1/%*BR1NI5T<9# ]00>HJMI^F:?I4!M]-L;6S
MA+;C';1+&I;UPH'/ H \[^'/B_PUH_@&W@U'7],M;B&>[:2"6Z19%'VB0CY,
M[N1@@8YS61I>C>)-3\.O<:?IL=SI&M:[=ZM<V=W-]GDEMV93#&25;"L5WL,<
MK@9PQKU:+0M'M[D7,.E6,<X.X2I;H&!]<@9K0XH \12+7]:\&?$FQ?2(H3)?
M7$Q,-UYK><J0DPJH0;@5'#=R<8[UUFLZ[I/B[6/!MKHFI0W<G]HC4F\AMWEP
M1Q2 EP.4RSJN&QR2.QKO8K>" R&&&.,ROYCE% WM@#<<=3P.?:HK73+"QGN)
MK.RMK>6Y;?/)#$J-*W/+$#YCR>3ZT +9ZA9ZAY_V.[AN/L\S03>4X;RY%^\C
M8Z,,C(ZU:JAIFDVVE_;&MP=]Y<O=3L0HW.V!T4 <*JCID[<DDDDWZ "BBB@#
MSNUU"R\*?%/Q(^MW,%C#K<5K/97-PPCCD\J/RW3><#<#M.W.<-5?Q9XOG\0^
M'O%5AX4C^V0VFF[FU2UE#(96/S0IQ\S"++94G!('!Q7HEY96FH6KVM[:PW-N
M_P!^*>,.C=^0>#2VMI;6-M';6EO#;V\8PD4*!%4>P' H \MU!O"[ZGX'_P"$
M(.FF]_M",C[#M\P66Q_.WXYQCKNYW>^:?XN'Q+?P%XC741X?V&Q.S^RC-YI&
M]?,SYG&/*\WISG&*]*M=+T^QN+BXL["UMYKEMT\D,*HTK<G+$#)/)Z^M7* /
M+';P9)X_\#MX;_LXW&^YQ_9X3 A^S28W[>AS]W=S]_'>N+L((Y_ EVFMZQX=
ML]5-W*+LR:>\FIQW7G-@JR2AB^<%=J],=0#7O5OI.FVDC26VGVD+M*9F:.%5
M)D((+D@?>()&>N":5M*TZ34DU)["U:_C78ET85,JKSP'QD#D\9[T >;^+[K4
M?"6NWLEC\UWXHL8[2!D)&-15EB5^<JH*2 _]L:HZKH\.C^/-(THW6DV]C9Z
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M;LX<T_@P]7^@M%%%=!X@4444 %%%% '3>&O^/27_ '_Z"MNL3PU_QZ2_[_\
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M:;=NVA%R0O"\9)Z\C( UK)/B3]OM_M\WA0V?F+YX@BN!)LS\VW+8W8SC/&:
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M*#";MV"00!@@DT =+X7UR[U>&^M]3M(K74].N3:W4<4F]&.U75T)P=K*X(R
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MENSAS3^##U?Z"T445T'B!1110 4444 =-X:_X])?]_\ H*VZQ/#7_'I+_O\
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MEL?_ $!]9_\  )J/^$MC_P"@/K/_ (!-1RL/;T^YT5%<[_PEL?\ T!]9_P#
M)J/^$MC_ .@/K/\ X!-1RL/;T^YT5%<[_P );'_T!]9_\ FH_P"$MC_Z ^L_
M^ 34<K#V]/N=%17._P#"6Q_] ?6?_ )J/^$MC_Z ^L_^ 34<K#V]/N=%17._
M\);'_P! ?6?_  ":C_A+8_\ H#ZS_P" 34<K#V]/N=%17._\);'_ - ?6?\
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M4<K#V]/N=%17._\ "6Q_] ?6?_ )J/\ A+8_^@/K/_@$U'*P]O3[G145SO\
MPEL?_0'UG_P":C_A+8_^@/K/_@$U'*P]O3[G145SO_"6Q_\ 0'UG_P  FH_X
M2V/_ * ^L_\ @$U'*P]O3[G145SO_"6Q_P#0'UG_ , FH_X2V/\ Z ^L_P#@
M$U'*P]O3[G145SO_  EL?_0'UG_P":C_ (2V/_H#ZS_X!-1RL/;T^YT5%<[_
M ,);'_T!]9_\ FH_X2V/_H#ZS_X!-1RL/;T^YT5%<[_PEL?_ $!]9_\  )J/
M^$MC_P"@/K/_ (!-1RL/;T^YT5%<[_PEL?\ T!]9_P# )J/^$MC_ .@/K/\
MX!-1RL/;T^YT5%<[_P );'_T!]9_\ FH_P"$MC_Z ^L_^ 34<K#V]/N=%17.
M_P#"6Q_] ?6?_ )J/^$MC_Z ^L_^ 34<K#V]/N=%17._\);'_P! ?6?_  ":
MC_A+8_\ H#ZS_P" 34<K#V]/N=%17._\);'_ - ?6?\ P":C_A+8_P#H#ZS_
M . 34<K#V]/N=%17._\ "6Q_] ?6?_ )J/\ A+8_^@/K/_@$U'*P]O3[G145
MSO\ PEL?_0'UG_P":C_A+8_^@/K/_@$U'*P]O3[G145SO_"6Q_\ 0'UG_P
MFH_X2V/_ * ^L_\ @$U'*P]O3[G145SO_"6Q_P#0'UG_ , FH_X2V/\ Z ^L
M_P#@$U'*P]O3[G145SO_  EL?_0'UG_P":C_ (2V/_H#ZS_X!-1RL/;T^YT5
M%<[_ ,);'_T!]9_\ FH_X2V/_H#ZS_X!-1RL/;T^YT5%<[_PEL?_ $!]9_\
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M%XR\/>%$B;7-4AM#*?D0Y9V]]J@MCWQB@+&[@>E&!Z5E_P#"2:+_ ,(^=?\
M[4M?[)";S=B0>7C..OKGC'7/'7BN+7XJ6>I^.?#^EZ#=6=[I-_%<-=2B-_.C
M:-&8 #((^[T*G(Z4!8](P/2C ]*Q!XOT ^&?^$C_ +3B_L@<&ZP=N=^STS][
MCI6Q',DT"3(3L=0P+ J<$9Y!Y% 6'X'I1@>E>3V/C;X@>+[:^UCPCI&C1Z-
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M_P"A&J5:K8\Z?Q,****" HHHH *]5^"_WM;_ .V'_M2O*J]5^"_WM;_[8?\
MM2LZOPG?EW^\(]8HHHKE/I0HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M#?WN3L>!?#=QX6\/R6-Q)$6DNI;A8(&8PVRNV1%'NP=H^@Y)XKIJ* "BBB@
MHHHH **** "BBB@ HHHH 0]*^-Z^R#TKXWK6GU/.Q^T0HHHK4\T**** "BBB
M@ HHHH **** "BBB@ K8\)_\CEH?_80M_P#T8M8];'A/_D<M#_["%O\ ^C%I
M/8N'Q(T=8_Y#FH?]?,G_ *$:I5=UC_D.:A_U\R?^A&J5:K8\Z?Q,****" HH
MHH *]5^"_P![6_\ MA_[4KRJO5?@O][6_P#MA_[4K.K\)WY=_O"/6****Y3Z
M4**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_P#WU1_PE_A__H*V_P#WU6QY:?W%_*CRT_N+^5%XA:MW7W?\$Q_^$O\ #_\
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MN]:GANUGM/%.D7,\9CABO87D<]%4."2?PK"W-_>/YUK^%"3XQT,$G_D(0?\
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M_P#OJC_A+_#_ /T%;?\ [ZK8\M/[B_E1Y:?W%_*B\0M6[K[O^"8__"7^'_\
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M /05M_\ OJC_ (2_P_\ ]!6W_P"^JV/+3^XOY4>6G]Q?RHO$+5NZ^[_@F/\
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M"A(4*6R-W3FNXJAI^C:7I+SOINF6=FTY#3&V@6,R$9Y;:!GJ>OJ:OT %%%%
M!1110 4444 %%%% !1110 AZ5\;U]D'I7QO6M/J>=C]HA1116IYH4444 %%%
M% !1110 4444 %%%% !6QX3_ .1RT/\ ["%O_P"C%K'K8\)_\CEH?_80M_\
MT8M)[%P^)&CK'_(<U#_KYD_]"-4JNZQ_R'-0_P"OF3_T(U2K5;'G3^)A1110
M0%%%% !7JOP7^]K?_;#_ -J5Y57JOP7^]K?_ &P_]J5G5^$[\N_WA'K%%%%<
MI]*%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@#.GT'1[K4H]2N-)L9K^+'EW4ENC2ICIAR,C'UK1HHH **** "BBB@ HHHH
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M-FW!WE1SQSFG:'X+U^TTW3X9-)%L8?%YU-H1=K+Y=J8V&[>3EL%@.?F.,XH
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M:,T %%&:,T %%&:,T %%&:,T %%&:,T %%&:,T %%&:,T %%&:,T %%&:,T
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M_0C5*KNL?\AN_P#^OF3_ -"-4JT6QYT_B84444R HHHH *]5^"_WM;_[8?\
MM2O*J]5^"Y^;6_\ MA_[4K.K\)WY=_O"/6**,T9KE/I0HHS1F@ HHS1F@ HH
MS1F@ HHS1F@ HHS1F@ HHS1F@ HHS1F@ HHS1F@ HHS1F@ HHS1F@ HHS1F@
M HHS1F@ HHS1F@ HHS1F@ HHS1F@ HHS1F@ HHS1F@ HHS1F@ HHS1F@ HHS
M1F@ HHS1F@ HHS1F@ HHS1F@ HHS1F@ HHS1F@ HHS1F@ HHS1F@ HHS1F@
MHHS1F@ HHS1F@ HHS1F@ HHS1F@ HI,BB@#ECX?ES_R'M9_[_K_\31_PC\O_
M $'M9_\  A?_ (FBBMSQFW</^$?E_P"@_K/_ ($+_P#$T?\ "/R_]!_6?_ A
M?_B:**8KL/\ A'Y?^@_K/_@0O_Q-'_"/R_\ 0?UG_P "%_\ B:** NP_X1^7
M_H/ZS_X$+_\ $T?\(_+_ -!_6?\ P(7_ .)HHH"[#_A'Y?\ H/ZS_P"!"_\
MQ-'_  C\O_0?UG_P(7_XFBB@+L/^$?E_Z#^L_P#@0O\ \31_PC\O_0?UG_P(
M7_XFBB@+L/\ A'Y?^@_K/_@0O_Q-'_"/R_\ 0?UG_P "%_\ B:** NP_X1^7
M_H/ZS_X$+_\ $T?\(_+_ -!_6?\ P(7_ .)HHH"[#_A'Y?\ H/ZS_P"!"_\
MQ-'_  C\O_0?UG_P(7_XFBB@+L/^$?E_Z#^L_P#@0O\ \31_PC\O_0?UG_P(
M7_XFBB@+L/\ A'Y?^@_K/_@0O_Q-'_"/R_\ 0?UG_P "%_\ B:** NP_X1^7
M_H/ZS_X$+_\ $T?\(_+_ -!_6?\ P(7_ .)HHH"[#_A'Y?\ H/ZS_P"!"_\
MQ-'_  C\O_0?UG_P(7_XFBB@+L/^$?E_Z#^L_P#@0O\ \31_PC\O_0?UG_P(
M7_XFBB@+L/\ A'Y?^@_K/_@0O_Q-'_"/R_\ 0?UG_P "%_\ B:** NP_X1^7
M_H/ZS_X$+_\ $T?\(_+_ -!_6?\ P(7_ .)HHH"[#_A'Y?\ H/ZS_P"!"_\
MQ-'_  C\O_0?UG_P(7_XFBB@+L/^$?E_Z#^L_P#@0O\ \31_PC\O_0?UG_P(
M7_XFBB@+L/\ A'Y?^@_K/_@0O_Q-'_"/R_\ 0?UG_P "%_\ B:** NP_X1^7
M_H/ZS_X$+_\ $T?\(_+_ -!_6?\ P(7_ .)HHH"[#_A'Y?\ H/ZS_P"!"_\
MQ-'_  C\O_0?UG_P(7_XFBB@+L/^$?E_Z#^L_P#@0O\ \31_PC\O_0?UG_P(
M7_XFBB@+L/\ A'Y?^@_K/_@0O_Q-'_"/R_\ 0?UG_P "%_\ B:** NP_X1^7
M_H/ZS_X$+_\ $T?\(_+_ -!_6?\ P(7_ .)HHH"[#_A'Y?\ H/ZS_P"!"_\
MQ-'_  C\O_0?UG_P(7_XFBB@+L/^$?E_Z#^L_P#@0O\ \31_PC\O_0?UG_P(
M7_XFBB@+L/\ A'Y?^@_K/_@0O_Q-'_"/R_\ 0?UG_P "%_\ B:** NP_X1^7
M_H/ZS_X$+_\ $T?\(_+_ -!_6?\ P(7_ .)HHH"[#_A'Y?\ H/ZS_P"!"_\
MQ-'_  C\O_0?UG_P(7_XFBB@+L/^$?E_Z#^L_P#@0O\ \31_PC\O_0?UG_P(
M7_XFBB@+L/\ A'Y?^@_K/_@0O_Q-'_"/R_\ 0?UG_P "%_\ B:** NQ?^$>E
MR/\ B?ZS_P"!"_\ Q-=.HPH'7CO116<SMPKW,O6=.:^\G;?WMILS_P >T@7=
MG'7(/3'ZFLO_ (1^7_H/ZS_X$+_\31151V,:[?M&'_"/R_\ 0?UG_P "%_\
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>tmb-20211110xex99d1018.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20211110xex99d1018.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  \ (4# 2(  A$! Q$!_\0
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' HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>tmb-20211110xex99d1019.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20211110xex99d1019.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !" (X# 2(  A$! Q$!_\0
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>tmb-20211110xex99d1014.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20211110xex99d1014.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  H (H# 2(  A$! Q$!_\0
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-K6S113D)"T444AG_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>tmb-20211110xex99d1017.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20211110xex99d1017.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  X '0# 2(  A$! Q$!_\0
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M/-NV @85<DDG X^I%,16-OJ4I!>^C@7NL$()_-B?Y4K::'SYEY>/D]IMG?\
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M6^4_]]5TM&*6ANX)6"BBBD,**** "BBB@ HHHH 2L'PY9/';W;W<&V5K^:1
KZ<J-Q"D9]@#GWHHIIZ,74WZ***0PHHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>tmb-20211110xex99d1002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20211110xex99d1002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  \ ,H# 2(  A$! Q$!_\0
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&F\OP1__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>tmb-20211110xex99d1016.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20211110xex99d1016.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  \ - # 2(  A$! Q$!_\0
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M*..#V+$,<^PINAZY]ETY+*?39K62W&S9(53/H>2,_49IN%US=0.@D6_8$QO
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,H **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>tmb-20211110xex99d1008.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20211110xex99d1008.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "% 0D# 2(  A$! Q$!_\0
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MK-);6ML%-W,F5=V89$:-VXP2PYY !ZXT;'3++385AL[6*%!SA%QSW/UIV2W
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M/9?4_@.Y$VJR2RF'3K=RDMUG>ZG#1Q#[[#WY 'NP/:K\,200I%$H6-%"JH[
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
%HHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>tmb-20211110xex99d1013.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20211110xex99d1013.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !+ &\# 2(  A$! Q$!_\0
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3 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>tmb-20211110xex99d1011.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20211110xex99d1011.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !" (4# 2(  A$! Q$!_\0
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M 4444 9EY_I>J6]D<^7&/M$GOSA1^>3^ K3HHH **** "BBB@ HHHH ****
M"BBB@!"**6B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
##__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>tmb-20211110xex99d1006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20211110xex99d1006.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" )_!98# 2(  A$! Q$!_\0
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MDNK>=<!40K(R ;FQUVYK:@\0:+<Z;+J4&KV$MA"2);I+E&B0C&07!P.H[]Z
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M&/AS0+N.TU76K.TN) "L4L@#8/0D=A[GB@#=HK'U3Q1H6C:?!J&H:M:6]I.
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M&S!0Y('WAMY'/;K7::9XIT+6=-GU'3]6M)[.W!,TPD 6( 9)?/W1@$\XXYH
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M\75/^%-GSQ;'7O/$GFC!L-OF[.G7'S_[WTKZ(M=-L[")HK&U@M5;M#&$&?7
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M4<OV;RBRER?.$>/W89,G Q@9'2OIQHT< ,H8 Y&1FG;5]!0!\ZW^H:7J%O\
M!QM*:-HX;Z*"?9&4Q,IMMX((&3GOW]:OVVI^&_"GCCQTGCZTS<WUP9;,W%L9
M_M%J2^U8S@@# 4=0,@ _=X]Y6)$4*J* .@ H:-'(+(I(Y!(Z4 ?/5MH=XGPD
M\!Z7KL#"*Z\4VX%O*""L$AD^4CMG+'Z-73ZYI]C#\:[R!+*3[/<^%)?/AL4
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MBB@ HHHH ***\UNK/5K?XQ^';K4M3^T)=1WXM[6)-D5O&BIM[Y9SNRS'V
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M(X ]#TO@BXFN_ ^B3W%\E],]G&9+E&W"1MO))/).>#GG(.: -^BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%;[)8TA7G&_:!DG SDUTL6@ZSJ_B_3=<UR&QM4TJWE6T@M)WE+RR@*[LQ5<
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M@<=*J?\ "3:[_P!!2X_3_"CD\S.><TH2<91=T>T9HS7B_P#PDVN_]!2?]/\
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MJ^-7\-ZY!8LSZ<+^&YLPZ# <(R,K%N<L,'/0=.>*7Q/)!\&X)&?%%D#C_@=
M'>T5PDGB#Q?J6O:_IVB66E)#I4JQI/>&0B9FB1PF%/!&YLMZ%0!U-)'XVU#6
M;3PS%H5G;B^UFU-Y*UR2T=K$FP.2%(+?,^T<C- '>45D:#<ZS-#<Q:W:0PW$
M$[(DMNW[NXCP"KJ"25ZX*G/(/)%3Z[J0T;P_J6J&/S!96LMP4SC=L4MC\<4
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M2I9VQ_AQ"BBB@84444 %%%% !1110 4444 6;'_C[3\?Y5LUC6/_ !]I^/\
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M>D+;F*%RS.Y(!#=  . "W7.:O:AX*\.:IJ;:C>Z3;S73X\QV7_68&!N'\7
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M'EC[ <GJ.@KYQT35[ ^,/!WB&/5XKSQ)J.K.VIJJL/*28K&J#( PJEAQT)]
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MR,GA2X +8]<#&>P)]35VB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MCZ5[E::)I5CY1M-/MH3$28RD8!4D8./PJ0Z78-I_V V<)L_^>&P;.N[I]>:
M."B.C#XD^+E\2M; O!:K:?;F4(;8Q_.(]W;S-V<=ZT?A$(E^&FFBWW^2)KH1
M[_O;?M,N,^^*ZN\TG3M1>-[VR@N'B.Y#(@8J?:K%O;PVL(B@B2*,$D*@P,DY
M/ZDT 2T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4AZ&EI#T-
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M-I7\#2_9XMQ;;R2"?J.E,YB3(]:,CUJ,6\08-L&02?Q/6D:UB9=I3C:%_ 4
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M&1$(SV3[H_"C0+S[%W</44;U_O"JJ:=:QR>8L0#>:9LY_C(P3^51+HU@BD"
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<L9HIJL&&00>W%.%!04444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0T6870448/H?RI<'^Z?3I19@FCO-5_U&D_\ 8,M__0*S:T-5=3#I(# D:;;
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M1.<X^8<XZ_E09X@NXR)MP&SN'0]#]*!&C8?ZFY^B_P ZDJ"QFB\JX'F)DE4
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M<T^BBD4%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MO+ ZC(DLL,<2,N50(.3[+3#\-]-E\,:QI%S=7-Q/J^UKR_D;,LCKC8?3"D#
MZ=?6@HY_2_$U]#XQT2VAU^\U6UOYGAN?.L_+B!\IW4QM@=UZ>E:>@ZCK^J2:
M]JL^JI!;Z7?W]G#;N@$4BQLVQY&ZC&0..R>]:<G@N[NM4TG4+[7[F>72YQ+
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MW]GB^N?MWV_^TO[1X\W[5G_6>G3C'3% &/HNGZEIOQI\G4-2;41_PCSF&>1
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M $.J],O%_P 3Y+\D%%%%!RA1110 4444 %%%% !1110!O:7_ ,@5_P#KX_\
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MP_\ ]!6#\S1_PF/A_P#Z"L'YFM+^S+#_ )\K?_OTO^%']F6'_/E;_P#?I?\
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M9O\ PF/A_P#Z"L'YFC_A,?#_ /T%8/S-:7]F6'_/E;_]^E_PH_LRP_Y\K?\
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M9O\ PF/A_P#Z"L'YFC_A,?#_ /T%8/S-:7]F6'_/E;_]^E_PH_LRP_Y\K?\
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M_P"$Q\/_ /05@_,T?\)CX?\ ^@K!^9K2_LRP_P"?*W_[]+_A1_9EA_SY6_\
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M%Q,XB=LD'WQ],5QOA[3M/U?X;^*=8U/7+R/5-/N+@VB_;2NTJ@9,+GG<Q*T
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MJ7AM2!%G/)$A>$^^#0!ZRTT:NJ,ZAV^ZI/)H>1(QEV50.Y.*\3\21PZCX?\
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MN^U F(>)Y+16MKHR-]F$,I\II!U(^9"?8'K0![(DJ.FY'5E]0<B@2H7*!U+
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M!IMBR87Y9HUVXQ]T]2/6L'PUK&NZ[X&\ []:N(KG4[^YCN[D$;WC7SSC/KA
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MOT.626VM'%W)$!@RPJ2LR,#T(7<?9D% '9T4R-UDC61&#*PR".A%/H ****
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M'E6)4!/O@_D:[>B@#QVXCUO5M"\!:2OAS4H9='U*PEO9)8\(@B&QB/4<DY[
M5M6^B:DO@_XD6QLIA/J%Y?O:)MYF5[=54KZY((%>D44 <&FE:DGA[P!%':.+
MBP:(SJP_U)%E*GS>@WL!^-<#K>@ZYK7@EHKC3/$-WXA"H9UG;;;H5E5F,:C
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *0]#2TAZ&@&?+DO\
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MP/\ A,=(_P">DO\ WZ;_  H_X3'2/^>DO_?IO\*.5A[:GW-^BL#_ (3'2/\
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M'*P]I#N:]%9'_"2Z;_?D_P"_;4?\)+IO]^3_ +]M1RL/:0[G06/_ !]I^/\
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MLI_"%\T<UZ;.TFW "X;<0NW_ 'NH^M6=6^)5[H'@J3Q!J_ARZLY%O1;+:RL
MS*5R'SZ9R/PI7*Y5V/0MB_W11L7^Z*X+3_''B>[U*UMI_ NI6T,LR1R3N1MC
M4D L?8#FJ5S\4M2;Q'K&DZ3X3O=2.ES"*=X&!ZYP<>^#^5%PY5V/2MB_W11L
M7^Z*\WF^,&GCP!+XI@T^X)@O!9SVDA"O')]>AX(/X^U6]/\ ''B>ZU*UMI_
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MYTSD+&GXL1SV&3VK1BD+ )(T?GJH,BHV<$_KCKBBX<J[#]B_W11L7^Z*C-S
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M?ZFY^B_SJ2DV=L4O9Q"BBBE<=D%%%%%PL@HHHHN%D%%%%%PL@HHHHN%D6+$
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MQN=,@DMK,@V\97_5$=-IZBK T/2_LEW:?8(#;W<K37$3("LCL<EB#W) /X4
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MY+_KI/\ >/\ .F4^7_72?[Q_G3*L^4G\3"BBBF(**** "BBB@ HHHH ****
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MNKB:PNH;]XXBLA+*)1O&"&8@\<@=Z[BRN9=!D\.>'EL8]LMJR.\#'9 8D7@
M\[<G _#UH M>*/$</A;1QJ-Q;S7">='#Y<(RQ+L%&!WY-9LGC.:.:QL?[!O3
MJ]X)'6P#IN2), R.V=JKD@#)Y)JUXPTRZU73K"&UB\QHM4LYW&<8C2968_@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !2'H:6D/0T SY<E_UTG^\?YTRGR_
MZZ3_ 'C_ #IE6?*3^)A1113$%%%% !1110 4444 %%%% ([W5?\ 4:3_ -@R
MW_\ 0*S:TM5_U&D_]@RW_P#0*S::.#%_QY>H4444',%%%% !1110 4444 %%
M%% '71_\BOH_TF_]#JO5B/\ Y%?1_I-_Z'5>F7B_XGR7Y(****#E"BBB@ HH
MHH **** "BBB@#>TO_D"O_U\?^RU+46E_P#(%?\ Z^/_ &6I:EGO0_A0] HH
MHH&%%%% !1110 4444 %%%% %VP_U-S]%_G4E1V'^IN?HO\ .I*EG;'^'$**
M**!A1110 4444 %%%% !1110!9L?^/M/Q_E6S6-8_P#'VGX_RK9I,]3!_P ,
M****1U"445FMK^EIJBZ:UY&+LG'EY[^GUH2;V)E.,?B=C2KF/$/BQ-.F73M/
MC^U:G*0J1KR%)[G_  J+QIXJ70K,6ULP.H3#Y!UV+_>/]*C\%>&#IUO_ &GJ
M"E]2N/F)?DQ@]OJ>_P"5:**2YI''5KRJ5/84M^K[?\$V=!L+^SM9)-2O&N+J
M=M[C^"/CHM:]%%0W<[(148I(6BBBD4%%%% &<L>F7FLFY012:A8H8&=6^:-7
M"N5/UPIY]JEO=2M-.DM$NI1&UW.+>$'^*0@L!^2G\J\TO6O=&/Q/U2TU.[%Q
M;[6B#%"JL;6)@V-O5?NCVZY/-.\3:)KXLO#23^(I)M1O-<A99GB4):9@G+>6
MO?&3C)/1: /3;RTM]0L;BRNHQ+;7$;12QGHR,""./4$TZUMH;.UAM;=!'!"B
MQQH/X5 P!^5>::S?>(M.U?Q!X9L-8N[FX.B?VO87#HC31.DFTQ< !@^!@XXR
M:#X[N;OQUHMU;WHB\-RPVT%RCK_R\7,,LL>3CJ L0_[:"@#T6?4K6UU&TL9I
M-D]V',.1PQ0 D9Z9P<X[@'T-7*\DUS5-1D^#DOBZXDD:\2_35K!9<+Y$1N (
MT&.H,1QSUWFO6Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH YW
M7?&^@^';G[-?WG^DX#&")#(Z@]"54$@<&M#1M=TWQ!9?:],NX[B$-M8J>4;K
M@CJ#STKDOAR^/#&KZPULTVLSW]V][&I!D:1)&"Q9/3"A0 3@9K,O_%MMX?L_
M&.J6WAZYTW68[6"ZF6X9665F+1QMA6(X()/0F@#U*BO,;;4]>T_5=",,_B#4
MUFN%MM0CO=.,401^LJ-M&W:0."3D$^E5#=^);WPWXTUO_A([FW;2+V_6RABB
M39L@9F ?(RV0-O&,  \F@#UFBO+[?6M9\3>/])L(=5N--T^[\,PZK+#;JA;S
M&DQ@,P./O#G!X7ISFLJYU/Q99>!->U^3Q'*]UHE]):PH(4$=PD,VPM*,9);.
M.", "@#V6J5QJMG:ZI9Z;-,%N[Q9&@CQ]\( 6_+(K@]9U:YG\1ZS91^(-4%Q
M"BK;6FC6?G"W^7K,2IRY8YVY  QZUC?:M2\6:C\,+S[<;*[NK&\DN)XE!; 2
M+=M!X!;'H<9/7% 'L5%<AX4OM2C\3>(O#VH7C7R:>T$UO<R8$ACF#'8X  RI
M0\]P1Q1XBO-3OO&&D^&].OVT^.2VEOKNX109&C1D4(A((!);DXX% '7T5Y#X
MI\1^(?#.@>,[%=5:>XTQ+2ZLKUE7S1'-+M*. -N1M(SCD'/%= [ZWX?\=^&;
M*;7)]0M=66YBN8YXU4*Z1F0-'M&0.,8)/% '?45R_CR^U*P\/0OI-RMO>2W]
MK DC+N'SS(I!'<$'FLG[7JGA7Q.\%YK%UJEB=$GO62=$#B6%DR5*@<,'Z'.,
M=: .^JO'>VTM[/9QSQM<P*CRQ!LL@;.TD=L[6_(UY);>)/$S>%[#Q!;SZY?:
MI*8KI[$::5M)8WQNC5MN1A6R&W') ]:Z'PQ9.GQ=\:RF]N6"1V3>6Q7:VY)"
M ?ESA>@_7- 'H54-8UBQT'2YM2U&80VD)7?(1G&Y@H_4@5SFNWNHZAXZT[PS
M97\VGP?8I=0N9X44O(%=8UC4L"!RQ)X/:O.?&-YK'_",_$C1]4U22_BTV73!
M;,Z*I57D1N<#D],^X[4 >\54N=0MK.XL[>>0++=RF* ?WF"LY'_?*D_A7'"Z
MU7Q+X]\0:3%JUQIEEHL4"*+4(7FDF3?O8L#@*!@ #GGFN;;4=;\1VWA^R-]'
M!J]CXCNM,DOA&,-Y<$P:15Z;BA..V[VH ]@HKSMM:U+0/%&N:!-K"SH-&.JV
MEYJ  %L0QC*R%0-RY ;H#U%8]MXGOK/4_"DUMJ^M:C;W]ZMG=M>6?E6\N]3A
MHVV#!##(&3D9]* /3=,UFQUC[9]AG$OV.Z>TGP,;)4QN7\,BKABC,JRE%,BJ
M5#D<@'!(!]#@?D*X+X6=/&G_ &-5]_[)6?XLUK6-.\0:S]OO]6TW3%AC&FW5
MC;++ K%>3+\K-NWD\<?*!ZT >H54O]2M=,BBENY1&DLR0(3W=V"J/Q)%<)J_
MB"1[[P_"_B-E@NK$3&/1X#+<74A'#J-K!8N"<]<\5@VVLZAK'A39J,\T[V/C
M*VM(I+B+RY3&)HF7>O&&&\CH.E 'K&IZ;::QI\UA?1>;:S "1-Y7< 0>H(/4
M5+:6L%C:0VEK$L5O @CCC7HJ@8 'X5YO=:[J6L>)_$$$=_K=G9V$GV.V73=/
M,W[P(K,\AVL#@MPO&139]>\67/A_PS>WMIJ5I&_GC5AIT :<%#MC;:P)5#@L
M>"1\HH ]%U'4[;2H(YKMF2*25(=^TD*SG:N3V!) R>Y%7*X7P^\/C#P%J]E/
MJ_\ :EO.T]NLSQ>7+&C+\JR*0,.H8'.!V-;7@?4I]7\#:'J%R[/<3V432NPP
M7?: 6_$@F@#H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ I#T-+2'H: 9\N2_ZZ3_>/\Z93Y?\
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MU"ZN;O6#";V_?&^0QD%  . !MZ>YK?U#08-1UW1]5DD=9=+>5HE'1C(A0Y_
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M5F:0@LTZ%"23_M% 3QW-=?10!RFI^#9KC6;C5-)UV\TF:]V?;5A576;:NU2
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M 'C_ #IE/E_UTG^\?YTRK/E)_$PHHHIB"BBB@ HHHH **** "BBB@$=[JO\
MJ-)_[!EO_P"@5FUI:K_J-)_[!EO_ .@5FTT<&+_CR]0HHHH.8**** "BBB@
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M%<SY7C/_ )^-(_[X>CRO&?\ S\:1_P!\/1R^8>V_NLZ:BN9\KQG_ ,_&D?\
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MYGRO&?\ S\:1_P!\/1Y7C/\ Y^-(_P"^'HY?,/;?W6=-17,^5XS_ .?C2/\
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M_P BOH_TF_\ 0ZKTR\7_ !/DOR04444'*%%%% !1110 4444 %%%% &]I?\
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MHG7/<C=&?^!BNWK(D?2K_P 11V\J ZGIJ"YB+ AE20,F5/\ $#A@1SR!GG%
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M9(SN7>,@J5)'4'!Q2R>"[^X\,>(!::"EA/J-W9&&"2Z,LSQ0RHQ:5V=AG&_
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M5W%% '!:YX9OH/">L1ZC>ZEXFAE@"_8"L<;\.#N0JH^88R!ZCO6/X<N-0?Q
M;33+[5=5T86,R3/JEFT<EJZA=JK*54N6)Y!_NYKU6B@#RJXTBZ_X0+X:VRV4
MOFVNI:;)<1B,YBVH=S,.V">35CQI%JD&K>)+K3].-SYNEV,2EK;SU_X^)=[!
M.C,JMNQ[ UZ;10!X]8B?5/B1X1U&UNM>U.SMOM:SW=_:>3%&S0L%"C8O4J<]
M?X:M^$-,O[?PUX#CFLYXY+;5[R2960@QJ5NL$^@.Y?S%>K44 <I\2=%OO$/P
M\UG3-..+N6$-&H)&_:ZN4X_O!2OXUF7.NIXO"Z5I6C72SO;7"37EY;-#_9K-
M"5&"R\L68+A>V3T%=]10!X9!8+>>$+#PK=GQ9)J*);V\^F+$L<491U&\2^40
M$!7<#N/ 'O6GXVTK4+G1/B8D%E/(]W/8FW5(R3*%CASM]<8/Y5[!10!FZ_&\
MOAS5(XU9G>TE5549))0\5Y];W$WAJW^'VIWMC>&TM]$:SNVB@9VMW:. KN4#
M(R8R.G6O4Z* /%=?@OM>\.?$&XATF^07U_IYMXIH&5Y40P*6"GG!"D^PZXKL
M?%%C<W'Q-\$7$,,I@A341-*JDB/="H7)[9/2NYHH \)US4GTOX%W/ABZT6[C
MOK6 6\F+=OL^%DSYPDQM(.-PYR6(KV3Q!83:KX;U33K:413W5I+!'(21L9D*
M@Y'/!-<^GPXTQ;>*P?4-2ET>*;SDTR296@R&W!3\NXJ#T4L>@KLJ /-O#>NA
M=!\->&O^$>O+C5;,6L%U%<VK)':^6 &FWLNWC:2N#DDC%<IJMQJVI>%->T^\
M.MPZNZW 71-.L EO$I9@,R;#O5A\Y(8;MQQS7NE% '"Z/:2O\2$U$VT@A/AN
MVB65D( ;S7)7/K]TD5RT&F:A9P7&HR:5<7$-EXWN;^2 1%F,#!D$RKU;:7##
M'IGM7L=% 'E'C">?QWX?UJ/1- FEA2T@<7DL)AFN"DX=H$#KE@%0GN,D#!S5
MC2?L^M>+-&DMY_$U^UC))-))?Q+#':GRRN#F)2Q;=C /J>U>GT4 <G\.;.:R
M\'1Q7$+PR_;+MF5UP>;B0@_B,?ABNLHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ I#T-+2'H: 9\N2_ZZ3_ 'C_ #IE/E_UTG^\?YTRK/E)
M_$PHHHIB"BBB@ HHHH **** "BBB@$=[JO\ J-)_[!EO_P"@5FUI:K_J-)_[
M!EO_ .@5FTT<&+_CR]0HHHH.8**** "BBB@ HHHH **** .NC_Y%?1_I-_Z'
M5>K$?_(KZ/\ 2;_T.J],O%_Q/DOR04444'*%%%% !1110 4444 %%%% &]I?
M_(%?_KX_]EJ6HM+_ .0*_P#U\?\ LM2U+/>A_"AZ!1110,**** "BBB@ HHH
MH **** +MA_J;GZ+_.I*CL/]3<_1?YU)4L[8_P .(4444#"BBB@"Q8_\?D?X
M_P JVJQ;'_C\C_'^5;5)GIX/^&%%%%(ZPHHHH **** "BBB@ HHHH 2BBN2\
M0>+)(;Q-(T6,76IR';QRL?U]_P"74TU%O8RJUH4HWD=;FEK(T'2I],LV^UW<
MMU=S-OFD=B5W>BCL*UJ3+@W**;5A:***"@HHHH XOPU*LWB3QGK4\I3RKQ+%
M1*0%BB@A5\Y[ M*['ZUQ+:[J$$6CZO9ZUXCU"2:ZMEN+F2T$5A)&\RJRJ&0=
M=V 5)/?Z=VNBM;^+]:M[B"2YT;Q#;!Y5P2D4J((I%;'0/&4P<\E&]JK-\-+2
M;2;;2[C7=9ELK,QFSC,L:^08R"A!"#<1C'S9&#TS@@ S;LZUKOB?QI9KKUY8
M6VD>0]D+4(#YC6ZN=^5.5##..,[FR>F,U-2U_3=*\"^(Y]<N;JYUR]L[6ZMG
M5!;^5.C-\J@9##CG/4>G%>B6_AVSMM1UJ^1IO-U?R_M +# V1^6-O''RCOGF
MJMQX,TVYTCP_ICR7(@T*>WN+4AQN9H5VIO..1@\XQ^% ')P^)-7M?"&B>);B
M^+V]OJ\\&I!]JJULUS)"K'C^ ^6>,< YJQ>>(M0N+/Q?JRZPNFZ;:SIIUC,]
MN7V,A FD"_QL78HN.,H.#SGJH?"NG0^%+GPYF9[&Y6=7+L"^)F9FP<8ZN<<<
M<56?P1I3>#X?#*O<QVD)5TF63]\) _F>9N(^\7Y)QW- '&:1K=_IWQ)T72K>
MY\03:=JBW7G'6H0FYD0.&B&U6&.AR,?-Q[8\>I^(D^$/_">2>)=0DU*W=FCM
MR(Q 4%QY95E"Y;(!YSQGCI7H\'@BW77].UR]U74K_4;#S!#)/(@4*ZE2-BJ!
MWSGKD#)( %(? .D'P$W@[S;O^S6W9?>OF\RF3KC'WCZ=* ,Q[4V_Q8U;4'U2
M>*.'1()F21D$(&^=<-\N=HQNZYR3SC@<D-<U"W.@ZI9:SXDOGN+NU2ZN;BU$
M5C+')(JL$#(IYW<%<G _$>E:CX1L=3UV35;B>Z_?6)T^XME<"*>$[SAAC.?G
M;D$5D_\ "MK.2PL;&ZUK5[FUT]HFLHWDC @,9781M0;B N/FSP3WP: ,O4_[
M:U;5O&JIKUY90:.8WL4M@@PYM5D._*G<N[G''5O;%2UOM;L;+P1XBN-<N[J?
M7;JV@NK5P@MQ'-$[@*H7(*G;SGG'X5WJ^';-9M;E#S;M8Q]I^88&(A$-O''R
MJ.N>:KR>$-.DTK0-.:2X\G0Y8);4[AN9HD*+O..1@G.,<T >6>(?$NHP^'KS
M7],U_7;^]@EE9+FUM0NFJHE(QED 9<?+D,3GIFNNN-&N=:^*&MQQZQ>:?;II
MEF9%LRJR2-OFV_,P. ,-D <Y%6W^%VERZ(^@R:IJIT0EC'8"9 D>XDC#;=Q"
MEL@,2,@9SBM6^\&P76N2:U;:IJ-CJ$D"6[2V[I@QJ2<%64@Y+=>O QCG(!@^
M&_&]S;Z1=0:K;ZAJ5S8ZG=:<;FTM&D,HB88=E084D,!]0:[VTN!=V<%RL<D8
MEC60)*I5UR,X8'D'U%4M"T.S\.Z3%IUB'\I"6:25M\DKL<L[M_$Q)))_I6G0
M 4444 %%%% !1110!X[++XBE^'>I^+CXFOUO;&:[>UA58Q#LCF9=KKMRV0IY
MR,9'IS=\2^([Z]\=ZEHH/B&.PTR" [=$MA(\DD@+[G?:=J@# 7')W<\8KM?^
M$/T[_A$;OPUON/L-UYWF-O'F?O79VP<8ZL<<4FI^%(;[6AK%KJ%[INH&'R))
MK1DQ-&#D!U=6!(YP<9&30!Y?K%SK.O>'/#)U=]3L[BW\70V<<DL*PR31ELI,
M5*\.!QQQG=D'M[!J_P!NA\.WW]F,KZ@EK)]F,I #2[3LW'@?>QZ"L1OA[HX\
M/6^D127<7V>\6_2[$@:<W(.?-9F!#,3UR,5OW6F6]_H\NEWVZZMYH#!-YAPT
MBD8).,<GVQ[8H \Y\)ZK<P^)K&TU/5=?L[ZX$JS6&KVRLETZJ#N@D4!5 (8]
M3D=N]<]XA\3ZE9>'[CQ%INNZYJ-]!*S"X@M0FEA1-C;\RC<N/E!#$D\YKTRP
M\%16E]87-WK&J:D-.!%G%>2(5C)79N.U07;;D;F)QD]SFLV7X7:7/H3:#/JN
MK/HHSY5CYR!(\DD8;;N(4G(#$@8'7% &3JVN2^&_$/Q%UB",23VNF6#QJPR-
M^)@I(] 2"?;-9VFZSXAL]5T.2W7Q7>/<W<,6HC4K$1VYC8;6D3"#9M)# 9QC
MK7HS>%M-FO=8N;A9)_[7MH[6[C=OD:- Z@#&",ASGGTQBLRS\ 6<%QIK7>JZ
MGJ,&EN)+*VNY$*1.!A6.U06([$DXH XW5-7U?3=:O[G6]4US2!'=L;2^2W2X
MTWR#* BN%&=Q48.6!&<Y'2NP\2#[/XV\'ZA"[!I)[BRD"#_61O"TG/L&B0_G
M1<?#VRN$O+5=5U2'2KV=I[C3HI5$+%F#.H.W<J,<Y4, =QZ9J:YL)]4\?Z=.
M898=/T2"21'(*K-<2KL 7CD)'NR1W<#L: .JHHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MDM$%%%% PHHHH **** "DK-75I&MDF_LV]!:.1_+*#<-I^Z1GJW:E35'?/\
MQ+KQ<>5]Y!_'U[_P_P 7]:=F1[2)<N4EDM9DMY5AF9"(Y"FX(Q'!(R,X/;(S
M6+X4\-?\(U87D4EXUY=7U[+?7,QC$8:1R,[5R=H  &,FK\>IO)<+$=/NT!E>
M/>R#: HSNZ_=/05$VLR"+?\ V5?D^0)MHC&<YQLZ_>[X]*+,/:1-6LFUT..'
MQ+?:Y-+YUS/$EO""@'D0KR4'KN<LQ/\ NC^'F>74GBEV"PNW'GK#N51C!&=_
M7[HZ$^M-_M23RD?^SKSYED;;L&1L/ //5NWK[468>TB:-+6:-5D,3O\ V=>
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M)E&0@XV=._\ %V]?:BS#VD32HK+EU>2.W,HTR^<B%)=BH-Q+'&WK]X=34O\
M:+^;L^Q76//\G=M&,;<[^OW>V?6BS#VD2_167'J\DD/F'3+Y3Y+R[&09RIQL
MZ_>/4"G#59"[K_9UX IB&2@P=_4CG^'OZ>]%F'M(FE13(W+KDJR\D8/L<4^D
M6%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MI$"^:'!17(5\CIN !QVS@]*LQ313KNBD5U]5.10!)BC%1RS1PIOED5%'\3'
MI5EC<$JZD#J0>E #\48J&*Y@G)$4T<F.NU@<4+<PO*8EFC,JC)0,,C\* )L4
M8K)TSQ#8ZI/J44+E3I]T;64N0 6"(V1ST^<#)QR#4]Q?S+=V<=I!'<12S-'<
M2"95\@!&.<?Q'< N!SSGM0!?Q28%1M<0I((VF02'HI89/X5)GB@ Q1BHX[B&
M5V2.5&=?O*K D?6@7$)E$0E3S#G"[ADXZ\>U $N*,444 &*,444 )BEQ110
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MCEV4B11M:0MSSG:.F*YZW@>T\-GP'JVR[?1_$-A""R';-:33*R$@D]BRD9.
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M+CS/(B"E\9QDCKC)^F: .7^%6@:=I_@;1=1BMXS?W-BAFNF7,KJV"%+=2HP
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MG+6-QXAOO#M]')HNL7X\/6TEQI>M(QW(W)GB;!&YF^4G'&!GJ*-/M] U:S\
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MI7A34?#/B?5O$ZP?;4U*\%]>/\T]J4D(C6-^67""/:%Z\#!SBNK^(-YJ%O\
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MTRGR_P"ND_WC_.F59\I/XF%%%%,04444 %%%% !1110 4444 CO=5_U&D_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJ_>,3LH60 <_*3QSTKS[Q%YGB;1?'6M:39736%YIMK;6S?9V0WKH79G52 Q
M#JH.,'!QG%=QX@M'D\7>#9HK=F2WN[C>ZID1J;64<GL"<#ZXH ?=_$#PY8RW
M2SWDXBM)_L]S<K9S/!#)D#:TJJ4!!8 Y/'?%7=5\5Z1HU_#87,TTE[+$9EMK
M6VDN)/+!P7*QJQ"Y[G@X..E>0ZE?ZAJ7@[7],GFU6TU<B?'AG2],58K=2S8+
MOY1+JP^<N' ;<0,GBNVMKIO#WC>^U6^M=1GL-6T^T%M<6]G).(6CW!HF5%+*
M3O5AD8//.10!O0^/?#$^@7.NQ:K&VFV\Q@>?8P!D&/E48RQY&-H.>U6],\4Z
M1JTEY%;W+QS68#7$-U!);R1*1D,5D53MQWQBO';"VN=2\.R:I#:ZE;VUIXTN
M+NXAMH%:XM4((#["K9,989 4]\=,CH;%[?5+_6-=T<ZSXBDAT*>".XU*UC2W
MG8G<+;8(HVD)*Y.,@9(ZF@#L[7Q_X<N[FRACNYU6^D\JTGELYHX9WYPJ2LH1
MB<<8//;-2^%]6N]3O?$<=TZLMEJKVT&% Q&(HV /KRQYKRTSW.LVGA(0:CJV
MHRV6L6<MY:1Z8+:TT]5D *X$0(*9"@%SQDXQ7I/@VWG@U#Q8TT,D8EUMY(RZ
MD;U\F$;AZC(//L: -+5O%&DZ+>V]E>3RF\N06BMK>WDGE91U;9&K-CWQBJY\
M;>'_ .R[#48[\S0:@Q2T6"%Y9)F&=P6-5+Y&#D8XQSBL+5]2MO"GQ$N=;UB&
MX&G7FF0V\-\EL\JQ2)*Y:([ 2N[>K#( .#Z5A:QK4T=QHNH-I8\,:=-=7DC:
MDNF^=<)EE"DAH\0M,,D[E8G YZT =NOCKPZVCZCJC7LD5MIKB.\$MM*DD#'&
M T97?W';U]#4FG^-=!U/5(-.M[N07-S&TML);:2);A%ZM$SJ%D&.?E)XYZ<U
MY%J.GZC>:+\39(H-:NUO8[ VLU]:&.:Y"D@D($7@$= HXQ7IOB2TED\>>"9X
MK=VC@GN_,D5,B,&V8#)[ G ^M %N?Q[X<MKR>WEOG"V]P+6>X%M*;>*4X^1Y
M@NQ3E@#EN#P<5)JGC70M(O+JTN;B=IK2(2W0MK26<6R$$@R&-6"< GYL<<]*
MX'PYJT7AGP2O@O5-'N=5\0QRSI_9TEJYCO\ =.Q$@D9"ACP02[=,'/:HU9O#
M'B3Q%!K.M^(=/DU#4WNK(:?9K/'>(ZKM56,+DNN-I7( XQW- 'H6K^-O#VAP
M64U]J2*E]&9;0Q(TOGJ"@^38#N_UBGCJ"3T!QLV5Y#J%C;WMLQ:WN(EEC8J5
M)5AD'!P1P>AYKS3P]X?;3]4^':+87\4-G8W[XO#YDEN9/+(5V"@ X9@!@8 Q
MVKU.@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ I#T-+2'H: 9\N2_P"ND_WC_.F4^7_72?[Q_G3*L^4G\3"BBBF(
M**** "BBB@ HHHH **** 1WNJ_ZC2?\ L&6__H%9M:6J_P"HTG_L&6__ *!6
M;31P8O\ CR]0HHHH.8**** "BBB@ HHHH **** .NC_Y%?1_I-_Z'5>K$?\
MR*^C_2;_ -#JO3+Q?\3Y+\D%%%%!RA1110 4444 %%%% !1110!O:7_R!7_Z
M^/\ V6I:BTO_ ) K_P#7Q_[+4M2SWH?PH>@4444#"BBB@#2T3_C^;_KF?YBN
MAKGM$_X_F_ZYG^8KH:AGOY?_  4%%%%([0HHHH **** "BBB@ HHHH ****
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M5S']M^(_^A:C_P# ]/\ XFC^V_$?_0M1_P#@>G_Q-'(P^LP.GHKF/[;\1_\
M0M1_^!Z?_$T?VWXC_P"A:C_\#T_^)HY&'UF!T]%<Q_;?B/\ Z%J/_P #T_\
MB:/[;\1_]"U'_P"!Z?\ Q-'(P^LP.GHKF/[;\1_]"U'_ .!Z?_$T?VWXC_Z%
MJ/\ \#T_^)HY&'UF!T]%<S_;?B/_ *%J/_P/3_XFD_MOQ'_T+4?_ ('I_P#$
MT<C#ZS Z>BJ]G+/-:1R7, @F9<M$'W[3Z9'6GS.Z02/$GF2*I*IG&X]AGM4F
MZ:M<EHKF/[;\1_\ 0M1_^!Z?_$T?VWXC_P"A:C_\#T_^)JN1F'UF!T]%<Q_;
M?B/_ *%J/_P/3_XFC^V_$?\ T+4?_@>G_P 31R,/K,#IZ*YC^V_$?_0M1_\
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M_$?_ $+4?_@>G_Q-']M^(_\ H6H__ ]/_B:.1A]9@=/1^%<Q_;?B/_H6H_\
MP/3_ .)H_MOQ'_T+4?\ X'I_\31R,/K,#IZ*YC^V_$?_ $+4?_@>G_Q-']M^
M(_\ H6H__ ]/_B:.1A]9@=/QZ45S']M^(_\ H6H__ ]/_B:/[;\1_P#0M1_^
M!Z?_ !-'(P^LP.GHKF/[;\1_]"U'_P"!Z?\ Q-']M^(_^A:C_P# ]/\ XFCD
M8?68'3T5S']M^(_^A:C_ / ]/_B:/[;\1_\ 0M1_^!Z?_$T<C#ZS Z>BN8_M
MOQ'_ -"U'_X'I_\ $T?VWXC_ .A:C_\  ]/_ (FCD8?68'3T5S']M^(_^A:C
M_P# ]/\ XFC^V_$?_0M1_P#@>G_Q-'(P^LP.GHKF/[;\1_\ 0M1_^!Z?_$T?
MVWXC_P"A:C_\#T_^)HY&'UF!T]%<Q_;?B/\ Z%J/_P #T_\ B:/[;\1_]"U'
M_P"!Z?\ Q-'(P^LP.GHKF/[;\1_]"U'_ .!Z?_$T?VWXC_Z%J/\ \#T_^)HY
M&'UF!T]%<Q_;?B/_ *%J/_P/3_XFC^V_$?\ T+4?_@>G_P 31R,/K,#IZ*YC
M^V_$?_0M1_\ @>G_ ,31_;?B/_H6H_\ P/3_ .)HY&'UF!T]%<Q_;?B/_H6H
M_P#P/3_XFC^V_$?_ $+4?_@>G_Q-'(P^LP.GHKF/[;\1_P#0M1_^!Z?_ !-'
M]M^(_P#H6H__  /3_P")HY&'UF!T]%<Q_;?B/_H6H_\ P/3_ .)H_MOQ'_T+
M4?\ X'I_\31R,/K,#IZ*YC^V_$?_ $+4?_@>G_Q-']M^(_\ H6H__ ]/_B:.
M1A]9@=/2'I7-?VWXC_Z%J/\ \#T_^)I#K7B,C_D6H_\ P/3_ .)HY6'UF!X%
M+_KI/]X_SIE=@_PW\1,[-]F09.<>:G^-)_PK7Q#_ ,^Z?]_4_P :OE9\_*G.
M[?*SD**Z_P#X5KXA_P"?=/\ OZG^-'_"M?$/_/NG_?U/\:.5B]E4_E9R%%=?
M_P *U\0_\^Z?]_4_QH_X5KXA_P"?=/\ OZG^-'*P]E4_E9R%%=?_ ,*U\0_\
M^Z?]_4_QH_X5KXA_Y]T_[^I_C1RL/95/Y6<A177_ /"M?$/_ #[I_P!_4_QH
M_P"%:^(?^?=/^_J?XT<K#V53^5G(45U__"M?$/\ S[I_W]3_ !H_X5KXB_Y]
MT_[^I_C1RL/95/Y67M5_U&D?]@RW_P#0*S:Z*Z\->(KI+1?[,1?L]M';Y^TH
M=VP8S[9]*K_\(?XB_P"@>G_@0G^-.QR8C#5IU92C%V,6BMK_ (1#Q#_T#T_\
M"$_QH_X1#Q#_ - ]/_ A/\:+&'U.O_(S%HK:_P"$0\0_] ]/_ A/\:/^$0\0
M_P#0/3_P(3_&BP?4Z_\ (S%HK:_X1#Q#_P! ]/\ P(3_ !H_X1#Q#_T#T_\
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%JM%G_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>tmb-20211110xex99d1020.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20211110xex99d1020.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  Z /X# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBHYIHX
M(FEE=411EF8X H DI*Q)/$!F8II=E->MVD'R1?\ ?1Z_@.U5Y)M:DNX+6?4;
M*QGG#M%%%$9&8+C=\S<?Q#M5<KZBN='FBL-M&U-CN/B&\!]%CC _]!JE8W>J
M6GBY=(DO?[0@:W:>5VB"M;<@*"5X.XYXQT%'+YA<ZJBBJD=VS:E-:-$RA$5U
M?G# YS[#I4C+=%%% !1110 4444 )1FC-8,K2ZYJ,MM%*\>G6K[)70X,\@ZI
MG^Z._J>.U"5Q&]2USW@EWD\(6,LA<^8'D3>>=C2,5_\ '2*Z&FU9V&@HJ"\N
M4L[.>YDX2&-I&^@&33;&[2^L+>[CR(YXEE4'KA@"/YT@+-&:AN+B*U@DGF<)
M%&I9F/85B^&KR\U&34[JZ+(IN1'# >D2!%(_X$=W/O3MI<5SH****0PHHHH
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MK$*JF3'?[H"_C7944N=ZCL<;X1T*Y-G'?:O$5?S)9H;1QQ$TDC.7(_O<@#T
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0B@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>tmb-20211110xex99d1015.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20211110xex99d1015.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  J ,P# 2(  A$! Q$!_\0
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GH**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>tmb-20211110xex99d1010.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20211110xex99d1010.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !- (0# 2(  A$! Q$!_\0
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$4 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>tmb-20211110xex99d1007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20211110xex99d1007.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &0!98# 2(  A$! Q$!_\0
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MT5Y%Y<H()7)7L#C(]B#6M0 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH \LL?AM::O\0_%VI^)M#CN+.XEMVT^65^& 0A\!6SU"]:
MN?$3P8U]X:\/Z/X?TB+[)::S!/+;PJB(D($F]L' /+<]SFO1Z* /-_'&@:S!
MX\\/>-=&TY]5.G1R6]S8K.(VV,K@.F[@GYVR.IPON1SLG@3Q#XNB\<ZQJ%B=
M'N=<@@BLK)YU<_N@A!?' W&-1ZC+<="?:J* /$9-*\8Z]'X"@F\*O8Q^'KZU
M%W))<1L6"%070 _<"ID^[ #.":M77A_Q+I7B7Q_:V6@SWUOXFA5;6\$T:1Q$
MHRL7R<@#S6Z#)V<#G(]DHH \+T?P?XJ\-Z/X$UF+1'O+S1/ML5[IPG19 DSR
M;64\@\-G&<_=XZD;GB2T\;>,OAOXGM;O0+>RDN)8?[-LDD7SV194=FD;=MR0
M.!P>#P<C/K%% &3X:NKN\\.6,U_ITFG71CVR6LK!F3!*]1Z@ _C6M110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <3\5]%U'Q#
M\.M1TS2K8W-Y*T12(,%)Q(I/)('0&E^)GA>^\5_#N\TK3\&^Q'+%&S[1(R$$
MJ3TY&<9XSC) YKM:* /'= \(7FK^)8[W4=%UZS$-A)$+S5=7^T/%+(C(Z1KD
M[EPY(;Y>F<=J3PLGQ!\,>'-/\(67A6V-Q9W3JVJ7$ZR6QA:1F,@4,K9^;IUP
M.F3@>QT4 <!HOA_4[7QUX]U">T9;;4H[86<A9?WNV)E;'.1@D=<5Q>E^!?$D
M&C_#*";2G5]'O[B:^4R)^Y5IPRD\\\<\9KW.B@#R#6_A_K&O^,/'V8C;6FK6
M%O'9W1D 5Y(UC.#C) W)@\=,]:HMHWC#Q-I'A#PK>>%Y=*@T6XMI+O4)+Q"I
M6%"G[O;DDL.>,X.!TYKVVB@#R"_^'^LZU<?$RV:+[*FLM:/83.P*RF++$<'(
M&0!D^N>:B_L[QAXJ'A+1;_PN='MM$NK>YO+QKA&5C"" L04]&'UP2.PR?9**
M /!YY==T*3XC:=I>GZ;K.FWTES=37L5_"K6)D1]ZRIEF.WD!2!DHWKQ62Q>'
M]G+P[KT12+4-"NOM]LT@ S_I+#;SV(8''<JHKU+6OAAX-\0ZJ^IZGHD<UY)C
M?(LTD>XCN0K $^Y%7-9\"^&O$,>FQ:II,,\6F@K:1!F1(E.WY=JD CY%&"",
M"@#(^$VDSZ?X$M[^]?S-1UB1]3NI,_?:7D'H,?+MR.QS7=4@  P!2T %%%%
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M>#3->\$>*GU7PEXDOUO]0NK6P%GJ::7<B&YC/SD.C[AN/[S#8/.T]FR/;J*
M/&/^$8\6Z9\/[Z70-/O].U2_U/S[NW_M,37,EOSN82$865B03@D\9Z_+4F@>
M$]5'CO5=3;P]>KIMYH#V:?VQ?^=)<R%EXF;>Y3< 1@9 &.,G%>QT4 >$^&/"
M'B;2_$6B-H>EZWH,2W._6+6XU".6P$8ZK$ 2SEAD G)4D<\;JCO/!.OV%YXE
MT]M$US4HM1U%[FU-GK AM9XY&!99E+#:P7C)!R>.@!/O5% %'1[!-*T2PT^-
M-B6MO' JAR^T*H4#<0,].N!FO$]"\ ^)K;P3HNGW&DNMQ!XMBOYHS(AVVX0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M<O\ \)G_ -2[KW_@'_\ 7H_X3/\ ZEW7O_ /_P"O1RL/;0[G445R_P#PF?\
MU+NO?^ ?_P!>C_A,_P#J7=>_\ __ *]'*P]M#N=117+_ /"9_P#4NZ]_X!__
M %Z/^$S_ .I=U[_P#_\ KT<K#VT.YU%%<O\ \)G_ -2[KW_@'_\ 7H_X3/\
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M[:LH:#:#Q6WB(-+]M:R%B5W#9Y8<OG&,YR>N>E<]_P +,TK_ )\-2_[]+_\
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MPI9Z-?7&H-<WFHZE<((GO;^022B,$D1K@!47))PH&3R<\56_X3/_ *EW7O\
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M*.DFU<@X;@@$$4FH^(M1'B5M#T72H;R>&U6ZNIKFZ,$409BJ)E4<EFVN<8
M'7F@+'28%&!7$3^/[A6TJP71TMM:O(9)[BTU&]6W2TC1BA9G"L6#/PFU?F&3
MQBLC6/%3Z[INFH8EL[VR\46-K<Q0W(F0@R*RLKC&Y&5@>0#G((XH"R/3L"C
MKG/#CNWB'Q:K,2JZE&%!/W1]DMS@?B34%[XIU*7Q!J.D:#HT.H2Z9#')=O<7
MAMP'<%DC3]VVYBHSDX R,F@+(ZGBEP*\=^'6JPC1/AW#=VDMS>7CZGY-R]RZ
MF#:TA.4'#Y''/W>HKJ/#_CZ^\1R0SV&BVTMB]VUO*D>HJ;RU4,RB2: H H^4
M$@.2 W&: LCNL"C K@;SXC3+)K,MAIME/9Z3,\$QN-2\B>9H_P#6>5%Y9W8.
M0,L-Q'%:T_BB_N5L9]%TF&>PN;);TW]_=_9855\;$!".Q<C)(P !CDYQ0%CJ
M,"C K@A\25/AO3-2^QV<4][?RV)^T:@$M8GC,F29]A!!$?RX7G<,5<OO&UUH
MWA^:_P!6TB.&[:Z2TL8(+U7BO7<#84E8+M4Y.2P& I/- 6.QP*,"N4T;Q?->
M^)/[#U"UL89Y+8W-O-8WXN8I K .A)1&5AN4XP003SQ764!83 HP*6B@+"8%
M&!2T4!83 I"  :=2-]TT,:2/DS4O^0K>?]=G_P#0C56K6I?\A2[_ .NS_P#H
M1JM7@R;N?64XKE0E%+14W9?*NPE%+11=ARKL)12T478<J["44M%%V'*NP444
M=J:;N)Q5MCO?%_/B:X_ZYP_^BDK#K<\7_P#(S7'_ %SA_P#125AUQUV_:2._
M!Q7L(:= HHHK&[.GECV"BBBB[#ECV"BBBB[#ECV"BBBB[#ECV"BBBFF[B<5;
M8[/52?L^D?\ 8.A_D:SJT-4_X]])_P"P=#_(UGU6(;]HS+ 17L%H%%%%879V
M<L>P444478<L>P444478<L>P444478<L>P4444[L7+'L=C9\^&],^DO_ *&:
M2EL_^1<TW_MK_P"AFCO7K-NR]$?/0BKR]7^88HQ112NR^5!BC%%%%V'*@Q1B
MBBB[#E08HQ111=ARH,48HHHNPY4:MI_R#$_ZZM_(4^FVO_(,3_KJW\A3JZV]
M$>=%*[]6%%%%*[*L@HHHHNPLC7T/[T__  '^M;.!Z5C:']Z?Z+_6MFO0HOW$
M>/B4O:L,"C I:*U,+(3 HP*6B@+"8%&!2T4!83 HP*6B@+"8%&!2T4!83 HP
M*6B@+"8%&!2T4!83 HP*6B@+"8%%+10.P5R?C[P7_P )SI%E8?VA]B^S7L=W
MO\GS-VU6&W&X8SNZ^W2NLHH Y2P\&?8==\5ZG_:&_P#M]8E\OR<>1L1DZ[OF
MSNST'2N?3X3-;^%/#VG6?B":VU;0999;/4X[<8_>2%F#1%B"",#KV]"0?2Z*
M /.[OX9WNI>#]<TC4_%5U>ZAK$D3S7LL \N/RW5@$A# +PN#@\]>P%/O?AO?
M'Q<GB+1O$\NEW+V<=G<@6:3&1%VYV%SA,A5['D9[D5Z#10!YC#\(1%X+TS1!
MKC+?Z3>F\T_48[0 Q,6W89"QW#//4=%]#G4LOAY<2Z=KT/B+Q)>:Q=:Q#Y#R
M^6((X4"X!2)25#9P<]\#CKGNJ* /*X?A'J3S^&I-3\827R^'KB)[.+^STC18
MD*'R_E;.3Y:C<2<8Z5LR_#CS/"OBK1/[5Q_;VI37_G?9_P#4>8R'9MW?-C9U
MR.O2N[HH XX>!L:AX,NCJ/'AJVD@V^1_Q\[X5CSG=\F-N>_7'O7(2_!*\?PW
M+X;3QC,FC"<SVUO_ &='N5]V09'# R87</X>2#T4+7L%% 'GFI?#C5)?&VJ>
M*M&\62:5?7T4<(5;%)E5%50P(9L-DH"#QCWK?\$^$+7P3X=32K:>2XD:1IKF
MYD&&FE;&6QDXZ  >@').2>DHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ JM>V=OJ-A<V-W'YEM<Q-#*A)&Y&!!''/(-6:* //?\ A7^O/H8\
M.OXTE_L$+]G\I=.C%P;;;M$1ESC[O&[9D_I6[!X1BM?'$7B*"X"0Q:.-*2S$
M7"J)=X;=GTXQC\:Z6B@#A]&\!76FOX:^TZV+M/#[SBW'V01EXGB\M48AB,KU
MW8YZ8'4FL_#P:OX1ET0:M+;3'4)[Z&\CCYC,LDC,NW=S\DKIU'7..U=Q10!P
MWB#X>MJMY>S:=JB:8EQH@T5(DM ZQ1>9N) W#@IE .,9SGC%=#JOAVPU3PI<
M^'3#'%92VAM8U"!A$-N%*@]UX(]"!6Q10!P]KX-U^POIM0L_%4?VV>PM[.=Y
M]/\ ,60Q*P\TCS =Y+9'.!ELALC;T7AW0XO#NB0:;%/+<;"[R3S'YY9'8N['
MW+,36M10 4444 %%%% !1110 445%/YWV>3[/L\[:?+\S.W=CC..<9H Y%O!
MVKZ;?W4WAGQ(=-L[J1YI+&YLQ<Q)*Y!9XSN5DR<MMR5R3P.E%MX",>G7(NM8
MGO-4O;VTO+R^EB4>:T#QL%6-<!5Q'@=2,\DXQ6-)KGQ,C\20:&;;PE]JFM7N
MU<27.P(C*I!.,YRX[>O-:;^.'T7Q3%H_B>YTJQ0:1'=RSB4JAG:1D*(7(RN%
M) QG@T 7;KPMJT&KZG?^']?331J:AKB&>R^T*DP4()8QO4*V ,Y# D#(JH/A
M^=/'A_\ L#5I+ Z)!-%$)H?.6X,K(7,H#+N!VL2 1\S @C;@]*VO:0NC_P!L
M'5+,:9C/VPSKY6,[?OYQUX^O%1VOB31+[2I]3M-6LIK"#/G7$<ZE(\#)W'/R
M\$'GUH YBZ^'!O;"=[G5A)K4^IPZG)?&T'EL\6!'&8MV3$J# 4N3DDYYQ5H>
M"M0N-?N-;U'75N+JXTV;36CBL_+ACC<J5*+O+ @JQ.YFW;L#: *V6\6>'5L[
MB\;7-.%M;R^1+*;E J2?W"<]?:GVOBC0KW2Y]3MM8L9;& XFN$G4I&?1CGCJ
M.OK0!-H6F?V+X>TS2O.\[[#:16WF[=N_8@7=C)QG&<9-</I'P^\7:%I46E:9
MX^6WL8V<HBZ-&S*&<N<,SGNQYKLM,\3Z#K=U):Z7K-A>SQKN>.WN%=@N0,X!
MZ9(&>G--_P"$L\/'5_[)&N:=_:&_R_LWVE/,W]-N,YW>W6@"AH_@C3]#;2XK
M)C]BT_3Y[$02J&,OFO&[.QZ9)C.1C!W]L8K*7X>WKZ-;>'+OQ!]I\-03(WV1
M[,>?)"AW) TV_&P$+G"!B%QD5VD-]:W%W<VL-S%)<6I43Q(X+1%AN7<.V1R/
M:N9U#X@Z19>)O#ND17-K,FM+(ZW N5VHH'[LX_BWM\HY&2#UH )O">JVNH:O
M/X?U^+38-5?SIXI; 3&*8J%:2)@ZX) 4D,&&1GOBHHOA_%I$NCW/AJ]33[O3
M;1K O<6PG2Y@)W$2*&0[M_S[E(Y)R"#@;D&M0V^CSZCJVH:=%!#/+&]Q'-B)
M%65D4,S='Z*P_O9 H@\4:!<Z3-JL.LV#Z="VV6Y%POEQMQPS9P#R.#ZCUH I
M>#?"\WA:SU&.YU1]2N+^^>^FG>$1G>ZH&&T$C&5)&.@..V3TM9VDZ[I.NPO+
MI.I6M]'&=KFWE5]A]#CI^-:- !1110 4444 %%%% !1110 4444 %8WBG0T\
M2>&-0TAFV-<PD129(\N0?-&_'/RN%/X5LT4 <UX6\/3Z=H=W%K7V>YO]2N)K
MF_\ ++/$[2'&U=W.T($7![+69IND>-/#>EMHVE2:/J%E;H(]/N+^66.6&/)P
MDBHC"3:,*""F0.E=Q10!PI^',?\ PB7]GC4"=8_M#^U_[4,0YOMV[S?+SMQ_
M#MZ;??FGW&E^-M?CLK+5;G2],LT=9+V72[B9IK@JP8(A*KY2G')W,??K7;T4
M 97B739M8\*ZOI=NR+/>64UO&TA(4,Z%03@$XR?0UAZ/X5OM/\76.K2RVY@M
M] CTQE1FW&59 Q(R,;<=\Y]J[&B@#G?"6A76@PZPEU)"YO=6NKZ/RB3A)'W*
M#D#GUZCW-<QXF\#ZUKYU.VN;;0;X7,N;+5;E3'=V$9(.U1''\Y3G:=ZY_BSS
M7I-% 'GM]\.I]4G\817=\%M]:M[*.WF4EI8Y+=3\[C !^?:< \C/2KE[I/C/
M7+*XMM2N-+L8FTV:W:"RD>5+J>1"H9R\8,:*>0J[CSR3C![:B@#@O#_@B\\+
MWNB76E?88L6$5EK5NN42X*+\LR$+S(&+<L/F5NQK-3X;7\7ASPE"\>D7]_H2
M212VMZI>UN8Y"-PW%"58;05;:<'J#7I]% '*^$/#MUHD^IW-U;:19?;)$\NR
MTNW5(X44$#,@1&D8Y))88'8#)HOM(UNR\63:YH8L+A+RTCM[NTO)7A^:-F*2
M*ZH_9V!7 ['-=510!YS?^ ]3O-0TG7;^+1=<U>*WDM;^#4(BEO)&SF1?*.U]
MAC)V@E264G.#3X_ NH'3K<&+1;.<:Y;:BUO80"*&&")P1&&"!I'P"=S <L0,
M 5Z'10!C:1I<]AJVNW4K1F/4+Q)X@I.54011X;(ZYC/3/!'TK'NM#\0:7XGU
M;5_#QTZX75H8_/AU"62,0SQKL1U*(VY2N-R'!RHPPS78T4 >:^&OA_J^C1^"
M5NKJSE;0GOVNF1V_>>?OV;,KS]X9SCVS39? FMW]]I[ZC!H37EK?I</K\ :*
M]FC1B0OEI&JAF&%.7*@$G:3BO3** /,+KX=W\%YK@L=,\,WT>I7+W4%[J< :
M>T:0Y<;?+82J#RH++UP<BKFH^![UM9L;H:=H>N6UMI<=C'!JF85@D4Y,D:)&
MZ#<,9 4$;0 0.*]#HH \ZL/!WB.P\.?V<6T.Z4:G/<36,L1%K>6\C%MK HQB
M92<@+N V@'<*H-\*YI])U0>7IEI-+J,.I6.EH7FL(9(EQM8%5)60%@V%  Q@
M'&#ZI10!QGA_PM<V7B3^TYM'\/:3;QVYBCM]+@5W=V/+M,8D*@ 8"@<[B2>
M*[.BB@ HHHH **** "D;[II:1ONFDP1\FZE_R%+S_KL__H1JK5K4O^0I>?\
M79__ $(U5KP9;L^NI_"@HHHJ2@HHHH **** "BBB@ H[44=J:W$]CO?%_P#R
M,UQ_USA_]%)6'6YXO_Y&:X_ZYP_^BDK#KCK_ ,21Z&#_ ($/1!1116)TA111
M0 4444 %%%% !11136XGL=EJG_'OI/\ V#H?Y&L^M#5/^/?2?^P=#_(UGU>(
M_B,QP'\!!1116!V!1110 4444 %%%% !1110!V-G_P BWIGTE_\ 0S119_\
M(MZ9_P!M?_0S17KO9>B/G8;R]7^84445)84444 %%%% !1110 4444 :UK_R
M#(_^NK?R%.IMK_R#(_\ KJW\A3J['LCSH[OU84444B@HHHH U]#^]/\ 1?ZU
MLUC:']Z?Z+_6MFO0H_ CQ\3_ !6+1116I@%%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 44F11D>M KH6BDR*,B@+H6BDR*,B@+H6BDR*,B@+H6B
MDR*,B@+H6BDR*,B@+H6BDR*,B@+H6BDR*,B@+H6BDR*,B@+H6BDR*,B@+H6B
MDR*,B@+H6BDR*,B@+H6BDR*,B@+H6BDR*,B@+H6BDR*,B@+H6BDR*,B@+H6B
MDR*,B@+H6BDR*,B@+H6BDR*,B@+H6BDR*,B@+H6BDR*,B@+H6BDR*,B@+H6B
MDR*,B@+H6BDR*,B@+HY&Z_Y*_IG_ & [G_T=#5,0QO\ '=Y612\?AM-A(^[F
MY?.*[K(HR/6@+H\-U"&YBTJTGBNTL-+TWQ=?F2;[&+A+3YY!%(4/ 56)&> I
M8'L*+R-KO3O'>JP^(SK<9T0V]S<VVGQP6TLH!* 2*Y\R15)!P" ' )X KW+B
MC(]: NCS[QEJ$7AT^$[&"#3K&T\YDCU*^B+V^GE(2$&T,HW,"0N6 &#U[<#=
MRO/I/Q1N)M0.HFXL+%TO?LP@2Z4>8A>,=T!!4,"0=O4U[_Q65XCT2#Q)X>O=
M'N)7BBNX_+=X\;E&<\9H"Z./?4M'USQEX3@\.HDK:7Y[W'DQ;5L8# T8BD7C
M8Q?8-AY&SD#%><VMO<_\(/'X9N_%,\&HI=")]!M],C:^6X\S?O5C(I89_>>9
MD#;W[5]%Y'K1Q0%T>;6NOZ?X8^(_C(:M,8)+W['-91;29+L"$1XB4<NV\%<#
MG-<[I$\=A_PI^_NB8K-;6Z@:=A\BR20J$4MT!8@X'?!]*]KR*.* NCR61X[7
M1]#U*^CWZ18^*;^:\/EEO*_?7*QRMZ*KL"3VR#VJSXBU3PMJT&JZE8QW:I#<
M63SZ]ID*R1I+&S-&[9^658AC?@-@.!VX]1R*.* NCS_P'JUS>^(]5MVN],UN
M)+>$OKUA:B'SI 6_=2$$JS*I!&TX //)KT&DR*,B@+H6BDR*,B@+H6BDR*,B
M@+H6BDR*,CUH"Z%HHS10,**** "BDR*,B@5T+129%&10%T+129%&10%T+129
M%&10%T+129%&10%T+129%&10%T+129%&10%T+129%&10%T+129%&10%T+129
M%&10%T+129%&10%T+129%&10%T+129%&10%T+129%&10%T+129%&10%T+129
M%&1ZT!="TC?=-&1ZTC$$'FAC31\G:E_R%+S_ *[/_P"A&JM6M2_Y"EY_UV?_
M -"-5:\&2?,SZRG)<JU"BBBILR^9=PHHHHLPYEW"BBBBS#F7<****+,.9=PH
M[44=J:3N)R5MSO?%_P#R,UQ_USA_]%)6'6YXO_Y&:X_ZYP_^BDK#KCKI^TD=
M^#E'V$->@4445C9G5S1[A11119AS1[A11119AS1[A11119AS1[A11132=R7*
M-MSLM4_X]])_[!T/\C6?6AJH(M])S_T#H?Y&L^JQ"?M&98&2]@M0HHHK&S.S
MFCW"BBBBS#FCW"BBBBS#FCW"BBBBS#FCW"BBBBS%S1[G8V?_ "+FF_\ ;7_T
M,T4MG_R+>F?27_T,TE>LT[+T1\["2O+7J_S"BBBE9FG,NX444468<R[A1111
M9AS+N%%%%%F',NX444468N9=S6M?^08G_75OY"G4VU_Y!D?_ %U;^0IU=;3L
MCSXR5WZL****5F5S(****+,.9&OH?WI_HO\ 6MFL;0_O3_\  ?ZULY'K7H4?
M@1X^):]HQ:*3(HR*U,+H6BDR*,B@+H6BDR*,B@+H6BDR*,B@+H6BDR*,B@+H
M6BDR*,B@+H6BDR*,B@+H6BDR*,CUH"Z%HI,BB@=SGCX20_\ ,8UG_P #6I/^
M$23_ *#.L_\ @:U='7-^*G\8K]D_X1./17^_]I_M,R<?=V[-A'^UG/M3YF9>
MQAV%_P"$23_H,ZS_ .!K4?\ "))_T&=9_P# UJX_X;>,/'7C1+?5;JV\/Q:(
M97BG\I9EG!5?X06*]2O7MFNU7QGX9;7#HJZY8'4@VS[/YPW;\XV>F[/&WK[4
M<S#V,.Q%_P (DG_09UG_ ,#6H_X1)/\ H,ZS_P"!K58UKQ=X>\.SQ0:OK%G9
MS2@%(Y90&()(W8Z@9!YZ<5CZ]XON+'Q;X.T[3_LEQ8:Z9S)/RYV(B,K1L&Q@
M[NN#D8Q1S,/8P[&A_P (DG_09UG_ ,#6H_X1)/\ H,ZS_P"!K5#I/B;%OKUW
MK>I:-'::?J$ENLMO*0(HP0%68L<"3)P0.,D 5:L/&OAK5+"[OK'6K.>WLT+W
M#+(,Q*/XF!Y XZ]*.9A[&'8C_P"$23_H,ZS_ .!K4?\ "))_T&=9_P# UJS_
M  E\2-%\2^$WUVXN;73Q!DW<,MP#]F!=E3>Q ^\%!'UQS6KIGC/PWK%E=WFG
MZS9SV]FADN&5_P#5*!DLP/(& >>G!I\S#V,.Q%_PB2?]!G6?_ UJ/^$23_H,
MZS_X&M0GCSPD]W':KXBTWSGB\Y5-PH^3&<D]!QS@\XYZ59TKQ9X?UNUNKG3=
M8L[F"TS]H=)1B(<\MGH.#ST.#Z4N9A[&'8K?\(DG_09UG_P-:C_A$D_Z#.L_
M^!K5)I/C7PSKM^]CI>N65U=+G]U'*-S8ZE?[P]QFN0\&_%K3M2LKQO$^IZ5I
MMVFI2VD$2N8]T:JI#-N8XY+#<<#BCF8>QAV.K_X1)/\ H,ZS_P"!K4?\(DG_
M $&=9_\  UJZ($$ CO2T<S#V,.QSG_"))_T&=9_\#6H_X1)/^@SK/_@:U='1
M1S,/8P['.?\ "))_T&=9_P# UJ/^$23_ *#.L_\ @:U='11S,/8P['.?\(DG
M_09UG_P-:C_A$D_Z#.L_^!K5T=%',P]C#L<Y_P (DG_09UG_ ,#6H_X1)/\
MH,ZS_P"!K5T=%',P]C#L<Y_PB2?]!G6?_ UJ/^$23_H,ZS_X&M71T4<S#V,.
MQSG_  B2?]!G6?\ P-:C_A$D_P"@SK/_ (&M71T4<S#V,.QSG_"))_T&=9_\
M#6H_X1)/^@SK/_@:U='11S,/8P['.?\ "))_T&=9_P# UJ/^$23_ *#.L_\
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M6B:.2-<-S\HVN2<C/0YQU.9A[&'8T?\ A$D_Z#.L_P#@:U'_  B2?]!G6?\
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MQ+HFK:7+J=CJEI-90AC-.)0%BP,G?G[N!SSCCFCF8>QAV*7_  B2?]!G6?\
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M>1(;B*1XSAU1P2I]#CI2YF'L8=C#_P"$23_H,ZS_ .!K4?\ "))_T&=9_P#
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M_P ^]O\ ]^Q1]L/_ #[V_P#W[%5J*/:R[A]3H]BS]L/_ #[V_P#W[%'VT_\
M/O;_ /?L56H/2FJL[[B>#HVV.Z\31"UUZ:(/)*!'$=\S;F.8U/4_7 ]JR-_^
MROY5M>+O^1FN/^N</_HI*PZY*U::J/4[\)@J$J$6UT';_P#97\J-_P#LK^5-
MHK+V\^YT?4*'\H[?_LK^5&__ &5_*FT4_K$^X?4:'\H[?_LK^5&__97\J;12
M]O/N'U&A_*.W_P"ROY4;_P#97\J;11[>?</J-#^4=O\ ]E?RHW_[*_E3:*:K
MSON)X&A;X3J]3M0L&F'[1<MOL(GP\I.W(/"^BCL*H?9Q_P ]9/\ OJM;5/\
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M]_W_ #1_9*_\_M]_W_-:%%+VLNY7U.CV,_\ LI?^?V^_[_FC^RE_Y_;[_O\
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MK44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5YQXYM9;SXG>
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M?%DC8Y50"?F!P#BI9_!-K_PCVB:'8W+VMEI=W;W&S:&\]8FW;7Z?>;!)]>U
M&?H'P]L]/^']WH=Q%%'>ZI$\E]+"B@"=QU0 84(<;0  -H.,YK9\$ZT_B'P3
MHVJRMOFN+5#,VT+F0##G X W!JN>(;R\L= O)M/MWN+[R]EK$BYW2M\J9]%W
M$9/0#). *7P[I":!X<TW2$<.+*VC@+A=N\JH!;';)R?QH TZ*** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4_X]])_[!T/\C6?5XC^(S' ?P$%%%%8'8%%%% !1110 4444 %%%% '8V?\
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MVTE[;@--;)*IDC! (++G(!!'7UJW@4778.2?\QA_\)!=?] #4_RB_P#BZ/\
MA(+K_H :G^47_P 76Y@48%%UV#DG_,8?_"077_0 U/\ *+_XNC_A(+K_ * &
MI_E%_P#%UN8%,C=)8UDC=71P&5E.00>A!HNNP<D_YC&_X2"Z_P"@!J?Y1?\
MQ='_  D%U_T -3_*+_XNMS HP*+KL')/^8P_^$@NO^@!J?Y1?_%T?\)!=?\
M0 U/\HO_ (NMS J.>:&UMY+BXECB@B0O))(P544#)))X  [T778.2?\ ,8__
M  D%U_T -3_*+_XNC_A(+K_H :G^47_Q=:MI=VM_:QW5G<0W%O(,I+"X=''J
M".#4^!1==@Y)_P QA_\ "077_0 U/\HO_BZ/^$@NO^@!J?Y1?_%UN8%&!1==
M@Y)_S&'_ ,)!=?\ 0 U/\HO_ (NC_A(+K_H :G^47_Q=;F!1@4778.2?\QA_
M\)!=?] #4_RB_P#BZ/\ A(+K_H :G^47_P 76Y@48%%UV#DG_,8?_"077_0
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M_0 U/\HO_BZW,"C HNNP<D_YC#_X2"Z_Z &I_E%_\71_PD%U_P! #4_RB_\
MBZW,"C HNNP<D_YC#_X2"Z_Z &I_E%_\71_PD%U_T -3_*+_ .+K<P*,"BZ[
M!R3_ )C#_P"$@NO^@!J?Y1?_ !='_"077_0 U/\ *+_XNMS HP*+KL')/^8P
M_P#A(+K_ * &I_E%_P#%T?\ "077_0 U/\HO_BZW./2CCTHNNP<D_P"8S;#4
MYKV8QR:9>6H"YWSA,'GIPQYK2HHJ6:132U=Q:AGE,,$D@C>0HI8(F-S8'09[
MU-24#,/_ (2"Z_Z &I_E%_\ %T?\)!=?] #4_P HO_BZW,#THP*JZ[&7)/\
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MF#\S_A4%%'/#^4/85O\ GY^1/]F7_GY@_,_X4?9E_P"?F#\S_A4%':FIPO\
M")T*UOXGX([KQ0YF\03R-&\),<7R28W#$:C/&1SU^AK'V_[2UM^+_P#D9;C_
M *YP_P#HI*PZY*U2'M'[IWX3#UW1C:IT[(7;_M+1M_VEI**R]I#^4Z/JU?\
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M_'C-_P!=3_(5NXKUZ$E[-:'SV)IU%5E>1A_\)!=?] #4_P HO_BZ/^$@NO\
MH :G^47_ ,76Y@48%;778PY)_P QA_\ "077_0 U/\HO_BZ/^$@NO^@!J?Y1
M?_%UN8%&!1==@Y)_S&'_ ,)!=?\ 0 U/\HO_ (NC_A(+K_H :G^47_Q=;F!1
M@4778.2?\QA_\)!=?] #4_RB_P#BZ/\ A(+K_H :G^47_P 76Y@48%%UV#DG
M_,8?_"077_0 U/\ *+_XNC_A(+K_ * &I_E%_P#%UN8%&!1==@Y)_P QA_\
M"077_0 U/\HO_BZ/^$@NO^@!J?Y1?_%UN8%&!1==@Y)_S&'_ ,)!=?\ 0 U/
M\HO_ (NC_A(+K_H :G^47_Q=;F!1@4778.2?\QA_\)!=?] #4_RB_P#BZ/\
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MC_A%-._YZ7O_ (&R_P#Q5%HAS5?Y?Q-O<OJ*-R^HK$_X133O^>E[_P"!LO\
M\51_PBFG?\]+W_P-E_\ BJ+1'S5?Y?Q-O<OJ*-R^HK$_X133O^>E[_X&R_\
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M_BJ+1%S5?Y?Q-O<OJ*-R^HK$_P"$4T[_ )Z7O_@;+_\ %4?\(IIW_/2]_P#
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M^*H_X133O^>E[_X&R_\ Q5%HAS5?Y?Q-O<OJ*-R^HK$_X133O^>E[_X&R_\
MQ5'_  BFG?\ /2]_\#9?_BJ+1#FJ_P OXFWN7U%&Y?45B?\ "*:=_P ]+W_P
M-E_^*H_X133O^>E[_P"!LO\ \51:(<U7^7\3;W+ZBC<OJ*Q/^$4T[_GI>_\
M@;+_ /%4?\(IIW_/2]_\#9?_ (JBT0YJO\OXFWN7U%&Y?45B?\(IIW_/2]_\
M#9?_ (JC_A%-._YZ7O\ X&R__%46B'-5_E_$V]R^HHW+ZBL3_A%-._YZ7O\
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M_P"$4T[_ )Z7O_@;+_\ %46B/FJ_R_B;>Y?44;E]16)_PBFG?\]+W_P-E_\
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M!LO_ ,51_P (IIW_ #TO?_ V7_XJBT0YJO\ +^)M[E]11N7U%8G_  BFG?\
M/2]_\#9?_BJ/^$4T[_GI>_\ @;+_ /%46B'-5_E_$V]R^HHW+ZBL3_A%-._Y
MZ7O_ (&R_P#Q5'_"*:=_STO?_ V7_P"*HM$.:K_+^)M[E]11N7U%8G_"*:=_
MSTO?_ V7_P"*H_X133O^>E[_ .!LO_Q5%HAS5?Y?Q-O<OJ*-R^HK$_X133O^
M>E[_ .!LO_Q5'_"*:=_STO?_  -E_P#BJ+1#FJ_R_B;>Y?44;E]16)_PBFG?
M\]+W_P #9?\ XJC_ (133O\ GI>_^!LO_P 51:(<U7^7\3;W+ZBC<OJ*Q/\
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M;?7B+N%X&/EH;AB=ZD<#:0>>,&@#U1OB+HFJ^%O$&I>&M1@O;C2K.:<HT;J
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M(_B,QP'\!!1116!V!1110 4444 %%%% !1110!V-G_R+FF_]M?\ T,T46?\
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M@Z9Z UKKXB^,;CX9VFIV]A/!>QWS6NHWMO8F4Q1*N[SDA?'!4C);"@@CC(P
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M44 %%%% "8%+110 4444 %%%% !1110 4444 %%%% !1110 4444 %)BEHH
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MA1116Q@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 5S?C;P;9>.- _LN]FF@V3+/#-$?FCD4$ X[\,1
MCWKI*Q_$NLG0="FO8X/M%SN2&VMPP'G32,$C3)Z99AD]AD]J .>U#X=&[N[#
M4[;Q'J=GKEK:_8Y=0C*EKF/.2)%(P3GD'MQUP,33_#RWD\.Z;I46N:U#-ITW
MGP7OVLO*7SGYP1M9>G&.,<=3F]XHUN_T'P_:FW-K-K5Y/!96PDC<0R3N0"2
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M(3"Y')KVBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *1ONFEI&^Z:3!'R9J7_ "%+S_KL_P#Z$:K5:U+_ )"EY_UV?_T(U5KP
M9;L^NI_"@HHHJ2@HHHH **** "BBB@ H[44=J:W$]CO?%_\ R,UQ_P!<X?\
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MZ?\ \]+[_P #IO\ XNC_ (1G3_\ GI??^!TW_P 76S11S,/8T^QC?\(SI_\
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MC=^,<XJAHWC7P_K]V+/3K_?<-$)HXY89(C+&21O3>HWKP>5R*.9A[&GV)_\
MA&=/_P">E]_X'3?_ !='_",Z?_STOO\ P.F_^+KD]-U_QGJ_A.?7X+[PY;QQ
MM<8BNK25558I'3+R^=@#"9)VX%=!;^--,7PQHVL:E)]C;5((I(;50TTKLZJ=
MJ(JEGQN'1>G/%',P]C3[%S_A&=/_ .>E]_X'3?\ Q='_  C.G_\ /2^_\#IO
M_BZ9#XOT"?P_/KR:I --MR1-,Y*^4PQE64@,K9(&TC/(XY%847Q&TVY\2S6T
M-RG]F6FDS7]XTEO*D\)C:/&48!@I1RWW>>,&CF8>QI]CH/\ A&=/_P">E]_X
M'3?_ !='_",Z?_STOO\ P.F_^+J:?7],MK73KF2Z'DZE+'#:.B,_FM("4QM!
MX(!.3P ,DBM.CF8>QI]C&_X1G3_^>E]_X'3?_%T?\(SI_P#STOO_  .F_P#B
MZV:*.9A[&GV,;_A&=/\ ^>E]_P"!TW_Q='_",Z?_ ,]+[_P.F_\ BZV:*.9A
M[&GV,;_A&=/_ .>E]_X'3?\ Q='_  C.G_\ /2^_\#IO_BZV:*.9A[&GV,;_
M (1G3_\ GI??^!TW_P 71_PC.G_\]+[_ ,#IO_BZY?X;_$&Z\6+-;:Q:Q6E_
MA[BV\D$1W%N)&C+#+$@JZD$'U4CK6O8^,;6'P[<:MKES;V<<>H7-HA /S^7,
MZ(JKR6<JF<#))S@4^9A[&GV-'_A&=/\ ^>E]_P"!TW_Q='_",Z?_ ,]+[_P.
MF_\ BZK)XX\./IEWJ)U)8[>RE6*Z\Z-XWMV9@BB2-E#)DGJ0!U/0$UI76L6-
MEJMCIL\Q2\OQ(;>/8QWB, N20,* ".I'7 I<S#V-/L5O^$9T_P#YZ7W_ ('3
M?_%T?\(SI_\ STOO_ Z;_P"+JIIWCOPUJVIQ:?9:FLD\QD$!,3K'.4.'\N1E
M"28_V2?7I5GQ;JUQH/A'5M6M4C>XL[5YHUE!*D@9&<$''XT<S#V-/L._X1G3
M_P#GI??^!TW_ ,71_P (SI__ #TOO_ Z;_XNL*V\:74_P_UG5)+:.WUW1K:<
M7MG(IVQW$<9;'7E&X8$$Y4]<YK4NO&.DZ39:<^JW0CNKV$2);P0R32-\NYB$
M0,VT8/.,#UHYF'L:?8L_\(SI_P#STOO_  .F_P#BZ/\ A&=/_P">E]_X'3?_
M !=5[KQMX;LM"M=<N-7MUTR[)$%R,LCD*S%>!UPC#!YR-O7 JO)\0_"T5I:7
M)U0E+N W,*I;RN_D@D&1D"EE3@_,P X/-/F8>QI]C0_X1G3_ /GI??\ @=-_
M\71_PC.G_P#/2^_\#IO_ (NLC0/%DNL:;HEY)<6*#4+^[MP$1V$R1-,$\L@D
M [8E8EN",XY(J\/''ATZN-,_M'_2&N?L8?R9/),^,^4)=OE[_P#9W9SQUXHY
MF'L:?8L_\(SI_P#STOO_  .F_P#BZ/\ A&=/_P">E]_X'3?_ !=4(/%L%L/$
M-QK$T-M::9J M(W56+.#%$X&!DLQ:0@!1SQQ721R"6))%# , P#*5//J#R/H
M:7,P]C3[&5_PC.G_ //2^_\  Z;_ .+H_P"$9T__ )Z7W_@=-_\ %ULT4<S#
MV-/L8W_",Z?_ ,]+[_P.F_\ BZ/^$9T__GI??^!TW_Q=;-%',P]C3[&-_P (
MSI__ #TOO_ Z;_XNC_A&=/\ ^>E]_P"!TW_Q=;-%',P]C3[&=9:1:V$QE@:Y
M+%=I\VYDD&/HS$=JT***1<8J*LA:BFB6>%XGW!74J=K%3@^A'(^HJ6B@>YC?
M\(SI_P#STOO_  .F_P#BZ/\ A&=/_P">E]_X'3?_ !=;-<_JOB7^R_%WA[0?
MLGF?VP+D^?YFWR?)0/\ =P=V<XZC'O3YF9^QI]B?_A&=/_YZ7W_@=-_\71_P
MC.G_ //2^_\  Z;_ .+J+5?$?]F>*?#^B_9/,_M=KA?.\S;Y/E1[_NX.[/3J
M,>]7FUS25U9=*;5+(:BPRMF;A/.(QGA,YZ#/3I1S,/8T^Q6_X1G3_P#GI??^
M!TW_ ,71_P (SI__ #TOO_ Z;_XNK&IZ]H^B^5_:NK6-AYN?+^U7"1;\8SC<
M1G&1^8JCJ7B:/3_$FB:5Y*21:I%<R_:?-PL0B56SC'(.[KD8QWHYF'L:?8F_
MX1G3_P#GI??^!TW_ ,71_P (SI__ #TOO_ Z;_XNL _$S2[BST^XT[R+S[5K
M*:7(B72[H0TDB+*=N>"(]P'&0>M=%%XFT&?39M2BUS39+"!@DMREW&8HV.,!
MG!P#R.OJ*.9A[&GV&?\ ",Z?_P ]+[_P.F_^+H_X1G3_ /GI??\ @=-_\76E
M-=6]LT*SSQ1-/)Y<0D<*9'P3M7/4X!.!V!HDN[:*ZAM9+B)+B8,T43. \@7&
MXJ.IQD9QTR*.9A[&GV,W_A&=/_YZ7W_@=-_\71_PC.G_ //2^_\  Z;_ .+J
M^VH6227,;7ENKVJ"2X4R#,*$$AG&?E! /)]#Z5FW7B?3?^$8U/6]+N[35(;"
M"65OLUPKJS(F_867(!QCZ9Z4<S#V-/L/_P"$9T__ )Z7W_@=-_\ %T?\(SI_
M_/2^_P# Z;_XNGZ+KUMK&G:;-OAAN[ZQCOA9^:&D5&"DG'!(!8#=C&:G&MZ4
M<XU.RXNOL9_?KQ/_ ,\NOW_]GK[4<S#V-/L5?^$9T_\ YZ7W_@=-_P#%T?\
M",Z?_P ]+[_P.F_^+J.X\7Z!#H%]K<6JV=U8V2%II+:XCD ('"9W8W'( !(R
M2/6DTKQ;I&I>%+7Q$]]:6UE+%&\KR7";('8#Y';. P+!2#WHYF'L:?8E_P"$
M9T__ )Z7W_@=-_\ %T?\(SI__/2^_P# Z;_XNM"VOK.]LDO;2[@GM74LL\4@
M9& ZD,."*@T_6]*U>"6?3=4LKV*(XDDMIUD5#C/)4G'%',P]C3[%;_A&=/\
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M_GI??^!TW_Q='_",Z?\ \]+[_P #IO\ XNMFBCF8>QI]C&_X1G3_ /GI??\
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MHT>2G^U_WT:DHK'V]3N=7U##?R(C\E/]K_OHT>2G^U_WT:DHH]O4[A]0P_\
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M_P ]+[_P.F_^+H_X1G3_ /GI??\ @=-_\76S11S,/8T^QC?\(SI__/2^_P#
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MVMZC=]*48HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^&CYC%?QI>H4445L8!1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MHH **** "BBB@ HHHH **** "BBB@ HHHH *1ONFEI&^Z:3!'R;J7_(4O/\
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MA;_CQF_ZZ'^0K>[5@^%O^/&;_KH?Y"M[M7M8?^&CYC%?QI>H4445L8!1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 8O_  EN@ _\A6U_[^"C_A+= _Z"MK_W\%;&Q?2DV+Z"JT,;5>Z,
M?_A+= _Z"MK_ -_!1_PEN@?]!6U_[^"MC:OH/RHV+Z"CW0M5[K[C'_X2W0/^
M@K:_]_!1_P );H'_ $%;7_OX*V-J^@HVKZ"CW0M5[K[C'_X2W0/^@K:_]_!1
M_P );H'_ $%;7_OX*V=B^@I-J^@HO$+5>Z^XQ_\ A+= _P"@K:_]_!1_PEN@
M?]!6U_[^"MC:OH/RHVKZ"CW0M5[K[C'_ .$MT#_H*VO_ '\%'_"6Z!_T%;7_
M +^"MG8OH*-B^@HO$+5>Z^XQO^$MT#_H*VO_ '\%'_"6Z!_T%;7_ +^"MG8O
MH*-B^@HO$+5>Z^XQO^$MT#_H*VO_ '\%'_"6Z!_T%;7_ +^"MG8OH*-B^@HO
M$+5>Z^XQO^$MT#_H*VO_ '\%'_"6Z!_T%;7_ +^"MG8OH*-B^@HO$+5>Z^XQ
MO^$MT#_H*VO_ '\%'_"6Z!_T%;7_ +^"MG8OH*-B^@HO$+5>Z^XQO^$MT#_H
M*VO_ '\%'_"6Z!_T%;7_ +^"MG8OH*-B^@HO$+5>Z^XQO^$MT#_H*VO_ '\%
M'_"6Z!_T%;7_ +^"MG8OH*-B^@HO$+5>Z^XQO^$MT#_H*VO_ '\%'_"6Z!_T
M%;7_ +^"MG8OH*-B^@HO$+5>Z^XQO^$MT#_H*VO_ '\%'_"6Z!_T%;7_ +^"
MMG8OH*-B^@HO$+5>Z^XQO^$MT#_H*VO_ '\%'_"6Z!_T%;7_ +^"MG8OH*-B
M^@HO$+5>Z^XQO^$MT#_H*VO_ '\%'_"6Z!_T%;7_ +^"MG8OH*-B^@HO$+5>
MZ^XQO^$MT#_H*VO_ '\%'_"6Z!_T%;7_ +^"MC8OH*-J^@HO$+5>Z^XQ_P#A
M+= _Z"MK_P!_!1_PEN@?]!6U_P"_@K8VKZ"C:OH*/="U7NON,?\ X2W0/^@K
M:_\ ?P4?\);H'_05M?\ OX*V-B^@HVKZ"B\0M5[K[C'_ .$MT#_H*VO_ '\%
M'_"6Z!_T%;7_ +^"MC:OH*-J^@HO$+5>Z^XQ_P#A+= _Z"MK_P!_!1_PEN@?
M]!6U_P"_@K9V+Z"C8OH*+Q"U7NON,;_A+= _Z"MK_P!_!1_PEN@?]!6U_P"_
M@K9V+Z"C8OH*+Q"U7NON,;_A+= _Z"MK_P!_!1_PEN@?]!6U_P"_@K9V+Z"C
M8OH*+Q"U7NON,;_A+= _Z"MK_P!_!1_PEN@?]!6U_P"_@K9V+Z"C8OH*+Q"U
M7NON,;_A+= _Z"MK_P!_!1_PEN@?]!6U_P"_@K8VKZ#\J78OH*/="U7NON,;
M_A+= _Z"MK_W\%'_  EN@?\ 05M?^_@K9V+Z"C8OH*+Q"U7NON,;_A+= _Z"
MMK_W\%'_  EN@?\ 05M?^_@K9V+Z"C8OH*+Q"U7NON,;_A+= _Z"MK_W\%'_
M  EN@?\ 05M?^_@K9V+Z"DVKZ"CW0M5[K[C'_P"$MT#_ *"MK_W\%'_"6Z!_
MT%;7_OX*V=B^@HV+Z"B\0M5[K[C&_P"$MT#_ *"MK_W\%'_"6Z!_T%;7_OX*
MV=B^@I-J^@H]T+5>Z^XQ_P#A+= _Z"MK_P!_!1_PEN@?]!6U_P"_@K8V+Z#\
MJ78OH*+Q"U7NON,;_A+= _Z"MK_W\%'_  EN@?\ 05M?^_@K9V+Z"C8OH*+Q
M"U7NON,;_A+= _Z"MK_W\%'_  EN@?\ 05M?^_@K9V+Z"C8OH*+Q"U7NON,;
M_A+= _Z"MK_W\%'_  EN@?\ 05M?^_@K9V+Z"C8OH*+Q"U7NON,^QUS3-3F,
M-E>PSR*NXJC9('3/ZUHT@4#L*6I=NAI%2M[P5'--';P233.$CC4NS'HH')-2
M4$9H&8O_  EN@?\ 05M?^_@H_P"$MT#_ *"MK_W\%;.Q?04;%]!57B96J]T8
MW_"6Z!_T%;7_ +^"C_A+= _Z"MK_ -_!6SL7T%&Q?047B%JO=?<8W_"6Z!_T
M%;7_ +^"C_A+= _Z"MK_ -_!6SL7T%&Q?047B%JO=?<84WB?PY<0203:C9R0
MR*4='8%64C!!!Z@BB#Q-X:M+>*WM]0LHH(D"1QQL%5% P  .  .U;NQ?04;%
M]!1>(6J]U]QC?\);H'_05M?^_@H_X2W0/^@K:_\ ?P5L[%]!1L7T%%XA:KW7
MW&-_PEN@?]!6U_[^"C_A+= _Z"MK_P!_!6SL7T%&Q?047B%JO=?<8W_"6Z!_
MT%;7_OX*/^$MT#_H*VO_ '\%;.Q?04;%]!1>(6J]U]QC?\);H'_05M?^_@H_
MX2W0/^@K:_\ ?P5L[%]!1L7T%%XA:KW7W&-_PEN@?]!6U_[^"C_A+= _Z"MK
M_P!_!6SL7T%&Q?047B%JO=?<8W_"6Z!_T%;7_OX*/^$MT#_H*VO_ '\%;.Q?
M04;%]!1>(6J]U]QC?\);H'_05M?^_@H_X2W0/^@K:_\ ?P5L[%]!1L7T%%XA
M:KW7W&-_PEN@?]!6U_[^"C_A+= _Z"MK_P!_!6SL7T%&Q?047B%JO=?<8W_"
M6Z!_T%;7_OX*/^$MT#_H*VO_ '\%;.Q?04;%]!1>(6J]U]QC?\);H'_05M?^
M_@H_X2W0/^@K:_\ ?P5L[%]!1L7T%%XA:KW7W&-_PEN@?]!6U_[^"C_A+= _
MZ"MK_P!_!6SL7T%&Q?047B%JO=?<8W_"6Z!_T%;7_OX*/^$MT#_H*VO_ '\%
M;.Q?04;%]!1>(6J]U]QC?\);H'_05M?^_@H/BW0""/[5M>?^F@K9V+Z"D*@
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MAP.N.V:IV_AGQCIEGXFTRSBTB6WUN_N[J*Z>[D5K59C_ !)Y9W$#!X(Y]N:
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MBB@ HHHH *.U%':FMQ/8[WQ?_P C-<?]<X?_ $4E8=;GB_\ Y&:X_P"N</\
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M^AF3_P  $_\ BJ.5=P]K+^5_@=)17-_V1XF_Z&9/_ !/_BJ/[(\3?]#,G_@
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M3_P 3_XJC^R/$W_0S)_X )_\55<J[F7M9?RO\#I**YO^R/$W_0S)_P" "?\
MQ5']D>)O^AF3_P  $_\ BJ.5=P]K+^5_@=)17-_V1XF_Z&9/_ !/_BJ/[(\3
M?]#,G_@ G_Q5'*NX>UE_*_P.DHKF_P"R/$W_ $,R?^ "?_%4?V1XF_Z&9/\
MP 3_ .*HY5W#VLOY7^!TE%<W_9'B;_H9D_\  !/_ (JC^R/$W_0S)_X )_\
M%4<J[A[67\K_  .DHKF_[(\3?]#,G_@ G_Q5']D>)O\ H9D_\ $_^*HY5W#V
MLOY7^!TE%<W_ &1XF_Z&9/\ P 3_ .*H_LCQ-_T,R?\ @ G_ ,51RKN'M9?R
MO\#I**YO^R/$W_0S)_X )_\ %4?V1XF_Z&9/_ !/_BJ.5=P]K+^5_@=)17-_
MV1XF_P"AF3_P 3_XJC^R/$W_ $,R?^ "?_%4<J[A[67\K_ Z2BN;_LCQ-_T,
MR?\ @ G_ ,51_9'B;_H9D_\  !/_ (JCE7</:R_E?X'245S?]D>)O^AF3_P
M3_XJC^R/$W_0S)_X )_\51RKN'M9?RO\#I**YO\ LCQ-_P!#,G_@ G_Q5']D
M>)O^AF3_ , $_P#BJ.5=P]K+^5_@=)17-_V1XF_Z&9/_   3_P"*H_LCQ-_T
M,R?^ "?_ !5'*NX>UE_*_P #I**YO^R/$W_0S)_X )_\51_9'B;_ *&9/_ !
M/_BJ.5=P]K+^5_@=)17-_P!D>)O^AF3_ , $_P#BJ/[(\3?]#,G_ ( )_P#%
M4<J[A[67\K_ Z2BN;_LCQ-_T,R?^ "?_ !5']D>)O^AF3_P 3_XJCE7</:R_
ME?X'24C?=/TKG/[(\3?]#,G_ ( +_P#%4?V1XE_Z&>/_ , $_P#BJ7*NX*K+
M^5_@?.&I?\A2\_Z[/_Z$:JU[1+\&8)IGE?5LL[%F/V<]3_P.F_\ "E+;_H+?
M^2Y_^+KS)8*;=[H]V.;P2MR/\/\ ,\9HKV;_ (4I;?\ 06_\ES_\71_PI2V_
MZ"W_ )+G_P"+I?49]T/^V(?R/\/\SQFBO9O^%*6W_06_\ES_ /%T?\*4MO\
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M ,!/_LZ/[)J]T'^L='^27X?YG$T5VW_"LI_^@X/_  $_^SH_X5E/_P!!P?\
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MW_9'B;_H9D_\ $_^*H_LCQ-_T,R?^ "?_%4<J[A[67\K_ Z2BN;_ +(\3?\
M0S)_X )_\51_9'B;_H9D_P# !/\ XJCE7</:R_E?X'245S?]D>)O^AF3_P
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<,]_K*W<14@1BU6/#9'.03[\>]%*WF4IO^5G_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>tmb-20211110xex99d1012.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tmb-20211110xex99d1012.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !K 1$# 2(  A$! Q$!_\0
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M?E0?9>@K550H 4  =A0!R%CX#TY+V&^O;:U\^)@Z1V\>Q%(Z'/4X]Z[ 444
M%%%% !1110 4444 %%,DD2)"\C!5'4L< 52&HM.^RT@>4?\ /0_*GY]Z -"J
M,VJV<191*)7'\$7SM^0J(Z?<73!KRY8IWAB^53]>YJW;V5O:+M@A2,=]HZT
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M"UC"01)&@[*,5G3:V'?RM.MWNY,XRO"+]6J)=,O[Z0OJ=X5B[6UO\H'U;J:
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
'!1110!__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
